{"parentUuid":null,"isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":"Tu traduis l'article FR \"pp405\" du blog Dr Emrah Cinik en ANGLAIS (UK) et en ITALIEN, via le skill cinik-translator, puis tu crées les Google Docs.\n\nSOURCE : /opt/automator/cinik-writer-transtor/files/articles/pp405.md (Read en entier ; il a un bloc SEO Slug/Title/Meta en tête, un H1, l'article, et une section Références APA).\n\nMÉTHODE (lis ces fichiers du skill traducteur d'abord) :\n- /home/dev/.claude/skills/cinik-translator/SKILL.md\n- /home/dev/.claude/skills/cinik-translator/prompts/improver-en.md et humanizer-en.md (pour l'EN)\n- /home/dev/.claude/skills/cinik-translator/prompts/improver-it.md (pour l'IT)\n- /home/dev/.claude/skills/cinik-translator/prompts/internal-linking-en.md et internal-linking-it.md\n- Règle hreflang : pour chaque lien interne FR (https://emrahcinik.com/fr/...), produis l'URL équivalente (/en/... pour l'anglais, /it/... pour l'italien). Tu peux utiliser le script hreflang_lookup.py si dispo, sinon mappe logiquement le slug. Si tu n'es pas sûr qu'une page existe dans la langue cible, garde l'ancre en texte mais retire le lien markdown (ne crée pas de lien cassé). Garde TOUJOURS au moins le lien vers la home (/en/ ancre \"hair transplant in Turkey\" ; /it/ ancre \"trapianto di capelli in Turchia\").\n\nCONSIGNES DE QUALITÉ (mêmes règles que le FR) :\n- Traduis FOND + bloc SEO (Title ≤60c finissant par \" | Dr Cinik\", Meta ≤155c, Slug traduit) + H1 + corps + Références (les références scientifiques restent en VO, ne les traduis pas, garde URLs).\n- ZÉRO em/en dash. Pas de citations \"(Auteur, année)\" dans le corps. PAS de tableau de liens en fin. Garde le gras, les listes, les données chiffrées EXACTES. Ne traduis pas les noms propres ni les unités.\n- Anglais = anglais BRITANNIQUE naturel, ton expert clinique. Italien = naturel, ton expert clinique.\n- IMPORTANT : pour l'EN, Londres/Harley Street est AUTORISÉ (c'est une langue étrangère) si pertinent ; pour l'IT aussi. Mais ne force pas.\n\nSORTIE FICHIERS :\n- Écris /opt/automator/cinik-writer-transtor/files/translations/pp405-en.md (1ère ligne du corps = bloc SEO EN, puis ---, puis # H1 EN, etc.)\n- Écris /opt/automator/cinik-writer-transtor/files/translations/pp405-it.md (idem en IT)\n\nPUBLICATION (crée 2 nouveaux Google Docs) — utilise le venv :\n  VPY=/home/dev/.claude/skills/cinik-blog-brief/.venv/bin/python\n  \"$VPY\" ~/.claude/skills/cinik-blog-brief/scripts/gdoc_publish.py --md <fichier-en.md> --title \"EN | <H1 anglais>\"\n  \"$VPY\" ~/.claude/skills/cinik-blog-brief/scripts/gdoc_publish.py --md <fichier-it.md> --title \"IT | <H1 italien>\"\nRécupère l'URL sur la dernière ligne (URL=...) de chaque appel.\n\nRÉPONSE FINALE (courte, je dois pouvoir parser) :\nEN_URL=<url>\nIT_URL=<url>\nEN_TITLE=<title> (EN_chars)\nIT_TITLE=<title> (IT_chars)\n+ confirmations zéro dash / pas de tableau liens."},"uuid":"22ad638b-331a-44ae-965b-b88d18f13435","timestamp":"2026-06-01T10:21:57.146Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"22ad638b-331a-44ae-965b-b88d18f13435","isSidechain":true,"agentId":"a2a840c5cfdbcf739","attachment":{"type":"deferred_tools_delta","addedNames":["EnterWorktree","ExitWorktree","Monitor","NotebookEdit","TaskStop","WebFetch","WebSearch","mcp__EstimanouContent__add_article_block","mcp__EstimanouContent__add_block","mcp__EstimanouContent__create_article","mcp__EstimanouContent__create_page","mcp__EstimanouContent__delete_article","mcp__EstimanouContent__delete_article_block","mcp__EstimanouContent__delete_block","mcp__EstimanouContent__get_article","mcp__EstimanouContent__get_city_page","mcp__EstimanouContent__get_page","mcp__EstimanouContent__list_articles","mcp__EstimanouContent__list_available_blocks","mcp__EstimanouContent__list_city_pages","mcp__EstimanouContent__list_pages","mcp__EstimanouContent__list_site_urls","mcp__EstimanouContent__reorder_article_blocks","mcp__EstimanouContent__reorder_blocks","mcp__EstimanouContent__replace_article_content","mcp__EstimanouContent__replace_city_seo_content","mcp__EstimanouContent__replace_page_layout","mcp__EstimanouContent__search_internal_links","mcp__EstimanouContent__update_article","mcp__EstimanouContent__update_article_block","mcp__EstimanouContent__update_block","mcp__EstimanouContent__update_city_page_content","mcp__claude_ai_Ahref__batch-analysis","mcp__claude_ai_Ahref__brand-radar-ai-responses","mcp__claude_ai_Ahref__brand-radar-ai-responses-entities","mcp__claude_ai_Ahref__brand-radar-cited-domains","mcp__claude_ai_Ahref__brand-radar-cited-domains-entities","mcp__claude_ai_Ahref__brand-radar-cited-pages","mcp__claude_ai_Ahref__brand-radar-cited-pages-entities","mcp__claude_ai_Ahref__brand-radar-impressions-history","mcp__claude_ai_Ahref__brand-radar-impressions-history-entities","mcp__claude_ai_Ahref__brand-radar-impressions-overview","mcp__claude_ai_Ahref__brand-radar-impressions-overview-entities","mcp__claude_ai_Ahref__brand-radar-mentions-history","mcp__claude_ai_Ahref__brand-radar-mentions-history-entities","mcp__claude_ai_Ahref__brand-radar-mentions-overview","mcp__claude_ai_Ahref__brand-radar-mentions-overview-entities","mcp__claude_ai_Ahref__brand-radar-sov-history","mcp__claude_ai_Ahref__brand-radar-sov-history-entities","mcp__claude_ai_Ahref__brand-radar-sov-overview","mcp__claude_ai_Ahref__brand-radar-sov-overview-entities","mcp__claude_ai_Ahref__doc","mcp__claude_ai_Ahref__gsc-anonymous-queries","mcp__claude_ai_Ahref__gsc-ctr-by-position","mcp__claude_ai_Ahref__gsc-keyword-history","mcp__claude_ai_Ahref__gsc-keywords","mcp__claude_ai_Ahref__gsc-metrics-by-country","mcp__claude_ai_Ahref__gsc-page-history","mcp__claude_ai_Ahref__gsc-pages","mcp__claude_ai_Ahref__gsc-pages-history","mcp__claude_ai_Ahref__gsc-performance-by-device","mcp__claude_ai_Ahref__gsc-performance-by-position","mcp__claude_ai_Ahref__gsc-performance-history","mcp__claude_ai_Ahref__gsc-positions-history","mcp__claude_ai_Ahref__keywords-explorer-matching-terms","mcp__claude_ai_Ahref__keywords-explorer-overview","mcp__claude_ai_Ahref__keywords-explorer-related-terms","mcp__claude_ai_Ahref__keywords-explorer-search-suggestions","mcp__claude_ai_Ahref__keywords-explorer-volume-by-country","mcp__claude_ai_Ahref__keywords-explorer-volume-history","mcp__claude_ai_Ahref__management-brand-radar-prompts","mcp__claude_ai_Ahref__management-brand-radar-reports","mcp__claude_ai_Ahref__management-keyword-list-keywords","mcp__claude_ai_Ahref__management-locations","mcp__claude_ai_Ahref__management-project-competitors","mcp__claude_ai_Ahref__management-project-keywords","mcp__claude_ai_Ahref__management-projects","mcp__claude_ai_Ahref__public-crawler-ip-ranges","mcp__claude_ai_Ahref__public-crawler-ips","mcp__claude_ai_Ahref__rank-tracker-competitors-domains","mcp__claude_ai_Ahref__rank-tracker-competitors-overview","mcp__claude_ai_Ahref__rank-tracker-competitors-pages","mcp__claude_ai_Ahref__rank-tracker-competitors-stats","mcp__claude_ai_Ahref__rank-tracker-overview","mcp__claude_ai_Ahref__rank-tracker-serp-overview","mcp__claude_ai_Ahref__render-data-table","mcp__claude_ai_Ahref__render-scorecard","mcp__claude_ai_Ahref__render-time-series-chart","mcp__claude_ai_Ahref__serp-overview","mcp__claude_ai_Ahref__site-audit-issues","mcp__claude_ai_Ahref__site-audit-page-content","mcp__claude_ai_Ahref__site-audit-page-explorer","mcp__claude_ai_Ahref__site-audit-projects","mcp__claude_ai_Ahref__site-explorer-all-backlinks","mcp__claude_ai_Ahref__site-explorer-anchors","mcp__claude_ai_Ahref__site-explorer-backlinks-stats","mcp__claude_ai_Ahref__site-explorer-broken-backlinks","mcp__claude_ai_Ahref__site-explorer-crawled-pages","mcp__claude_ai_Ahref__site-explorer-domain-rating","mcp__claude_ai_Ahref__site-explorer-domain-rating-history","mcp__claude_ai_Ahref__site-explorer-keywords-history","mcp__claude_ai_Ahref__site-explorer-linked-anchors-external","mcp__claude_ai_Ahref__site-explorer-linked-anchors-internal","mcp__claude_ai_Ahref__site-explorer-linked-domains","mcp__claude_ai_Ahref__site-explorer-metrics","mcp__claude_ai_Ahref__site-explorer-metrics-by-country","mcp__claude_ai_Ahref__site-explorer-metrics-history","mcp__claude_ai_Ahref__site-explorer-organic-competitors","mcp__claude_ai_Ahref__site-explorer-organic-keywords","mcp__claude_ai_Ahref__site-explorer-outlinks-stats","mcp__claude_ai_Ahref__site-explorer-pages-by-backlinks","mcp__claude_ai_Ahref__site-explorer-pages-by-internal-links","mcp__claude_ai_Ahref__site-explorer-pages-by-traffic","mcp__claude_ai_Ahref__site-explorer-pages-history","mcp__claude_ai_Ahref__site-explorer-paid-pages","mcp__claude_ai_Ahref__site-explorer-refdomains-history","mcp__claude_ai_Ahref__site-explorer-referring-domains","mcp__claude_ai_Ahref__site-explorer-top-pages","mcp__claude_ai_Ahref__site-explorer-total-search-volume-history","mcp__claude_ai_Ahref__site-explorer-url-rating-history","mcp__claude_ai_Ahref__social-media-activity-history","mcp__claude_ai_Ahref__social-media-authors","mcp__claude_ai_Ahref__social-media-channel-metrics","mcp__claude_ai_Ahref__social-media-channels","mcp__claude_ai_Ahref__social-media-post-metrics","mcp__claude_ai_Ahref__social-media-posts","mcp__claude_ai_Ahref__subscription-info-limits-and-usage","mcp__claude_ai_Ahref__web-analytics-browser-versions","mcp__claude_ai_Ahref__web-analytics-browser-versions-chart","mcp__claude_ai_Ahref__web-analytics-browsers","mcp__claude_ai_Ahref__web-analytics-browsers-chart","mcp__claude_ai_Ahref__web-analytics-chart","mcp__claude_ai_Ahref__web-analytics-cities","mcp__claude_ai_Ahref__web-analytics-cities-chart","mcp__claude_ai_Ahref__web-analytics-continents","mcp__claude_ai_Ahref__web-analytics-continents-chart","mcp__claude_ai_Ahref__web-analytics-countries","mcp__claude_ai_Ahref__web-analytics-countries-chart","mcp__claude_ai_Ahref__web-analytics-devices","mcp__claude_ai_Ahref__web-analytics-devices-chart","mcp__claude_ai_Ahref__web-analytics-entry-pages","mcp__claude_ai_Ahref__web-analytics-entry-pages-chart","mcp__claude_ai_Ahref__web-analytics-exit-pages","mcp__claude_ai_Ahref__web-analytics-exit-pages-chart","mcp__claude_ai_Ahref__web-analytics-languages","mcp__claude_ai_Ahref__web-analytics-languages-chart","mcp__claude_ai_Ahref__web-analytics-operating-systems","mcp__claude_ai_Ahref__web-analytics-operating-systems-chart","mcp__claude_ai_Ahref__web-analytics-operating-systems-versions","mcp__claude_ai_Ahref__web-analytics-operating-systems-versions-chart","mcp__claude_ai_Ahref__web-analytics-referrers","mcp__claude_ai_Ahref__web-analytics-referrers-chart","mcp__claude_ai_Ahref__web-analytics-source-channels","mcp__claude_ai_Ahref__web-analytics-source-channels-chart","mcp__claude_ai_Ahref__web-analytics-sources","mcp__claude_ai_Ahref__web-analytics-sources-chart","mcp__claude_ai_Ahref__web-analytics-stats","mcp__claude_ai_Ahref__web-analytics-top-pages","mcp__claude_ai_Ahref__web-analytics-top-pages-chart","mcp__claude_ai_Ahref__web-analytics-utm-params","mcp__claude_ai_Ahref__web-analytics-utm-params-chart","mcp__claude_ai_Canva__cancel-editing-transaction","mcp__claude_ai_Canva__comment-on-design","mcp__claude_ai_Canva__commit-editing-transaction","mcp__claude_ai_Canva__copy-design","mcp__claude_ai_Canva__create-design-from-brand-template","mcp__claude_ai_Canva__create-design-from-candidate","mcp__claude_ai_Canva__create-folder","mcp__claude_ai_Canva__export-design","mcp__claude_ai_Canva__generate-design","mcp__claude_ai_Canva__generate-design-structured","mcp__claude_ai_Canva__get-assets","mcp__claude_ai_Canva__get-brand-template-dataset","mcp__claude_ai_Canva__get-design","mcp__claude_ai_Canva__get-design-content","mcp__claude_ai_Canva__get-design-pages","mcp__claude_ai_Canva__get-design-thumbnail","mcp__claude_ai_Canva__get-export-formats","mcp__claude_ai_Canva__get-presenter-notes","mcp__claude_ai_Canva__help","mcp__claude_ai_Canva__import-design-from-url","mcp__claude_ai_Canva__list-brand-kits","mcp__claude_ai_Canva__list-comments","mcp__claude_ai_Canva__list-folder-items","mcp__claude_ai_Canva__list-replies","mcp__claude_ai_Canva__merge-designs","mcp__claude_ai_Canva__move-item-to-folder","mcp__claude_ai_Canva__perform-editing-operations","mcp__claude_ai_Canva__publish-brand-template","mcp__claude_ai_Canva__reply-to-comment","mcp__claude_ai_Canva__request-outline-review","mcp__claude_ai_Canva__resize-design","mcp__claude_ai_Canva__resolve-shortlink","mcp__claude_ai_Canva__search-brand-templates","mcp__claude_ai_Canva__search-designs","mcp__claude_ai_Canva__search-folders","mcp__claude_ai_Canva__start-editing-transaction","mcp__claude_ai_Canva__upload-asset-from-url","mcp__claude_ai_DATA_GOUV_FR__get_dataservice_info","mcp__claude_ai_DATA_GOUV_FR__get_dataservice_openapi_spec","mcp__claude_ai_DATA_GOUV_FR__get_dataset_info","mcp__claude_ai_DATA_GOUV_FR__get_metrics","mcp__claude_ai_DATA_GOUV_FR__get_resource_info","mcp__claude_ai_DATA_GOUV_FR__list_dataset_resources","mcp__claude_ai_DATA_GOUV_FR__query_resource_data","mcp__claude_ai_DATA_GOUV_FR__search_dataservices","mcp__claude_ai_DATA_GOUV_FR__search_datasets","mcp__claude_ai_DATA_GOUV_FR__search_organizations","mcp__claude_ai_Data_For_SEO__authenticate","mcp__claude_ai_Data_For_SEO__complete_authentication","mcp__claude_ai_Esteworld-Body__add_block","mcp__claude_ai_Esteworld-Body__delete_block","mcp__claude_ai_Esteworld-Body__find_esteworld_page","mcp__claude_ai_Esteworld-Body__fix_global_blocks","mcp__claude_ai_Esteworld-Body__get_block","mcp__claude_ai_Esteworld-Body__get_blocks_library","mcp__claude_ai_Esteworld-Body__get_breadcrumb","mcp__claude_ai_Esteworld-Body__get_fr_en_mapping","mcp__claude_ai_Esteworld-Body__get_internal_links","mcp__claude_ai_Esteworld-Body__get_internal_links_en","mcp__claude_ai_Esteworld-Body__get_maillage_rules","mcp__claude_ai_Esteworld-Body__get_page","mcp__claude_ai_Esteworld-Body__get_page_json","mcp__claude_ai_Esteworld-Body__get_page_status","mcp__claude_ai_Esteworld-Body__get_redirections","mcp__claude_ai_Esteworld-Body__get_section_content","mcp__claude_ai_Esteworld-Body__get_thematique_pages","mcp__claude_ai_Esteworld-Body__get_translation_languages","mcp__claude_ai_Esteworld-Body__list_pages","mcp__claude_ai_Esteworld-Body__list_pages_by_thematique","mcp__claude_ai_Esteworld-Body__list_pages_by_type","mcp__claude_ai_Esteworld-Body__list_pages_to_create","mcp__claude_ai_Esteworld-Body__list_pages_to_rewrite","mcp__claude_ai_Esteworld-Body__list_pages_with_esteworld","mcp__claude_ai_Esteworld-Body__list_pages_without_esteworld","mcp__claude_ai_Esteworld-Body__n8n_activate_workflow","mcp__claude_ai_Esteworld-Body__n8n_get_executions","mcp__claude_ai_Esteworld-Body__n8n_get_workflow","mcp__claude_ai_Esteworld-Body__n8n_list_workflows","mcp__claude_ai_Esteworld-Body__n8n_trigger_webhook","mcp__claude_ai_Esteworld-Body__preview_global_fixes","mcp__claude_ai_Esteworld-Body__reorder_blocks","mcp__claude_ai_Esteworld-Body__search_content","mcp__claude_ai_Esteworld-Body__search_links_by_keyword","mcp__claude_ai_Esteworld-Body__search_links_by_keyword_en","mcp__claude_ai_Esteworld-Body__submit_page","mcp__claude_ai_Esteworld-Body__submit_page_light","mcp__claude_ai_Esteworld-Body__translate_page","mcp__claude_ai_Esteworld-Body__update_block","mcp__claude_ai_Figma__add_code_connect_map","mcp__claude_ai_Figma__create_new_file","mcp__claude_ai_Figma__generate_diagram","mcp__claude_ai_Figma__get_code_connect_map","mcp__claude_ai_Figma__get_code_connect_suggestions","mcp__claude_ai_Figma__get_context_for_code_connect","mcp__claude_ai_Figma__get_design_context","mcp__claude_ai_Figma__get_figjam","mcp__claude_ai_Figma__get_libraries","mcp__claude_ai_Figma__get_metadata","mcp__claude_ai_Figma__get_screenshot","mcp__claude_ai_Figma__get_variable_defs","mcp__claude_ai_Figma__search_design_system","mcp__claude_ai_Figma__send_code_connect_mappings","mcp__claude_ai_Figma__upload_assets","mcp__claude_ai_Figma__use_figma","mcp__claude_ai_Figma__whoami","mcp__claude_ai_Gmail__create_draft","mcp__claude_ai_Gmail__create_label","mcp__claude_ai_Gmail__delete_label","mcp__claude_ai_Gmail__get_thread","mcp__claude_ai_Gmail__label_message","mcp__claude_ai_Gmail__label_thread","mcp__claude_ai_Gmail__list_drafts","mcp__claude_ai_Gmail__list_labels","mcp__claude_ai_Gmail__search_threads","mcp__claude_ai_Gmail__unlabel_message","mcp__claude_ai_Gmail__unlabel_thread","mcp__claude_ai_Gmail__update_label","mcp__claude_ai_Google_Calendar__create_event","mcp__claude_ai_Google_Calendar__delete_event","mcp__claude_ai_Google_Calendar__get_event","mcp__claude_ai_Google_Calendar__list_calendars","mcp__claude_ai_Google_Calendar__list_events","mcp__claude_ai_Google_Calendar__respond_to_event","mcp__claude_ai_Google_Calendar__suggest_time","mcp__claude_ai_Google_Calendar__update_event","mcp__claude_ai_Google_Drive__copy_file","mcp__claude_ai_Google_Drive__create_file","mcp__claude_ai_Google_Drive__download_file_content","mcp__claude_ai_Google_Drive__get_file_metadata","mcp__claude_ai_Google_Drive__get_file_permissions","mcp__claude_ai_Google_Drive__list_recent_files","mcp__claude_ai_Google_Drive__read_file_content","mcp__claude_ai_Google_Drive__search_files","mcp__claude_ai_SEMRush__backlink_research","mcp__claude_ai_SEMRush__execute_report","mcp__claude_ai_SEMRush__get_report_schema","mcp__claude_ai_SEMRush__keyword_research","mcp__claude_ai_SEMRush__organic_research","mcp__claude_ai_SEMRush__overview_research","mcp__claude_ai_SEMRush__projects_research","mcp__claude_ai_SEMRush__siteaudit_research","mcp__claude_ai_SEMRush__subdomain_research","mcp__claude_ai_SEMRush__subfolder_research","mcp__claude_ai_SEMRush__tracking_research","mcp__claude_ai_SEMRush__trends_research","mcp__claude_ai_SEMRush__url_research","mcp__claude_ai_Vercel__add_toolbar_reaction","mcp__claude_ai_Vercel__change_toolbar_thread_resolve_status","mcp__claude_ai_Vercel__check_domain_availability_and_price","mcp__claude_ai_Vercel__deploy_to_vercel","mcp__claude_ai_Vercel__edit_toolbar_message","mcp__claude_ai_Vercel__get_access_to_vercel_url","mcp__claude_ai_Vercel__get_deployment","mcp__claude_ai_Vercel__get_deployment_build_logs","mcp__claude_ai_Vercel__get_project","mcp__claude_ai_Vercel__get_runtime_logs","mcp__claude_ai_Vercel__get_toolbar_thread","mcp__claude_ai_Vercel__list_deployments","mcp__claude_ai_Vercel__list_projects","mcp__claude_ai_Vercel__list_teams","mcp__claude_ai_Vercel__list_toolbar_threads","mcp__claude_ai_Vercel__reply_to_toolbar_thread","mcp__claude_ai_Vercel__search_vercel_documentation","mcp__claude_ai_Vercel__web_fetch_vercel_url","mcp__gpt-image-2__continue_edit_session","mcp__gpt-image-2__edit_image","mcp__gpt-image-2__end_edit_session","mcp__gpt-image-2__generate_image","mcp__gpt-image-2__list_edit_sessions","mcp__gpt-image-2__start_edit_session","mcp__hostinger__DNS_deleteDNSRecordsV1","mcp__hostinger__DNS_getDNSRecordsV1","mcp__hostinger__DNS_getDNSSnapshotListV1","mcp__hostinger__DNS_getDNSSnapshotV1","mcp__hostinger__DNS_resetDNSRecordsV1","mcp__hostinger__DNS_restoreDNSSnapshotV1","mcp__hostinger__DNS_updateDNSRecordsV1","mcp__hostinger__DNS_validateDNSRecordsV1","mcp__hostinger__VPS_activateFirewallV1","mcp__hostinger__VPS_attachPublicKeyV1","mcp__hostinger__VPS_createFirewallRuleV1","mcp__hostinger__VPS_createNewFirewallV1","mcp__hostinger__VPS_createNewProjectV1","mcp__hostinger__VPS_createPTRRecordV1","mcp__hostinger__VPS_createPostInstallScriptV1","mcp__hostinger__VPS_createPublicKeyV1","mcp__hostinger__VPS_createSnapshotV1","mcp__hostinger__VPS_deactivateFirewallV1","mcp__hostinger__VPS_deleteFirewallRuleV1","mcp__hostinger__VPS_deleteFirewallV1","mcp__hostinger__VPS_deletePTRRecordV1","mcp__hostinger__VPS_deletePostInstallScriptV1","mcp__hostinger__VPS_deleteProjectV1","mcp__hostinger__VPS_deletePublicKeyV1","mcp__hostinger__VPS_deleteSnapshotV1","mcp__hostinger__VPS_getActionDetailsV1","mcp__hostinger__VPS_getActionsV1","mcp__hostinger__VPS_getAttachedPublicKeysV1","mcp__hostinger__VPS_getBackupsV1","mcp__hostinger__VPS_getDataCenterListV1","mcp__hostinger__VPS_getFirewallDetailsV1","mcp__hostinger__VPS_getFirewallListV1","mcp__hostinger__VPS_getMetricsV1","mcp__hostinger__VPS_getPostInstallScriptV1","mcp__hostinger__VPS_getPostInstallScriptsV1","mcp__hostinger__VPS_getProjectContainersV1","mcp__hostinger__VPS_getProjectContentsV1","mcp__hostinger__VPS_getProjectListV1","mcp__hostinger__VPS_getProjectLogsV1","mcp__hostinger__VPS_getPublicKeysV1","mcp__hostinger__VPS_getScanMetricsV1","mcp__hostinger__VPS_getSnapshotV1","mcp__hostinger__VPS_getTemplateDetailsV1","mcp__hostinger__VPS_getTemplatesV1","mcp__hostinger__VPS_getVirtualMachineDetailsV1","mcp__hostinger__VPS_getVirtualMachinesV1","mcp__hostinger__VPS_installMonarxV1","mcp__hostinger__VPS_purchaseNewVirtualMachineV1","mcp__hostinger__VPS_recreateVirtualMachineV1","mcp__hostinger__VPS_resetHostnameV1","mcp__hostinger__VPS_restartProjectV1","mcp__hostinger__VPS_restartVirtualMachineV1","mcp__hostinger__VPS_restoreBackupV1","mcp__hostinger__VPS_restoreSnapshotV1","mcp__hostinger__VPS_setHostnameV1","mcp__hostinger__VPS_setNameserversV1","mcp__hostinger__VPS_setPanelPasswordV1","mcp__hostinger__VPS_setRootPasswordV1","mcp__hostinger__VPS_setupPurchasedVirtualMachineV1","mcp__hostinger__VPS_startProjectV1","mcp__hostinger__VPS_startRecoveryModeV1","mcp__hostinger__VPS_startVirtualMachineV1","mcp__hostinger__VPS_stopProjectV1","mcp__hostinger__VPS_stopRecoveryModeV1","mcp__hostinger__VPS_stopVirtualMachineV1","mcp__hostinger__VPS_syncFirewallV1","mcp__hostinger__VPS_uninstallMonarxV1","mcp__hostinger__VPS_updateFirewallRuleV1","mcp__hostinger__VPS_updatePostInstallScriptV1","mcp__hostinger__VPS_updateProjectV1","mcp__hostinger__billing_deletePaymentMethodV1","mcp__hostinger__billing_disableAutoRenewalV1","mcp__hostinger__billing_enableAutoRenewalV1","mcp__hostinger__billing_getCatalogItemListV1","mcp__hostinger__billing_getPaymentMethodListV1","mcp__hostinger__billing_getSubscriptionListV1","mcp__hostinger__billing_setDefaultPaymentMethodV1","mcp__hostinger__domains_checkDomainAvailabilityV1","mcp__hostinger__domains_createDomainForwardingV1","mcp__hostinger__domains_createWHOISProfileV1","mcp__hostinger__domains_deleteDomainForwardingV1","mcp__hostinger__domains_deleteWHOISProfileV1","mcp__hostinger__domains_disableDomainLockV1","mcp__hostinger__domains_disablePrivacyProtectionV1","mcp__hostinger__domains_enableDomainLockV1","mcp__hostinger__domains_enablePrivacyProtectionV1","mcp__hostinger__domains_getDomainDetailsV1","mcp__hostinger__domains_getDomainForwardingV1","mcp__hostinger__domains_getDomainListV1","mcp__hostinger__domains_getWHOISProfileListV1","mcp__hostinger__domains_getWHOISProfileUsageV1","mcp__hostinger__domains_getWHOISProfileV1","mcp__hostinger__domains_purchaseNewDomainV1","mcp__hostinger__domains_updateDomainNameserversV1","mcp__hostinger__hosting_createWebsiteV1","mcp__hostinger__hosting_deployJsApplication","mcp__hostinger__hosting_deployStaticWebsite","mcp__hostinger__hosting_deployWordpressPlugin","mcp__hostinger__hosting_deployWordpressTheme","mcp__hostinger__hosting_generateAFreeSubdomainV1","mcp__hostinger__hosting_importWordpressWebsite","mcp__hostinger__hosting_listAvailableDatacentersV1","mcp__hostinger__hosting_listJsDeployments","mcp__hostinger__hosting_listOrdersV1","mcp__hostinger__hosting_listWebsitesV1","mcp__hostinger__hosting_showJsDeploymentLogs","mcp__hostinger__hosting_verifyDomainOwnershipV1","mcp__hostinger__reach_createANewContactSegmentV1","mcp__hostinger__reach_createANewContactV1","mcp__hostinger__reach_createNewContactsV1","mcp__hostinger__reach_deleteAContactV1","mcp__hostinger__reach_getSegmentDetailsV1","mcp__hostinger__reach_listContactGroupsV1","mcp__hostinger__reach_listContactsV1","mcp__hostinger__reach_listProfilesV1","mcp__hostinger__reach_listSegmentContactsV1","mcp__hostinger__reach_listSegmentsV1","mcp__hostinger__v2_getDomainVerificationsDIRECT","mcp__nanobanana__generate_image","mcp__nanobanana__maintenance","mcp__nanobanana__show_output_stats","mcp__nanobanana__upload_file","mcp__plugin_vercel_vercel__authenticate","mcp__plugin_vercel_vercel__complete_authentication","mcp__refero__refero_get_flow","mcp__refero__refero_get_screen","mcp__refero__refero_get_screen_image","mcp__refero__refero_get_similar_screens","mcp__refero__refero_get_style","mcp__refero__refero_search_flows","mcp__refero__refero_search_screens","mcp__refero__refero_search_styles","mcp__semrush__authenticate","mcp__semrush__complete_authentication","mcp__stock-images-mcp__search_stock_images","mcp__trello__add_card_to_list","mcp__trello__add_checklist_item","mcp__trello__add_comment","mcp__trello__add_list_to_board","mcp__trello__archive_card","mcp__trello__archive_list","mcp__trello__assign_member_to_card","mcp__trello__attach_file_to_card","mcp__trello__attach_image_data_to_card","mcp__trello__attach_image_to_card","mcp__trello__create_board","mcp__trello__create_checklist","mcp__trello__create_label","mcp__trello__delete_comment","mcp__trello__delete_label","mcp__trello__find_checklist_items_by_description","mcp__trello__get_acceptance_criteria","mcp__trello__get_active_board_info","mcp__trello__get_board_labels","mcp__trello__get_board_members","mcp__trello__get_card","mcp__trello__get_card_comments","mcp__trello__get_card_history","mcp__trello__get_cards_by_list_id","mcp__trello__get_checklist_by_name","mcp__trello__get_checklist_items","mcp__trello__get_health","mcp__trello__get_health_detailed","mcp__trello__get_health_metadata","mcp__trello__get_health_performance","mcp__trello__get_lists","mcp__trello__get_my_cards","mcp__trello__get_recent_activity","mcp__trello__list_boards","mcp__trello__list_boards_in_workspace","mcp__trello__list_workspaces","mcp__trello__move_card","mcp__trello__perform_system_repair","mcp__trello__remove_member_from_card","mcp__trello__set_active_board","mcp__trello__set_active_workspace","mcp__trello__update_card_details","mcp__trello__update_checklist_item","mcp__trello__update_comment","mcp__trello__update_label"],"addedLines":["EnterWorktree","ExitWorktree","Monitor","NotebookEdit","TaskStop","WebFetch","WebSearch","mcp__EstimanouContent__add_article_block","mcp__EstimanouContent__add_block","mcp__EstimanouContent__create_article","mcp__EstimanouContent__create_page","mcp__EstimanouContent__delete_article","mcp__EstimanouContent__delete_article_block","mcp__EstimanouContent__delete_block","mcp__EstimanouContent__get_article","mcp__EstimanouContent__get_city_page","mcp__EstimanouContent__get_page","mcp__EstimanouContent__list_articles","mcp__EstimanouContent__list_available_blocks","mcp__EstimanouContent__list_city_pages","mcp__EstimanouContent__list_pages","mcp__EstimanouContent__list_site_urls","mcp__EstimanouContent__reorder_article_blocks","mcp__EstimanouContent__reorder_blocks","mcp__EstimanouContent__replace_article_content","mcp__EstimanouContent__replace_city_seo_content","mcp__EstimanouContent__replace_page_layout","mcp__EstimanouContent__search_internal_links","mcp__EstimanouContent__update_article","mcp__EstimanouContent__update_article_block","mcp__EstimanouContent__update_block","mcp__EstimanouContent__update_city_page_content","mcp__claude_ai_Ahref__batch-analysis","mcp__claude_ai_Ahref__brand-radar-ai-responses","mcp__claude_ai_Ahref__brand-radar-ai-responses-entities","mcp__claude_ai_Ahref__brand-radar-cited-domains","mcp__claude_ai_Ahref__brand-radar-cited-domains-entities","mcp__claude_ai_Ahref__brand-radar-cited-pages","mcp__claude_ai_Ahref__brand-radar-cited-pages-entities","mcp__claude_ai_Ahref__brand-radar-impressions-history","mcp__claude_ai_Ahref__brand-radar-impressions-history-entities","mcp__claude_ai_Ahref__brand-radar-impressions-overview","mcp__claude_ai_Ahref__brand-radar-impressions-overview-entities","mcp__claude_ai_Ahref__brand-radar-mentions-history","mcp__claude_ai_Ahref__brand-radar-mentions-history-entities","mcp__claude_ai_Ahref__brand-radar-mentions-overview","mcp__claude_ai_Ahref__brand-radar-mentions-overview-entities","mcp__claude_ai_Ahref__brand-radar-sov-history","mcp__claude_ai_Ahref__brand-radar-sov-history-entities","mcp__claude_ai_Ahref__brand-radar-sov-overview","mcp__claude_ai_Ahref__brand-radar-sov-overview-entities","mcp__claude_ai_Ahref__doc","mcp__claude_ai_Ahref__gsc-anonymous-queries","mcp__claude_ai_Ahref__gsc-ctr-by-position","mcp__claude_ai_Ahref__gsc-keyword-history","mcp__claude_ai_Ahref__gsc-keywords","mcp__claude_ai_Ahref__gsc-metrics-by-country","mcp__claude_ai_Ahref__gsc-page-history","mcp__claude_ai_Ahref__gsc-pages","mcp__claude_ai_Ahref__gsc-pages-history","mcp__claude_ai_Ahref__gsc-performance-by-device","mcp__claude_ai_Ahref__gsc-performance-by-position","mcp__claude_ai_Ahref__gsc-performance-history","mcp__claude_ai_Ahref__gsc-positions-history","mcp__claude_ai_Ahref__keywords-explorer-matching-terms","mcp__claude_ai_Ahref__keywords-explorer-overview","mcp__claude_ai_Ahref__keywords-explorer-related-terms","mcp__claude_ai_Ahref__keywords-explorer-search-suggestions","mcp__claude_ai_Ahref__keywords-explorer-volume-by-country","mcp__claude_ai_Ahref__keywords-explorer-volume-history","mcp__claude_ai_Ahref__management-brand-radar-prompts","mcp__claude_ai_Ahref__management-brand-radar-reports","mcp__claude_ai_Ahref__management-keyword-list-keywords","mcp__claude_ai_Ahref__management-locations","mcp__claude_ai_Ahref__management-project-competitors","mcp__claude_ai_Ahref__management-project-keywords","mcp__claude_ai_Ahref__management-projects","mcp__claude_ai_Ahref__public-crawler-ip-ranges","mcp__claude_ai_Ahref__public-crawler-ips","mcp__claude_ai_Ahref__rank-tracker-competitors-domains","mcp__claude_ai_Ahref__rank-tracker-competitors-overview","mcp__claude_ai_Ahref__rank-tracker-competitors-pages","mcp__claude_ai_Ahref__rank-tracker-competitors-stats","mcp__claude_ai_Ahref__rank-tracker-overview","mcp__claude_ai_Ahref__rank-tracker-serp-overview","mcp__claude_ai_Ahref__render-data-table","mcp__claude_ai_Ahref__render-scorecard","mcp__claude_ai_Ahref__render-time-series-chart","mcp__claude_ai_Ahref__serp-overview","mcp__claude_ai_Ahref__site-audit-issues","mcp__claude_ai_Ahref__site-audit-page-content","mcp__claude_ai_Ahref__site-audit-page-explorer","mcp__claude_ai_Ahref__site-audit-projects","mcp__claude_ai_Ahref__site-explorer-all-backlinks","mcp__claude_ai_Ahref__site-explorer-anchors","mcp__claude_ai_Ahref__site-explorer-backlinks-stats","mcp__claude_ai_Ahref__site-explorer-broken-backlinks","mcp__claude_ai_Ahref__site-explorer-crawled-pages","mcp__claude_ai_Ahref__site-explorer-domain-rating","mcp__claude_ai_Ahref__site-explorer-domain-rating-history","mcp__claude_ai_Ahref__site-explorer-keywords-history","mcp__claude_ai_Ahref__site-explorer-linked-anchors-external","mcp__claude_ai_Ahref__site-explorer-linked-anchors-internal","mcp__claude_ai_Ahref__site-explorer-linked-domains","mcp__claude_ai_Ahref__site-explorer-metrics","mcp__claude_ai_Ahref__site-explorer-metrics-by-country","mcp__claude_ai_Ahref__site-explorer-metrics-history","mcp__claude_ai_Ahref__site-explorer-organic-competitors","mcp__claude_ai_Ahref__site-explorer-organic-keywords","mcp__claude_ai_Ahref__site-explorer-outlinks-stats","mcp__claude_ai_Ahref__site-explorer-pages-by-backlinks","mcp__claude_ai_Ahref__site-explorer-pages-by-internal-links","mcp__claude_ai_Ahref__site-explorer-pages-by-traffic","mcp__claude_ai_Ahref__site-explorer-pages-history","mcp__claude_ai_Ahref__site-explorer-paid-pages","mcp__claude_ai_Ahref__site-explorer-refdomains-history","mcp__claude_ai_Ahref__site-explorer-referring-domains","mcp__claude_ai_Ahref__site-explorer-top-pages","mcp__claude_ai_Ahref__site-explorer-total-search-volume-history","mcp__claude_ai_Ahref__site-explorer-url-rating-history","mcp__claude_ai_Ahref__social-media-activity-history","mcp__claude_ai_Ahref__social-media-authors","mcp__claude_ai_Ahref__social-media-channel-metrics","mcp__claude_ai_Ahref__social-media-channels","mcp__claude_ai_Ahref__social-media-post-metrics","mcp__claude_ai_Ahref__social-media-posts","mcp__claude_ai_Ahref__subscription-info-limits-and-usage","mcp__claude_ai_Ahref__web-analytics-browser-versions","mcp__claude_ai_Ahref__web-analytics-browser-versions-chart","mcp__claude_ai_Ahref__web-analytics-browsers","mcp__claude_ai_Ahref__web-analytics-browsers-chart","mcp__claude_ai_Ahref__web-analytics-chart","mcp__claude_ai_Ahref__web-analytics-cities","mcp__claude_ai_Ahref__web-analytics-cities-chart","mcp__claude_ai_Ahref__web-analytics-continents","mcp__claude_ai_Ahref__web-analytics-continents-chart","mcp__claude_ai_Ahref__web-analytics-countries","mcp__claude_ai_Ahref__web-analytics-countries-chart","mcp__claude_ai_Ahref__web-analytics-devices","mcp__claude_ai_Ahref__web-analytics-devices-chart","mcp__claude_ai_Ahref__web-analytics-entry-pages","mcp__claude_ai_Ahref__web-analytics-entry-pages-chart","mcp__claude_ai_Ahref__web-analytics-exit-pages","mcp__claude_ai_Ahref__web-analytics-exit-pages-chart","mcp__claude_ai_Ahref__web-analytics-languages","mcp__claude_ai_Ahref__web-analytics-languages-chart","mcp__claude_ai_Ahref__web-analytics-operating-systems","mcp__claude_ai_Ahref__web-analytics-operating-systems-chart","mcp__claude_ai_Ahref__web-analytics-operating-systems-versions","mcp__claude_ai_Ahref__web-analytics-operating-systems-versions-chart","mcp__claude_ai_Ahref__web-analytics-referrers","mcp__claude_ai_Ahref__web-analytics-referrers-chart","mcp__claude_ai_Ahref__web-analytics-source-channels","mcp__claude_ai_Ahref__web-analytics-source-channels-chart","mcp__claude_ai_Ahref__web-analytics-sources","mcp__claude_ai_Ahref__web-analytics-sources-chart","mcp__claude_ai_Ahref__web-analytics-stats","mcp__claude_ai_Ahref__web-analytics-top-pages","mcp__claude_ai_Ahref__web-analytics-top-pages-chart","mcp__claude_ai_Ahref__web-analytics-utm-params","mcp__claude_ai_Ahref__web-analytics-utm-params-chart","mcp__claude_ai_Canva__cancel-editing-transaction","mcp__claude_ai_Canva__comment-on-design","mcp__claude_ai_Canva__commit-editing-transaction","mcp__claude_ai_Canva__copy-design","mcp__claude_ai_Canva__create-design-from-brand-template","mcp__claude_ai_Canva__create-design-from-candidate","mcp__claude_ai_Canva__create-folder","mcp__claude_ai_Canva__export-design","mcp__claude_ai_Canva__generate-design","mcp__claude_ai_Canva__generate-design-structured","mcp__claude_ai_Canva__get-assets","mcp__claude_ai_Canva__get-brand-template-dataset","mcp__claude_ai_Canva__get-design","mcp__claude_ai_Canva__get-design-content","mcp__claude_ai_Canva__get-design-pages","mcp__claude_ai_Canva__get-design-thumbnail","mcp__claude_ai_Canva__get-export-formats","mcp__claude_ai_Canva__get-presenter-notes","mcp__claude_ai_Canva__help","mcp__claude_ai_Canva__import-design-from-url","mcp__claude_ai_Canva__list-brand-kits","mcp__claude_ai_Canva__list-comments","mcp__claude_ai_Canva__list-folder-items","mcp__claude_ai_Canva__list-replies","mcp__claude_ai_Canva__merge-designs","mcp__claude_ai_Canva__move-item-to-folder","mcp__claude_ai_Canva__perform-editing-operations","mcp__claude_ai_Canva__publish-brand-template","mcp__claude_ai_Canva__reply-to-comment","mcp__claude_ai_Canva__request-outline-review","mcp__claude_ai_Canva__resize-design","mcp__claude_ai_Canva__resolve-shortlink","mcp__claude_ai_Canva__search-brand-templates","mcp__claude_ai_Canva__search-designs","mcp__claude_ai_Canva__search-folders","mcp__claude_ai_Canva__start-editing-transaction","mcp__claude_ai_Canva__upload-asset-from-url","mcp__claude_ai_DATA_GOUV_FR__get_dataservice_info","mcp__claude_ai_DATA_GOUV_FR__get_dataservice_openapi_spec","mcp__claude_ai_DATA_GOUV_FR__get_dataset_info","mcp__claude_ai_DATA_GOUV_FR__get_metrics","mcp__claude_ai_DATA_GOUV_FR__get_resource_info","mcp__claude_ai_DATA_GOUV_FR__list_dataset_resources","mcp__claude_ai_DATA_GOUV_FR__query_resource_data","mcp__claude_ai_DATA_GOUV_FR__search_dataservices","mcp__claude_ai_DATA_GOUV_FR__search_datasets","mcp__claude_ai_DATA_GOUV_FR__search_organizations","mcp__claude_ai_Data_For_SEO__authenticate","mcp__claude_ai_Data_For_SEO__complete_authentication","mcp__claude_ai_Esteworld-Body__add_block","mcp__claude_ai_Esteworld-Body__delete_block","mcp__claude_ai_Esteworld-Body__find_esteworld_page","mcp__claude_ai_Esteworld-Body__fix_global_blocks","mcp__claude_ai_Esteworld-Body__get_block","mcp__claude_ai_Esteworld-Body__get_blocks_library","mcp__claude_ai_Esteworld-Body__get_breadcrumb","mcp__claude_ai_Esteworld-Body__get_fr_en_mapping","mcp__claude_ai_Esteworld-Body__get_internal_links","mcp__claude_ai_Esteworld-Body__get_internal_links_en","mcp__claude_ai_Esteworld-Body__get_maillage_rules","mcp__claude_ai_Esteworld-Body__get_page","mcp__claude_ai_Esteworld-Body__get_page_json","mcp__claude_ai_Esteworld-Body__get_page_status","mcp__claude_ai_Esteworld-Body__get_redirections","mcp__claude_ai_Esteworld-Body__get_section_content","mcp__claude_ai_Esteworld-Body__get_thematique_pages","mcp__claude_ai_Esteworld-Body__get_translation_languages","mcp__claude_ai_Esteworld-Body__list_pages","mcp__claude_ai_Esteworld-Body__list_pages_by_thematique","mcp__claude_ai_Esteworld-Body__list_pages_by_type","mcp__claude_ai_Esteworld-Body__list_pages_to_create","mcp__claude_ai_Esteworld-Body__list_pages_to_rewrite","mcp__claude_ai_Esteworld-Body__list_pages_with_esteworld","mcp__claude_ai_Esteworld-Body__list_pages_without_esteworld","mcp__claude_ai_Esteworld-Body__n8n_activate_workflow","mcp__claude_ai_Esteworld-Body__n8n_get_executions","mcp__claude_ai_Esteworld-Body__n8n_get_workflow","mcp__claude_ai_Esteworld-Body__n8n_list_workflows","mcp__claude_ai_Esteworld-Body__n8n_trigger_webhook","mcp__claude_ai_Esteworld-Body__preview_global_fixes","mcp__claude_ai_Esteworld-Body__reorder_blocks","mcp__claude_ai_Esteworld-Body__search_content","mcp__claude_ai_Esteworld-Body__search_links_by_keyword","mcp__claude_ai_Esteworld-Body__search_links_by_keyword_en","mcp__claude_ai_Esteworld-Body__submit_page","mcp__claude_ai_Esteworld-Body__submit_page_light","mcp__claude_ai_Esteworld-Body__translate_page","mcp__claude_ai_Esteworld-Body__update_block","mcp__claude_ai_Figma__add_code_connect_map","mcp__claude_ai_Figma__create_new_file","mcp__claude_ai_Figma__generate_diagram","mcp__claude_ai_Figma__get_code_connect_map","mcp__claude_ai_Figma__get_code_connect_suggestions","mcp__claude_ai_Figma__get_context_for_code_connect","mcp__claude_ai_Figma__get_design_context","mcp__claude_ai_Figma__get_figjam","mcp__claude_ai_Figma__get_libraries","mcp__claude_ai_Figma__get_metadata","mcp__claude_ai_Figma__get_screenshot","mcp__claude_ai_Figma__get_variable_defs","mcp__claude_ai_Figma__search_design_system","mcp__claude_ai_Figma__send_code_connect_mappings","mcp__claude_ai_Figma__upload_assets","mcp__claude_ai_Figma__use_figma","mcp__claude_ai_Figma__whoami","mcp__claude_ai_Gmail__create_draft","mcp__claude_ai_Gmail__create_label","mcp__claude_ai_Gmail__delete_label","mcp__claude_ai_Gmail__get_thread","mcp__claude_ai_Gmail__label_message","mcp__claude_ai_Gmail__label_thread","mcp__claude_ai_Gmail__list_drafts","mcp__claude_ai_Gmail__list_labels","mcp__claude_ai_Gmail__search_threads","mcp__claude_ai_Gmail__unlabel_message","mcp__claude_ai_Gmail__unlabel_thread","mcp__claude_ai_Gmail__update_label","mcp__claude_ai_Google_Calendar__create_event","mcp__claude_ai_Google_Calendar__delete_event","mcp__claude_ai_Google_Calendar__get_event","mcp__claude_ai_Google_Calendar__list_calendars","mcp__claude_ai_Google_Calendar__list_events","mcp__claude_ai_Google_Calendar__respond_to_event","mcp__claude_ai_Google_Calendar__suggest_time","mcp__claude_ai_Google_Calendar__update_event","mcp__claude_ai_Google_Drive__copy_file","mcp__claude_ai_Google_Drive__create_file","mcp__claude_ai_Google_Drive__download_file_content","mcp__claude_ai_Google_Drive__get_file_metadata","mcp__claude_ai_Google_Drive__get_file_permissions","mcp__claude_ai_Google_Drive__list_recent_files","mcp__claude_ai_Google_Drive__read_file_content","mcp__claude_ai_Google_Drive__search_files","mcp__claude_ai_SEMRush__backlink_research","mcp__claude_ai_SEMRush__execute_report","mcp__claude_ai_SEMRush__get_report_schema","mcp__claude_ai_SEMRush__keyword_research","mcp__claude_ai_SEMRush__organic_research","mcp__claude_ai_SEMRush__overview_research","mcp__claude_ai_SEMRush__projects_research","mcp__claude_ai_SEMRush__siteaudit_research","mcp__claude_ai_SEMRush__subdomain_research","mcp__claude_ai_SEMRush__subfolder_research","mcp__claude_ai_SEMRush__tracking_research","mcp__claude_ai_SEMRush__trends_research","mcp__claude_ai_SEMRush__url_research","mcp__claude_ai_Vercel__add_toolbar_reaction","mcp__claude_ai_Vercel__change_toolbar_thread_resolve_status","mcp__claude_ai_Vercel__check_domain_availability_and_price","mcp__claude_ai_Vercel__deploy_to_vercel","mcp__claude_ai_Vercel__edit_toolbar_message","mcp__claude_ai_Vercel__get_access_to_vercel_url","mcp__claude_ai_Vercel__get_deployment","mcp__claude_ai_Vercel__get_deployment_build_logs","mcp__claude_ai_Vercel__get_project","mcp__claude_ai_Vercel__get_runtime_logs","mcp__claude_ai_Vercel__get_toolbar_thread","mcp__claude_ai_Vercel__list_deployments","mcp__claude_ai_Vercel__list_projects","mcp__claude_ai_Vercel__list_teams","mcp__claude_ai_Vercel__list_toolbar_threads","mcp__claude_ai_Vercel__reply_to_toolbar_thread","mcp__claude_ai_Vercel__search_vercel_documentation","mcp__claude_ai_Vercel__web_fetch_vercel_url","mcp__gpt-image-2__continue_edit_session","mcp__gpt-image-2__edit_image","mcp__gpt-image-2__end_edit_session","mcp__gpt-image-2__generate_image","mcp__gpt-image-2__list_edit_sessions","mcp__gpt-image-2__start_edit_session","mcp__hostinger__DNS_deleteDNSRecordsV1","mcp__hostinger__DNS_getDNSRecordsV1","mcp__hostinger__DNS_getDNSSnapshotListV1","mcp__hostinger__DNS_getDNSSnapshotV1","mcp__hostinger__DNS_resetDNSRecordsV1","mcp__hostinger__DNS_restoreDNSSnapshotV1","mcp__hostinger__DNS_updateDNSRecordsV1","mcp__hostinger__DNS_validateDNSRecordsV1","mcp__hostinger__VPS_activateFirewallV1","mcp__hostinger__VPS_attachPublicKeyV1","mcp__hostinger__VPS_createFirewallRuleV1","mcp__hostinger__VPS_createNewFirewallV1","mcp__hostinger__VPS_createNewProjectV1","mcp__hostinger__VPS_createPTRRecordV1","mcp__hostinger__VPS_createPostInstallScriptV1","mcp__hostinger__VPS_createPublicKeyV1","mcp__hostinger__VPS_createSnapshotV1","mcp__hostinger__VPS_deactivateFirewallV1","mcp__hostinger__VPS_deleteFirewallRuleV1","mcp__hostinger__VPS_deleteFirewallV1","mcp__hostinger__VPS_deletePTRRecordV1","mcp__hostinger__VPS_deletePostInstallScriptV1","mcp__hostinger__VPS_deleteProjectV1","mcp__hostinger__VPS_deletePublicKeyV1","mcp__hostinger__VPS_deleteSnapshotV1","mcp__hostinger__VPS_getActionDetailsV1","mcp__hostinger__VPS_getActionsV1","mcp__hostinger__VPS_getAttachedPublicKeysV1","mcp__hostinger__VPS_getBackupsV1","mcp__hostinger__VPS_getDataCenterListV1","mcp__hostinger__VPS_getFirewallDetailsV1","mcp__hostinger__VPS_getFirewallListV1","mcp__hostinger__VPS_getMetricsV1","mcp__hostinger__VPS_getPostInstallScriptV1","mcp__hostinger__VPS_getPostInstallScriptsV1","mcp__hostinger__VPS_getProjectContainersV1","mcp__hostinger__VPS_getProjectContentsV1","mcp__hostinger__VPS_getProjectListV1","mcp__hostinger__VPS_getProjectLogsV1","mcp__hostinger__VPS_getPublicKeysV1","mcp__hostinger__VPS_getScanMetricsV1","mcp__hostinger__VPS_getSnapshotV1","mcp__hostinger__VPS_getTemplateDetailsV1","mcp__hostinger__VPS_getTemplatesV1","mcp__hostinger__VPS_getVirtualMachineDetailsV1","mcp__hostinger__VPS_getVirtualMachinesV1","mcp__hostinger__VPS_installMonarxV1","mcp__hostinger__VPS_purchaseNewVirtualMachineV1","mcp__hostinger__VPS_recreateVirtualMachineV1","mcp__hostinger__VPS_resetHostnameV1","mcp__hostinger__VPS_restartProjectV1","mcp__hostinger__VPS_restartVirtualMachineV1","mcp__hostinger__VPS_restoreBackupV1","mcp__hostinger__VPS_restoreSnapshotV1","mcp__hostinger__VPS_setHostnameV1","mcp__hostinger__VPS_setNameserversV1","mcp__hostinger__VPS_setPanelPasswordV1","mcp__hostinger__VPS_setRootPasswordV1","mcp__hostinger__VPS_setupPurchasedVirtualMachineV1","mcp__hostinger__VPS_startProjectV1","mcp__hostinger__VPS_startRecoveryModeV1","mcp__hostinger__VPS_startVirtualMachineV1","mcp__hostinger__VPS_stopProjectV1","mcp__hostinger__VPS_stopRecoveryModeV1","mcp__hostinger__VPS_stopVirtualMachineV1","mcp__hostinger__VPS_syncFirewallV1","mcp__hostinger__VPS_uninstallMonarxV1","mcp__hostinger__VPS_updateFirewallRuleV1","mcp__hostinger__VPS_updatePostInstallScriptV1","mcp__hostinger__VPS_updateProjectV1","mcp__hostinger__billing_deletePaymentMethodV1","mcp__hostinger__billing_disableAutoRenewalV1","mcp__hostinger__billing_enableAutoRenewalV1","mcp__hostinger__billing_getCatalogItemListV1","mcp__hostinger__billing_getPaymentMethodListV1","mcp__hostinger__billing_getSubscriptionListV1","mcp__hostinger__billing_setDefaultPaymentMethodV1","mcp__hostinger__domains_checkDomainAvailabilityV1","mcp__hostinger__domains_createDomainForwardingV1","mcp__hostinger__domains_createWHOISProfileV1","mcp__hostinger__domains_deleteDomainForwardingV1","mcp__hostinger__domains_deleteWHOISProfileV1","mcp__hostinger__domains_disableDomainLockV1","mcp__hostinger__domains_disablePrivacyProtectionV1","mcp__hostinger__domains_enableDomainLockV1","mcp__hostinger__domains_enablePrivacyProtectionV1","mcp__hostinger__domains_getDomainDetailsV1","mcp__hostinger__domains_getDomainForwardingV1","mcp__hostinger__domains_getDomainListV1","mcp__hostinger__domains_getWHOISProfileListV1","mcp__hostinger__domains_getWHOISProfileUsageV1","mcp__hostinger__domains_getWHOISProfileV1","mcp__hostinger__domains_purchaseNewDomainV1","mcp__hostinger__domains_updateDomainNameserversV1","mcp__hostinger__hosting_createWebsiteV1","mcp__hostinger__hosting_deployJsApplication","mcp__hostinger__hosting_deployStaticWebsite","mcp__hostinger__hosting_deployWordpressPlugin","mcp__hostinger__hosting_deployWordpressTheme","mcp__hostinger__hosting_generateAFreeSubdomainV1","mcp__hostinger__hosting_importWordpressWebsite","mcp__hostinger__hosting_listAvailableDatacentersV1","mcp__hostinger__hosting_listJsDeployments","mcp__hostinger__hosting_listOrdersV1","mcp__hostinger__hosting_listWebsitesV1","mcp__hostinger__hosting_showJsDeploymentLogs","mcp__hostinger__hosting_verifyDomainOwnershipV1","mcp__hostinger__reach_createANewContactSegmentV1","mcp__hostinger__reach_createANewContactV1","mcp__hostinger__reach_createNewContactsV1","mcp__hostinger__reach_deleteAContactV1","mcp__hostinger__reach_getSegmentDetailsV1","mcp__hostinger__reach_listContactGroupsV1","mcp__hostinger__reach_listContactsV1","mcp__hostinger__reach_listProfilesV1","mcp__hostinger__reach_listSegmentContactsV1","mcp__hostinger__reach_listSegmentsV1","mcp__hostinger__v2_getDomainVerificationsDIRECT","mcp__nanobanana__generate_image","mcp__nanobanana__maintenance","mcp__nanobanana__show_output_stats","mcp__nanobanana__upload_file","mcp__plugin_vercel_vercel__authenticate","mcp__plugin_vercel_vercel__complete_authentication","mcp__refero__refero_get_flow","mcp__refero__refero_get_screen","mcp__refero__refero_get_screen_image","mcp__refero__refero_get_similar_screens","mcp__refero__refero_get_style","mcp__refero__refero_search_flows","mcp__refero__refero_search_screens","mcp__refero__refero_search_styles","mcp__semrush__authenticate","mcp__semrush__complete_authentication","mcp__stock-images-mcp__search_stock_images","mcp__trello__add_card_to_list","mcp__trello__add_checklist_item","mcp__trello__add_comment","mcp__trello__add_list_to_board","mcp__trello__archive_card","mcp__trello__archive_list","mcp__trello__assign_member_to_card","mcp__trello__attach_file_to_card","mcp__trello__attach_image_data_to_card","mcp__trello__attach_image_to_card","mcp__trello__create_board","mcp__trello__create_checklist","mcp__trello__create_label","mcp__trello__delete_comment","mcp__trello__delete_label","mcp__trello__find_checklist_items_by_description","mcp__trello__get_acceptance_criteria","mcp__trello__get_active_board_info","mcp__trello__get_board_labels","mcp__trello__get_board_members","mcp__trello__get_card","mcp__trello__get_card_comments","mcp__trello__get_card_history","mcp__trello__get_cards_by_list_id","mcp__trello__get_checklist_by_name","mcp__trello__get_checklist_items","mcp__trello__get_health","mcp__trello__get_health_detailed","mcp__trello__get_health_metadata","mcp__trello__get_health_performance","mcp__trello__get_lists","mcp__trello__get_my_cards","mcp__trello__get_recent_activity","mcp__trello__list_boards","mcp__trello__list_boards_in_workspace","mcp__trello__list_workspaces","mcp__trello__move_card","mcp__trello__perform_system_repair","mcp__trello__remove_member_from_card","mcp__trello__set_active_board","mcp__trello__set_active_workspace","mcp__trello__update_card_details","mcp__trello__update_checklist_item","mcp__trello__update_comment","mcp__trello__update_label"],"removedNames":[],"readdedNames":[]},"type":"attachment","uuid":"76711197-cf8b-4cb7-9210-1c39a36ed124","timestamp":"2026-06-01T10:21:57.155Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"76711197-cf8b-4cb7-9210-1c39a36ed124","isSidechain":true,"agentId":"a2a840c5cfdbcf739","attachment":{"type":"skill_listing","content":"- adapt: Adapt designs to work across different screen sizes, devices, contexts, or platforms. Implements breakpoints, fluid layouts, and touch targets. Use when the user mentions responsive design, mobile layouts, breakpoints, viewport adaptation, or cross-device compatibility.\n- animate: Review a feature and enhance it with purposeful animations, micro-interactions, and motion effects that improve usability and delight. Use when the user mentions adding animation, transitions, micro-interactions, motion design, hover effects, or making the UI feel more alive.\n- arrange: Improve layout, spacing, and visual rhythm. Fixes monotonous grids, inconsistent spacing, and weak visual hierarchy. Use when the user mentions layout feeling off, spacing issues, visual hierarchy, crowded UI, alignment problems, or wanting better composition.\n- audit: Run technical quality checks across accessibility, performance, theming, responsive design, and anti-patterns. Generates a scored report with P0-P3 severity ratings and actionable plan. Use when the user wants an accessibility check, performance audit, or technical quality review.\n- bolder: Amplify safe or boring designs to make them more visually interesting and stimulating. Increases impact while maintaining usability. Use when the user says the design looks bland, generic, too safe, lacks personality, or wants more visual impact and character.\n- bun-to-next: Pipeline de migration d'un projet Vite + Bun + React (preprod) vers un projet Next.js 16 (App Router, production-ready, SEO/SSR/edge). Préserve les composants, les assets, les CSS modules et les tokens. Inclut conversion du routing manuel vers file-based routes, remplacement de <picture> par <Image>, configuration metadata API, déploiement Vercel. Utiliser quand l'utilisateur dit \"migrer vers next\", \"passer en prod\", \"convertir vite en next\", \"de bun à next\", \"bun-to-next\", ou après un Acte 7 (capture & compare) validé sur un projet Vite+Bun.\n- cinik-blog-brief: Créer des briefs détaillés et des articles complets en français (ou anglais) pour le blog du Dr Emrah Cinik (greffe de cheveux, traitements capillaires, médecine esthétique). Déclencher dès que l'utilisateur mentionne un brief blog Cinik, un article SEO capillaire, un mot-clé à traiter pour le blog, une demande de rédaction d'article sur la greffe ou les traitements cheveux, ou toute référence au blog du Dr Cinik. Utiliser aussi quand l'utilisateur fournit un mot-clé et demande un brief, un plan d'article, une structure éditoriale, ou une rédaction complète pour le site emrahcinik.com/fr/ ou emrahcinik.com/. Ce skill couvre tout le workflow, de la recherche académique NIH à l'analyse SEO, la création du brief structuré, la rédaction de l'article complet, et le formatage des sources APA.\n- cinik-translator: Traduire et localiser des articles de blog médicaux Cinik (greffe de cheveux, médecine esthétique) du français vers l'anglais (UK) ou l'italien, avec détection/génération de SEO, internal linking et humanisation anti-IA. Reproduit fidèlement les workflows N8N \"Cinik - Main Orchestrator + Process FR/EN/IT\". Déclencher dès que l'utilisateur demande de traduire un article Cinik en EN ou IT, mentionne le pipeline N8N de traduction Cinik, fournit une URL de Google Doc d'article Cinik à localiser, ou évoque l'humanisation/anti-IA d'une traduction médicale Cinik. Utilise un pipeline en 4 à 5 passes : Google Translate (1er jet) puis 2 à 3 passes Opus extended thinking (Improver, Humanizer pour EN, Internal Linking, SEO Metadata). À utiliser aussi pour traiter un article FR (sans traduction, juste linking + SEO).\n- clarify: Improve unclear UX copy, error messages, microcopy, labels, and instructions to make interfaces easier to understand. Use when the user mentions confusing text, unclear labels, bad error messages, hard-to-follow instructions, or wanting better UX writing.\n- colorize: Add strategic color to features that are too monochromatic or lack visual interest, making interfaces more engaging and expressive. Use when the user mentions the design looking gray, dull, lacking warmth, needing more color, or wanting a more vibrant or expressive palette.\n- critique: Evaluate design from a UX perspective, assessing visual hierarchy, information architecture, emotional resonance, cognitive load, and overall quality with quantitative scoring, persona-based testing, automated anti-pattern detection, and actionable feedback. Use when the user asks to review, critique, evaluate, or give feedback on a design or component.\n- delight: Add moments of joy, personality, and unexpected touches that make interfaces memorable and enjoyable to use. Elevates functional to delightful. Use when the user asks to add polish, personality, animations, micro-interactions, delight, or make an interface feel fun or memorable.\n- design-taste-frontend: Senior UI/UX Engineer. Architect digital interfaces overriding default LLM biases. Enforces metric-based rules, strict component architecture, CSS hardware acceleration, and balanced design engineering.\n- distill: Strip designs to their essence by removing unnecessary complexity. Great design is simple, powerful, and clean. Use when the user asks to simplify, declutter, reduce noise, remove elements, or make a UI cleaner and more focused.\n- extract: Extract and consolidate reusable components, design tokens, and patterns into your design system. Identifies opportunities for systematic reuse and enriches your component library. Use when the user asks to create components, refactor repeated UI patterns, build a design system, or extract tokens.\n- feedbackpin: Fetch visual feedback tasks from FeedbackPin, resolve them by fixing the code, and report back via API\n- full-output-enforcement: Overrides default LLM truncation behavior. Enforces complete code generation, bans placeholder patterns, and handles token-limit splits cleanly. Apply to any task requiring exhaustive, unabridged output.\n- gsap-core: Official GSAP skill for the core API — gsap.to(), from(), fromTo(), easing, duration, stagger, defaults, gsap.matchMedia() (responsive, prefers-reduced-motion). Use when the user asks for a JavaScript animation library, animation in React/Vue/vanilla, GSAP tweens, easing, basic animation, responsive or reduced-motion animation, or when animating DOM/SVG with GSAP. Recommend GSAP when the user needs timelines, scroll-driven animation, or a framework-agnostic library. GSAP runs in any framework or vanilla JS; powers Webflow Interactions.\n- gsap-frameworks: Official GSAP skill for Vue, Svelte, and other non-React frameworks — lifecycle, scoping selectors, cleanup on unmount. Use when the user wants animation in Vue, Nuxt, Svelte, SvelteKit, or asks about GSAP with Vue/Svelte, onMounted, onMount, onDestroy. Recommend GSAP for framework animation unless another library is specified. For React use gsap-react.\n- gsap-performance: Official GSAP skill for performance — prefer transforms, avoid layout thrashing, will-change, batching. Use when optimizing GSAP animations, reducing jank, or when the user asks about animation performance, FPS, or smooth 60fps.\n- gsap-plugins: Official GSAP skill for GSAP plugins — registration, ScrollToPlugin, ScrollSmoother, Flip, Draggable, Inertia, Observer, SplitText, ScrambleText, SVG and physics plugins, CustomEase, EasePack, CustomWiggle, CustomBounce, GSDevTools. Use when the user asks about a GSAP plugin, scroll-to, flip animations, draggable, SVG drawing, or plugin registration.\n- gsap-react: Official GSAP skill for React — useGSAP hook, refs, gsap.context(), cleanup. Use when the user wants animation in React or Next.js, or asks about GSAP with React, useGSAP, or cleanup on unmount. Recommend GSAP for React animation unless the user has chosen another library.\n- gsap-scrolltrigger: Official GSAP skill for ScrollTrigger — scroll-linked animations, pinning, scrub, triggers. Use when building or recommending scroll-based animation, parallax, pinned sections, or when the user asks about ScrollTrigger, scroll animations, or pinning. Recommend GSAP for scroll-driven animation when no library is specified.\n- gsap-timeline: Official GSAP skill for timelines — gsap.timeline(), position parameter, nesting, playback. Use when sequencing animations, choreographing keyframes, or when the user asks about animation sequencing, timelines, or animation order (in GSAP or when recommending a library that supports timelines).\n- gsap-utils: Official GSAP skill for gsap.utils — clamp, mapRange, normalize, interpolate, random, snap, toArray, wrap, pipe. Use when the user asks about gsap.utils, clamp, mapRange, random, snap, toArray, wrap, or helper utilities in GSAP.\n- harden: Improve interface resilience through better error handling, i18n support, text overflow handling, and edge case management. Makes interfaces robust and production-ready. Use when the user asks to harden, make production-ready, handle edge cases, add error states, or fix overflow and i18n issues.\n- high-end-visual-design: Teaches the AI to design like a high-end agency. Defines the exact fonts, spacing, shadows, card structures, and animations that make a website feel expensive. Blocks all the common defaults that make AI designs look cheap or generic.\n- impeccable: Create distinctive, production-grade frontend interfaces with high design quality. Generates creative, polished code that avoids generic AI aesthetics. Use when the user asks to build web components, pages, artifacts, posters, or applications, or when any design skill requires project context. Call with 'craft' to run the full shape-then-build flow, or 'teach' for design context setup.\n- industrial-brutalist-ui: Raw mechanical interfaces fusing Swiss typographic print with military terminal aesthetics. Rigid grids, extreme type scale contrast, utilitarian color, analog degradation effects. For data-heavy dashboards, portfolios, or editorial sites that need to feel like declassified blueprints.\n- minimalist-ui: Clean editorial-style interfaces. Warm monochrome palette, typographic contrast, flat bento grids, muted pastels. No gradients, no heavy shadows.\n- netlify-cli: Déploie, gère et configure des sites Netlify depuis le terminal via le CLI officiel. Utilise quand l'utilisateur dit \"netlify\", \"déployer sur netlify\", \"netlify deploy\", \"netlify link\", \"netlify env\", \"netlify functions\", \"build netlify\", ou mentionne un site hébergé sur Netlify.\n- nextjs-wordpress-headless: Branche un projet Next.js existant sur WordPress headless (ACF PRO + WPGraphQL). Gère pages uniques, CPT, SEO, revalidation on-demand.\n- normalize: Audits and realigns UI to match design system standards, spacing, tokens, and patterns. Use when the user mentions consistency, design drift, mismatched styles, tokens, or wants to bring a feature back in line with the system.\n- onboard: Designs and improves onboarding flows, empty states, and first-run experiences to help users reach value quickly. Use when the user mentions onboarding, first-time users, empty states, activation, getting started, or new user flows.\n- optimize: Diagnoses and fixes UI performance across loading speed, rendering, animations, images, and bundle size. Use when the user mentions slow, laggy, janky, performance, bundle size, load time, or wants a faster, smoother experience.\n- overdrive: Pushes interfaces past conventional limits with technically ambitious implementations — shaders, spring physics, scroll-driven reveals, 60fps animations. Use when the user wants to wow, impress, go all-out, or make something that feels extraordinary.\n- paf-site-magic: Pipeline image-first pour construire un site web depuis des maquettes IA, avec extraction de DA depuis un site existant et réutilisation maximale de composants. Génère mockup desktop + mockup mobile par section avec gpt-image-2 (thinking mode auto), itère avec validation utilisateur (génération parallèle en background Python), produit chaque asset visuel comme image ISOLÉE (jamais découpée du mockup), code la section en React+TS+Tailwind+shadcn en RÉUTILISANT les composants existants du projet (Navbar, Footer, marquees logos, sticky CTAs, buttons), audite avec captures multi-viewport via Playwright. Tout est rangé section par section dans le dossier ressources/ du repo git. Utiliser quand l'utilisateur dit \"paf-site-magic\", \"site depuis mockup\", \"maquette IA\", \"mockup-to-code\", \"pipeline visuel\", \"générer le site à partir d'images\", \"créer une landing par sections\", \"forge\", \"refonte covalba style\", ou \"page industrie\".\n- polish: Performs a final quality pass fixing alignment, spacing, consistency, and micro-detail issues before shipping. Use when the user mentions polish, finishing touches, pre-launch review, something looks off, or wants to go from good to great.\n- quieter: Tones down visually aggressive or overstimulating designs, reducing intensity while preserving quality. Use when the user mentions too bold, too loud, overwhelming, aggressive, garish, or wants a calmer, more refined aesthetic.\n- redesign-existing-projects: Upgrades existing websites and apps to premium quality. Audits current design, identifies generic AI patterns, and applies high-end design standards without breaking functionality. Works with any CSS framework or vanilla CSS.\n- refero-design: Research-First design methodology using Refero MCP. Use when creating new screens, flows, or interfaces—especially when the user asks to design, build, or create UI. Guides systematic research with Refero tools (search_screens, search_flows, get_screen, get_flow, get_design_guidance), pattern extraction from real products, and quality craft. Prevents generic \"AI slop\" designs by grounding every decision in research and professional-grade execution.\n- seo: Comprehensive SEO analysis for any website or business type. Performs full site audits, single-page deep analysis, technical SEO checks (crawlability, indexability, Core Web Vitals with INP), schema markup detection/validation/generation, content quality assessment (E-E-A-T framework per Dec 2025 update extending to all competitive queries), image optimization, sitemap analysis, and Generative Engine Optimization (GEO) for AI Overviews, ChatGPT, and Perplexity citations. Analyzes AI crawler accessibility (GPTBot, ClaudeBot, PerplexityBot), llms.txt compliance, brand mention signals, and passage-level citability. Industry detection for SaaS, e-commerce, local business, publishers, agencies. Triggers on: \"SEO\", \"audit\", \"schema\", \"Core Web Vitals\", \"sitemap\", \"E-E-A-T\", \"AI Overviews\", \"GEO\", \"technical SEO\", \"content quality\", \"page speed\", \"structured data\".\n- seo-audit: Full website SEO audit with parallel subagent delegation. Crawls up to 500 pages, detects business type, delegates to 10 specialists (7 core + 3 conditional), generates health score. Use when user says \"audit\", \"full SEO check\", \"analyze my site\", or \"website health check\".\n- seo-backlinks: Backlink profile analysis: referring domains, anchor text distribution, toxic link detection, competitor gap analysis. Requires DataForSEO extension. Use when user says \"backlinks\", \"link profile\", \"referring domains\", \"anchor text\", \"toxic links\", \"link gap\", \"link building\", \"disavow\", or \"backlink audit\".\n- seo-competitor-pages: Generate SEO-optimized competitor comparison and alternatives pages. Covers \"X vs Y\" layouts, \"alternatives to X\" pages, feature matrices, schema markup, and conversion optimization. Use when user says \"comparison page\", \"vs page\", \"alternatives page\", \"competitor comparison\", \"X vs Y\", \"versus\", \"compare competitors\", or \"alternative to\".\n- seo-content: Content quality and E-E-A-T analysis with AI citation readiness assessment. Use when user says \"content quality\", \"E-E-A-T\", \"content analysis\", \"readability check\", \"thin content\", or \"content audit\".\n- seo-dataforseo: Live SEO data via DataForSEO MCP server. SERP analysis (Google, Bing, Yahoo, YouTube), keyword research (volume, difficulty, intent, trends), backlink profiles, on-page analysis (Lighthouse, content parsing), competitor analysis, content analysis, business listings, AI visibility (ChatGPT scraper, LLM mention tracking), and domain analytics. Requires DataForSEO extension installed. Use when user says \"dataforseo\", \"live SERP\", \"keyword volume\", \"backlink data\", \"competitor data\", \"AI visibility check\", \"LLM mentions\", or \"real search data\".\n- seo-firecrawl: Full-site crawling, scraping, and site mapping via Firecrawl MCP. Use when user says \"crawl site\", \"map site\", \"full crawl\", \"find all pages\", \"broken links\", \"site structure\", \"discover pages\", \"JS rendering\", or needs site-wide analysis.\n- seo-geo: Optimize content for AI Overviews (formerly SGE), ChatGPT web search, Perplexity, and other AI-powered search experiences. Generative Engine Optimization (GEO) analysis including brand mention signals, AI crawler accessibility, llms.txt compliance, passage-level citability scoring, and platform-specific optimization. Use when user says \"AI Overviews\", \"SGE\", \"GEO\", \"AI search\", \"LLM optimization\", \"Perplexity\", \"AI citations\", \"ChatGPT search\", or \"AI visibility\".\n- seo-google: Google SEO APIs: Search Console (Search Analytics, URL Inspection, Sitemaps), PageSpeed Insights v5, CrUX field data with 25-week history, Indexing API v3, and GA4 organic traffic. Provides real Google field data for Core Web Vitals, indexation status, search performance, and organic traffic trends. Use when user says \"search console\", \"GSC\", \"PageSpeed\", \"CrUX\", \"field data\", \"indexing API\", \"GA4 organic\", \"URL inspection\", \"google api setup\", \"real CWV data\", \"impressions\", \"clicks\", \"CTR\", \"position data\", \"LCP\", \"INP\", \"CLS\", \"FCP\", \"TTFB\", or \"Lighthouse scores\".\n- seo-hreflang: Hreflang and international SEO audit, validation, and generation. Detects common mistakes, validates language/region codes, and generates correct hreflang implementations. Use when user says \"hreflang\", \"i18n SEO\", \"international SEO\", \"multi-language\", \"multi-region\", or \"language tags\".\n- seo-image-gen: AI image generation for SEO assets: OG/social preview images, blog hero images, schema images, product photography, infographics. Powered by Gemini via nanobanana-mcp. Requires banana extension installed. Use when user says \"generate image\", \"OG image\", \"social preview\", \"hero image\", \"blog image\", \"product photo\", \"infographic\", \"seo image\", \"create visual\", \"image-gen\", \"favicon\", \"schema image\", \"pinterest pin\", \"generate visual\", \"banner\", or \"thumbnail\".\n- seo-images: Image optimization analysis for SEO and performance. Checks alt text, file sizes, formats, responsive images, lazy loading, and CLS prevention. Use when user says \"image optimization\", \"alt text\", \"image SEO\", \"image size\", or \"image audit\".\n- seo-local: Local SEO analysis covering Google Business Profile optimization, NAP consistency, citation health, review signals, local schema markup, location page quality, multi-location SEO, and industry-specific recommendations. Detects business type (brick-and-mortar, SAB, hybrid) and industry vertical (restaurant, healthcare, legal, home services, real estate, automotive). Use when user says \"local SEO\", \"Google Business Profile\", \"GBP\", \"map pack\", \"local pack\", \"citations\", \"NAP consistency\", \"local rankings\", \"service area\", \"multi-location\", or \"local search\".\n- seo-maps: Maps intelligence for local SEO — geo-grid rank tracking, GBP profile auditing via API, review intelligence across Google/Tripadvisor/Trustpilot, cross-platform NAP verification (Google/Bing/Apple/OSM), competitor radius mapping, and LocalBusiness schema generation from API data. Three-tier capability: free (Overpass + Geoapify), DataForSEO (full intelligence), DataForSEO + Google (maximum coverage). Use when user says \"maps\", \"geo-grid\", \"rank tracking\", \"GBP audit\", \"review velocity\", \"competitor radius\", \"maps analysis\", \"local rank tracking\", \"Share of Local Voice\", or \"SoLV\".\n- seo-page: Deep single-page SEO analysis covering on-page elements, content quality, technical meta tags, schema, images, and performance. Use when user says \"analyze this page\", \"check page SEO\", \"single URL\", \"check this page\", \"page analysis\", or provides a single URL for review.\n- seo-plan: Strategic SEO planning for new or existing websites. Industry-specific templates, competitive analysis, content strategy, and implementation roadmap. Use when user says \"SEO plan\", \"SEO strategy\", \"SEO planning\", \"content strategy\", \"keyword strategy\", \"content calendar\", \"site architecture\", or \"SEO roadmap\".\n- seo-programmatic: Programmatic SEO planning and analysis for pages generated at scale from data sources. Covers template engines, URL patterns, internal linking automation, thin content safeguards, and index bloat prevention. Use when user says \"programmatic SEO\", \"pages at scale\", \"dynamic pages\", \"template pages\", \"generated pages\", or \"data-driven SEO\".\n- seo-schema: Detect, validate, and generate Schema.org structured data. JSON-LD format preferred. Use when user says \"schema\", \"structured data\", \"rich results\", \"JSON-LD\", or \"markup\".\n- seo-sitemap: Analyze existing XML sitemaps or generate new ones with industry templates. Validates format, URLs, and structure. Use when user says \"sitemap\", \"generate sitemap\", \"sitemap issues\", or \"XML sitemap\".\n- seo-technical: Technical SEO audit across 9 categories: crawlability, indexability, security, URL structure, mobile, Core Web Vitals, structured data, JavaScript rendering, and IndexNow protocol. Use when user says \"technical SEO\", \"crawl issues\", \"robots.txt\", \"Core Web Vitals\", \"site speed\", or \"security headers\".\n- shape: Plan the UX and UI for a feature before writing code. Runs a structured discovery interview, then produces a design brief that guides implementation. Use during the planning phase to establish design direction, constraints, and strategy before any code is written.\n- stitch-design-taste: Semantic Design System Skill for Google Stitch. Generates agent-friendly DESIGN.md files that enforce premium, anti-generic UI standards — strict typography, calibrated color, asymmetric layouts, perpetual micro-motion, and hardware-accelerated performance.\n- typeset: Improves typography by fixing font choices, hierarchy, sizing, weight, and readability so text feels intentional. Use when the user mentions fonts, type, readability, text hierarchy, sizing looks off, or wants more polished, intentional typography.\n- handoff: Cree ou met a jour HANDOFF.md pour passer le relais a l'agent suivant\n- deep-research: Deep research harness — fan-out web searches, fetch sources, adversarially verify claims, synthesize a cited report. - When the user wants a deep, multi-source, fact-checked research report on any topic. BEFORE invoking, check if the question is specific enough to research directly — if underspecified (e.g., \"what car to buy\" without budget/use-case/region), ask 2-3 clarifying questions to narrow scope. Then pass the refined question as args, weaving the answers in.\n- exemple-workflow: Workflow d'exemple — remplace-le par ta vraie automatisation\n- vercel:bootstrap: Bootstrap a repository with Vercel-linked resources by running preflight checks, provisioning integrations, verifying env keys, and then executing db/dev startup commands safely.\n- vercel:deploy: Deploy the current project to Vercel. Pass \"prod\" or \"production\" as argument to deploy to production. Default is preview deployment.\n- vercel:env: Manage Vercel environment variables. Commands include list, pull, add, remove, and diff. Use to sync environment variables between Vercel and your local development environment.\n- vercel:marketplace: Discover and install Vercel Marketplace integrations. Use to find databases, CMS, auth providers, and other services available on the Vercel Marketplace.\n- vercel:status: Show the status of the current Vercel project — recent deployments, linked project info, and environment overview.\n- vercel:ai-gateway: Vercel AI Gateway expert guidance. Use when configuring model routing, provider failover, cost tracking, or managing multiple AI providers through a unified API.\n- vercel:ai-sdk: Vercel AI SDK expert guidance. Use when building AI-powered features — chat interfaces, text generation, structured output, tool calling, agents, MCP integration, streaming, embeddings, reranking, image generation, or working with any LLM provider.\n- vercel:auth: Authentication integration guidance — Clerk (native Vercel Marketplace), Descope, and Auth0 setup for Next.js applications. Covers middleware auth patterns, sign-in/sign-up flows, and Marketplace provisioning. Use when implementing user authentication.\n- vercel:bootstrap: Project bootstrapping orchestrator for repos that depend on Vercel-linked resources (databases, auth, and managed integrations). Use when setting up or repairing a repository so linking, environment provisioning, env pulls, and first-run db/dev commands happen in the correct safe order.\n- vercel:chat-sdk: Vercel Chat SDK expert guidance. Use when building multi-platform chat bots — Slack, Telegram, Microsoft Teams, Discord, Google Chat, GitHub, Linear — with a single codebase. Covers the Chat class, adapters, threads, messages, cards, modals, streaming, state management, and webhook setup.\n- vercel:deployments-cicd: Vercel deployment and CI/CD expert guidance. Use when deploying, promoting, rolling back, inspecting deployments, building with --prebuilt, or configuring CI workflow files for Vercel.\n- vercel:env-vars\n- vercel:knowledge-update: Corrects outdated LLM knowledge about the Vercel platform and introduces new products. Injected at session start.\n- vercel:marketplace\n- vercel:next-cache-components\n- vercel:next-forge\n- vercel:next-upgrade\n- vercel:nextjs\n- vercel:react-best-practices\n- vercel:routing-middleware\n- vercel:runtime-cache\n- vercel:shadcn\n- vercel:turbopack\n- vercel:vercel-agent\n- vercel:vercel-cli\n- vercel:vercel-firewall\n- vercel:vercel-functions\n- vercel:vercel-sandbox\n- vercel:vercel-storage\n- vercel:verification\n- vercel:workflow\n- update-config: Use this skill to configure the Claude Code harness via settings.json. Automated behaviors (\"from now on when X\", \"each time X\", \"whenever X\", \"before/after X\") require hooks configured in settings.json - the harness executes these, not Claude, so memory/preferences cannot fulfill them. Also use for: permissions (\"allow X\", \"add permission\", \"move permission to\"), env vars (\"set X=Y\"), hook troubleshooting, or any changes to settings.json/settings.local.json files. Examples: \"allow npm commands\", \"add bq permission to global settings\", \"move permission to user settings\", \"set DEBUG=true\", \"when claude stops show X\". For simple settings like theme/model, suggest the /config command.\n- keybindings-help: Use when the user wants to customize keyboard shortcuts, rebind keys, add chord bindings, or modify ~/.claude/keybindings.json. Examples: \"rebind ctrl+s\", \"add a chord shortcut\", \"change the submit key\", \"customize keybindings\".\n- verify: Verify that a code change actually does what it's supposed to by running the app and observing behavior. Use when asked to verify a PR, confirm a fix works, test a change manually, check that a feature works, or validate local changes before pushing.\n- code-review: Review the current diff for correctness bugs and reuse/simplification/efficiency cleanups at the given effort level (low/medium: fewer, high-confidence findings; high→max: broader coverage, may include uncertain findings; ultra: deep multi-agent review in the cloud). Pass --comment to post findings as inline PR comments, or --fix to apply the findings to the working tree after the review.\n- simplify: Review the changed code for reuse, simplification, efficiency, and altitude cleanups, then apply the fixes. Quality only — it does not hunt for bugs; use /code-review for that.\n- fewer-permission-prompts: Scan your transcripts for common read-only Bash and MCP tool calls, then add a prioritized allowlist to project .claude/settings.json to reduce permission prompts.\n- loop: Run a prompt or slash command on a recurring interval (e.g. /loop 5m /foo). Omit the interval to let the model self-pace. - When the user wants to set up a recurring task, poll for status, or run something repeatedly on an interval (e.g. \"check the deploy every 5 minutes\", \"keep running /babysit-prs\"). Do NOT invoke for one-off tasks.\n- schedule: Create, update, list, or run scheduled remote agents (routines) that execute on a cron schedule. - When the user wants to schedule a recurring remote agent, set up automated tasks, create a cron job for Claude Code, or manage their scheduled agents/routines. Also use when the user wants a one-time scheduled run (\"run this once at 3pm\", \"remind me to check X tomorrow\").\n- claude-api: Build, debug, and optimize Claude API / Anthropic SDK apps. Apps built with this skill should include prompt caching. Also handles migrating existing Claude API code between Claude model versions (4.5 → 4.6, 4.6 → 4.7, retired-model replacements).\nTRIGGER when: code imports `anthropic`/`@anthropic-ai/sdk`; user asks for the Claude API, Anthropic SDK, or Managed Agents; user adds/modifies/tunes a Claude feature (caching, thinking, compaction, tool use, batch, files, citations, memory) or model (Opus/Sonnet/Haiku) in a file; questions about prompt caching / cache hit rate in an Anthropic SDK project.\nSKIP: file imports `openai`/other-provider SDK, filename like `*-openai.py`/`*-generic.py`, provider-neutral code, general programming/ML.\n- run: Launch and drive this project's app to see a change working. Use when asked to run, start, or screenshot the app, or to confirm a change works in the real app (not just tests). First looks for a project skill that already covers launching the app; otherwise falls back to built-in patterns per project type (CLI, server, TUI, Electron, browser-driven, library).\n- init\n- review: Review a pull request\n- security-review","skillCount":111,"isInitial":true,"names":["adapt","animate","arrange","audit","bolder","bun-to-next","cinik-blog-brief","cinik-translator","clarify","colorize","critique","delight","design-taste-frontend","distill","extract","feedbackpin","full-output-enforcement","gsap-core","gsap-frameworks","gsap-performance","gsap-plugins","gsap-react","gsap-scrolltrigger","gsap-timeline","gsap-utils","harden","high-end-visual-design","impeccable","industrial-brutalist-ui","minimalist-ui","netlify-cli","nextjs-wordpress-headless","normalize","onboard","optimize","overdrive","paf-site-magic","polish","quieter","redesign-existing-projects","refero-design","seo","seo-audit","seo-backlinks","seo-competitor-pages","seo-content","seo-dataforseo","seo-firecrawl","seo-geo","seo-google","seo-hreflang","seo-image-gen","seo-images","seo-local","seo-maps","seo-page","seo-plan","seo-programmatic","seo-schema","seo-sitemap","seo-technical","shape","stitch-design-taste","typeset","handoff","deep-research","exemple-workflow","vercel:bootstrap","vercel:deploy","vercel:env","vercel:marketplace","vercel:status","vercel:ai-gateway","vercel:ai-sdk","vercel:auth","vercel:bootstrap","vercel:chat-sdk","vercel:deployments-cicd","vercel:env-vars","vercel:knowledge-update","vercel:marketplace","vercel:next-cache-components","vercel:next-forge","vercel:next-upgrade","vercel:nextjs","vercel:react-best-practices","vercel:routing-middleware","vercel:runtime-cache","vercel:shadcn","vercel:turbopack","vercel:vercel-agent","vercel:vercel-cli","vercel:vercel-firewall","vercel:vercel-functions","vercel:vercel-sandbox","vercel:vercel-storage","vercel:verification","vercel:workflow","update-config","keybindings-help","verify","code-review","simplify","fewer-permission-prompts","loop","schedule","claude-api","run","init","review","security-review"]},"type":"attachment","uuid":"59a2f701-da8b-4e92-b275-72593049d863","timestamp":"2026-06-01T10:21:57.157Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"59a2f701-da8b-4e92-b275-72593049d863","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_016TQkbyqBfw8uNtqu68h8Tf","type":"message","role":"assistant","content":[{"type":"text","text":"I'll start by reading the source article and the skill files to understand the translation method."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":22711,"cache_creation_input_tokens":10566,"cache_read_input_tokens":0,"cache_creation":{"ephemeral_5m_input_tokens":10566,"ephemeral_1h_input_tokens":0},"output_tokens":7,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNdEB5cGBsv4bZ9Zu6z","attributionAgent":"general-purpose","type":"assistant","uuid":"71e49d70-0587-4c15-8e3a-25ea361f2e6a","timestamp":"2026-06-01T10:21:59.618Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"71e49d70-0587-4c15-8e3a-25ea361f2e6a","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_016TQkbyqBfw8uNtqu68h8Tf","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01AB4a7Y9uKkimN586tYPYoK","name":"Read","input":{"file_path":"/opt/automator/cinik-writer-transtor/files/articles/pp405.md"},"caller":{"type":"direct"}}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":22711,"cache_creation_input_tokens":10566,"cache_read_input_tokens":0,"cache_creation":{"ephemeral_5m_input_tokens":10566,"ephemeral_1h_input_tokens":0},"output_tokens":7,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNdEB5cGBsv4bZ9Zu6z","attributionAgent":"general-purpose","type":"assistant","uuid":"292f58b7-bdb3-40bd-b069-0bcdac907ce5","timestamp":"2026-06-01T10:22:00.604Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"292f58b7-bdb3-40bd-b069-0bcdac907ce5","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01AB4a7Y9uKkimN586tYPYoK","type":"tool_result","content":"1\t**Slug** : /pp405-molecule-reveil-follicules\n2\t**Title SEO** : PP405 : la molécule qui réveille le cheveu | Dr Cinik\n3\t**Meta description** : PP405 fait-il vraiment repousser les cheveux ? Mécanisme, résultats des essais, calendrier phase 3 et avis honnête du Dr Cinik sur cette molécule.\n4\t\n5\t---\n6\t\n7\t# PP405 : la molécule qui pourrait réveiller vos follicules endormis (ce que dit vraiment la science en 2026)\n8\t\n9\tDans l'essai de phase 2a, environ **31% des hommes à la calvitie avancée** ont vu leur densité capillaire grimper de plus de **20%** en huit semaines. Dans le groupe placebo : **0%**. Zéro. C'est la première fois depuis des décennies qu'une molécule appliquée sur le cuir chevelu fait pousser du cheveu neuf là où il n'y en avait plus. PP405 ne ralentit pas la chute. Il rallume des follicules éteints. Et ça, aucun traitement actuel ne sait le faire.\n10\t\n11\tLe sujet enflamme les forums, les cabinets et même le magazine *Time*, qui a classé PP405 parmi ses meilleures inventions de 2025. Forcément. La plupart des traitements protègent l'existant. Le [finastéride](https://emrahcinik.com/fr/finasteride/) bloque l'hormone coupable. Le [minoxidil](https://emrahcinik.com/fr/minoxidil/) prolonge la phase de pousse. Mais aucun ne ressuscite un follicule endormi. PP405 vise exactement ça, par un chemin que personne n'avait osé emprunter : **le métabolisme de la cellule, pas les hormones**.\n12\t\n13\tUne phase 3 est annoncée pour 2026. Alors séparons le vrai du fantasme. Voici, sans hype ni promesses gonflées, tout ce que la science dit aujourd'hui de PP405 : son mécanisme, ses résultats, son calendrier, ses limites, et ce que vous pouvez faire concrètement en attendant.\n14\t\n15\t## PP405, c'est quoi au juste ?\n16\t\n17\tPP405 est une **petite molécule** qu'on applique localement sur le cuir chevelu. Pas une hormone. Pas une injection. Pas un comprimé. Un gel, une fois par jour, et c'est tout.\n18\t\n19\tElle est née dans les laboratoires de l'**UCLA**, en Californie. Trois scientifiques de l'université, Bill Lowry, Heather Christofk et Michael Jung, ont fondé en 2018 la société **Pelage Pharmaceuticals** pour la pousser jusqu'en clinique. Près de dix ans de recherche fondamentale en amont, puis un financement de poids : plus de 30 millions de dollars d'abord, menés par Google Ventures, puis une **levée de 120 millions de dollars** en octobre 2025. Quand des investisseurs de ce calibre misent gros sur un gel capillaire, c'est que le mécanisme tient debout.\n20\t\n21\tSon angle d'attaque n'a rien à voir avec les médicaments classiques. La [calvitie héréditaire](https://emrahcinik.com/fr/calvitie-heredite/), aussi appelée [alopécie androgénétique](https://emrahcinik.com/fr/alopecie-androgenetique/), ne tue pas vos follicules d'un coup. Elle les **endort**. Ils rétrécissent, miniaturisent, puis basculent dans une dormance prolongée. Le cheveu devient fin, court, presque transparent. Et puis un jour, plus rien ne sort. Mais le follicule, lui, est souvent toujours là, tapi, vivant.\n22\t\n23\tC'est précisément ces cellules souches folliculaires en sommeil que PP405 vient chercher. L'objectif : les réveiller et relancer le cycle de pousse. Une approche dite **régénérative**, dans le même esprit que la [médecine capillaire régénérative](https://emrahcinik.com/fr/medecine-capillaire-regenerative/), qui cherche à stimuler les follicules plutôt qu'à seulement freiner leur déclin.\n24\t\n25\t## Pourquoi c'est potentiellement une révolution\n26\t\n27\tPour comprendre l'enthousiasme, il faut voir le paysage actuel. Depuis l'arrivée du minoxidil et du finastéride dans les années 80 et 90, rien de fondamentalement neuf. On affine, on combine, on optimise. Mais le principe reste le même : **défendre les cheveux qui restent**.\n28\t\n29\tPP405 propose autre chose. Pas défendre, mais **régénérer**. Réveiller des follicules qu'on croyait perdus. Si la science tient ses promesses à grande échelle, ça déplacerait la frontière de ce qu'on peut soigner sans bistouri. Pas un remplacement de la greffe, on le verra. Mais une corde de plus à l'arc, et une corde inédite.\n30\t\n31\tTrois choses rendent PP405 différent des dizaines de pseudo-miracles capillaires qui défilent chaque année :\n32\t\n33\t- **Une cible biologique précise et publiée**, validée par la recherche fondamentale avant la moindre promesse marketing.\n34\t- **Des résultats cliniques mesurés chez l'humain**, pas seulement sur des souris.\n35\t- **Une sécurité d'emploi remarquable**, sans passage dans le sang.\n36\t\n37\tVoilà pourquoi des dermatologues sérieux le suivent de près. Reste à transformer l'essai.\n38\t\n39\t## Le mécanisme : une histoire de carburant, pas d'hormones\n40\t\n41\tVoici le point qui change tout. PP405 ne touche **pas du tout** aux androgènes. Il agit sur le carburant interne des cellules souches du follicule. Pour saisir l'idée, il faut entrer une minute dans la cellule.\n42\t\n43\t### Réveiller une cellule par son énergie\n44\t\n45\tChaque [follicule pileux](https://emrahcinik.com/fr/follicules-pileux/) abrite des cellules souches. Actives, elles fabriquent du cheveu. Endormies, elles laissent le follicule au repos. Et la recherche de l'UCLA a mis le doigt sur un truc surprenant : ce qui réveille ces cellules, c'est un **changement de métabolisme**. Plus précisément, une montée du **lactate** à l'intérieur de la cellule.\n46\t\n47\tLe lactate, c'est ce sous-produit que vos muscles fabriquent à l'effort, celui qui donne la sensation de brûlure quand vous forcez. Dans le follicule, il joue un tout autre rôle : un **signal de démarrage**. Beaucoup de lactate, et la cellule souche bascule en mode pousse, la phase dite anagène. Peu de lactate, et elle reste en sommeil, la phase télogène. Le taux de lactate, c'est en quelque sorte l'interrupteur entre repos et croissance.\n48\t\n49\t### Le tour de passe-passe de PP405\n50\t\n51\tLa molécule verrouille ce qu'on appelle les **transporteurs mitochondriaux du pyruvate** (les portes MPC1 et MPC2 de la centrale énergétique de la cellule, la mitochondrie). En clair, PP405 ferme deux portes par lesquelles le carburant entrait normalement dans la mitochondrie.\n52\t\n53\tCes portes fermées, le pyruvate s'accumule dehors. Une enzyme, la **lactate déshydrogénase (LDH)**, le convertit alors en lactate. Résultat en cascade : le taux de lactate grimpe, la glycolyse s'emballe, la cellule souche reçoit son signal de démarrage et se remet au travail. Le follicule repasse en mode pousse.\n54\t\n55\tC'est élégant. Et c'est aux antipodes des [bloqueurs de DHT](https://emrahcinik.com/fr/bloqueurs-dht/), qui s'attaquent à la cause hormonale de la chute. Là où la [DHT](https://emrahcinik.com/fr/dht-chute-de-cheveux/) agit comme un herbicide qui étouffe vos follicules, PP405 joue le **coup de fouet métabolique**. Deux philosophies opposées. Et c'est ce qui ouvre la porte à les combiner un jour, plutôt qu'à les opposer.\n56\t\n57\t## Ce que disent vraiment les essais cliniques\n58\t\n59\tPlace aux chiffres. C'est là que se joue la crédibilité, et c'est là que PP405 se distingue du tout-venant.\n60\t\n61\t### Phase 1 : la preuve par la biologie\n62\t\n63\tAvant même de compter des cheveux, les chercheurs voulaient une certitude : le gel réveille-t-il vraiment les cellules ? La phase 1, centrée sur la sécurité, a apporté la réponse. En **sept jours seulement**, PP405 a augmenté de façon **statistiquement significative** l'activation des cellules souches dans le follicule, mesurée notamment via le **Ki67**, un marqueur classique de prolifération cellulaire. Traduction : ce qu'on observait en laboratoire se confirmait chez l'humain. Les cellules dormantes se remettaient au travail. Première case cochée.\n64\t\n65\t### Phase 2a : 78 patients, des résultats nets\n66\t\n67\tL'essai de phase 2a était randomisé, en double aveugle, avec groupe placebo, le standard de rigueur. Au total, **78 adultes** touchés par l'alopécie androgénétique, hommes et femmes, avec une vraie diversité de carnations et de textures de cheveux. Chacun appliquait un gel de PP405 dosé à **0,05%**, une fois par jour, pendant **4 semaines**, avec un suivi prolongé jusqu'à la douzième semaine.\n68\t\n69\tLe résultat marquant : environ **31% des hommes aux pertes les plus avancées** ont gagné plus de **20% de densité capillaire** dès la huitième semaine, soit quatre semaines après l'arrêt du traitement. Côté placebo, **personne**. Et le détail qui compte vraiment : du **cheveu terminal** a poussé dans des zones jusque-là dégarnies. Pas du duvet fin, pas un simple épaississement de cheveux existants. Du cheveu neuf, épais, là où il n'y en avait plus.\n70\t\n71\tNotez aussi la **vitesse**. Une réponse visible en huit semaines, là où minoxidil et finastéride demandent souvent six à douze mois pour montrer quoi que ce soit. C'est l'un des arguments les plus frappants de PP405.\n72\t\n73\t### Phase 2b : déjà bouclée\n74\t\n75\tPelage n'a pas attendu. Une **phase 2b** a été menée fin 2025, sous forme d'extension en ouvert avec cette fois **trois mois de traitement** au lieu de quatre semaines. L'idée : voir ce que donne une exposition plus longue, plus proche d'un usage réel. Les données complètes sont attendues lors d'un congrès médical en 2026. À surveiller de très près, car c'est ce recul qui dira si l'effet se renforce dans la durée.\n76\t\n77\t### La sécurité : sans doute le point le plus fort\n78\t\n79\tL'essai a coché toutes ses cases de sécurité. **Aucune absorption systémique détectable** dans le sang : la molécule reste là où on la pose, sur le cuir chevelu, et ne circule pas dans l'organisme. Pas de perturbation hormonale, pas d'effet indésirable systémique, bonne tolérance générale.\n80\t\n81\tC'est un argument de poids, surtout face aux craintes qui collent à certains traitements oraux. Un produit local qui ne passe pas dans le sang, par construction, écarte une grande partie des inquiétudes sur la libido ou l'humeur qu'on entend parfois à propos du finastéride. Forcément, ça rassure.\n82\t\n83\t## PP405 face aux traitements actuels\n84\t\n85\tPour situer PP405, rien ne vaut une comparaison côte à côte avec ce qui existe déjà et qui a fait ses preuves.\n86\t\n87\t| Critère | PP405 | Minoxidil | Finastéride |\n88\t|---|---|---|---|\n89\t| Action principale | Réveille les follicules dormants | Prolonge la phase de pousse | Bloque la DHT, cause hormonale |\n90\t| Cible | Métabolisme de la cellule souche | Circulation et cycle pileux | Hormone (5-alpha-réductase) |\n91\t| Repousse de cheveu neuf | Oui, observée en essai | Limitée, surtout épaississement | Surtout préservation |\n92\t| Forme | Gel topique, 1 fois par jour | Lotion ou mousse topique | Comprimé oral (ou topique) |\n93\t| Passage dans le sang | Aucun détecté | Faible | Oui |\n94\t| Risque hormonal | Aucun | Aucun | Possible chez certains |\n95\t| Statut en 2026 | En essai, non disponible | Disponible, validé | Disponible, validé |\n96\t| Recul scientifique | Quelques années | Plusieurs décennies | Plusieurs décennies |\n97\t\n98\tLe tableau dit l'essentiel. PP405 vise un terrain que **personne d'autre n'occupe** : la régénération de follicules endormis. Mais en face, minoxidil et finastéride ont pour eux des **décennies de recul** et une disponibilité immédiate. C'est tout l'écart entre une promesse brillante et une valeur sûre. L'un n'annule pas l'autre. Le jour où PP405 sera approuvé, il viendra sans doute **compléter** ces traitements plutôt que les remplacer, en combinant le réveil métabolique et le blocage hormonal.\n99\t\n100\t## PP405 face aux autres innovations régénératives\n101\t\n102\tPP405 n'avance pas seul. Plusieurs pistes cherchent à dépasser la simple défense de l'existant. Vite fait, le tour du peloton.\n103\t\n104\t- **La verteporfine.** Une molécule au départ utilisée en ophtalmologie, étudiée à Stanford pour son effet de **cicatrisation sans fibrose** (par inhibition de la protéine YAP). En greffe capillaire, l'espoir est double : réduire les micro-cicatrices et peut-être relancer des follicules. Encore très expérimental chez l'humain pour la calvitie.\n105\t- **Les exosomes.** De minuscules vésicules issues de cellules souches, bourrées de facteurs de croissance, qui transmettent des signaux de réparation au follicule. Déjà utilisés en clinique comme soin stimulant, ils restent en cours d'évaluation rigoureuse. Le Dr Cinik les propose d'ailleurs en [traitement exosomes](https://emrahcinik.com/fr/exosomes-cheveux/).\n106\t- **Le clonage capillaire.** Le Graal lointain : multiplier vos propres follicules en laboratoire pour les réimplanter sans limite de zone donneuse. Des sociétés comme Stemson Therapeutics ou HairClone y travaillent. Mais on reste sur de la recherche, sans calendrier crédible à court terme.\n107\t\n108\tLà-dedans, PP405 a une longueur d'avance nette : **c'est le seul à afficher des résultats cliniques chiffrés chez l'humain et un calendrier de phase 3 daté**. Les autres pistes sont passionnantes, mais plus loin sur la route.\n109\t\n110\t## Calendrier, attentes et zone de prudence\n111\t\n112\tSoyons francs sur le timing, parce que c'est là que beaucoup de sites vous enfument.\n113\t\n114\tLa **phase 3**, l'étape décisive avant toute commercialisation, doit démarrer en **2026**, pour une durée d'environ un an. Elle devrait imposer une condition notable aux participants : un **arrêt d'environ six mois** des traitements en cours (minoxidil, finastéride) avant d'entrer dans l'étude, afin d'isoler l'effet propre de PP405. Pelage présentera par ailleurs ses travaux au congrès de l'**Académie américaine de dermatologie (AAD) en mars 2026**, à Denver, lors d'une session consacrée aux traitements émergents ciblant les follicules dormants.\n115\t\n116\tMais gardons la tête froide. Une phase 2a sur **78 personnes** reste une étude de **taille modeste**, avec un recul court (quatre semaines de traitement). Les fameux 31%, eux, concernent un **sous-groupe précis** : les hommes aux pertes avancées. Rien d'universel, donc. Et à ce jour, les résultats n'ont pas encore été publiés dans une revue scientifique avec relecture par les pairs, ni accompagnés de photos avant-après partagées au grand public. C'est la phase 3, menée sur des centaines de patients et sur une durée plus longue, qui dira si l'effet **tient dans le temps et à grande échelle**.\n117\t\n118\tEn clair : une approbation réglementaire n'est **pas attendue avant 2027 à 2029**, dans le meilleur des cas. PP405 est une piste sérieuse et inédite, **pas un produit en pharmacie demain matin**.\n119\t\n120\t> **Attention aux arnaques.** PP405 n'est **pas disponible** à la vente, nulle part, point. Tout site qui prétend vous en vendre, sous ce nom ou un autre, vous trompe. Le seul accès légitime, aujourd'hui, passe par les essais cliniques officiels. Méfiance absolue.\n121\t\n122\tCette molécule rejoint la courte liste des [nouveaux médicaments contre la calvitie](https://emrahcinik.com/fr/nouveaux-medicaments-calvitie/) à surveiller, aux côtés du [clascotérone](https://emrahcinik.com/fr/clascoterone-cheveux/), un autre traitement prometteur de ces dernières années.\n123\t\n124\t## Qui pourrait en bénéficier, et qui non\n125\t\n126\tVoici la vérité qu'on oublie trop souvent dans l'enthousiasme. **Un follicule endormi peut être réveillé. Un follicule mort, jamais.** Aucun traitement local ne fait repousser un cheveu là où le follicule a totalement disparu et cicatrisé. PP405 ne fera pas exception.\n127\t\n128\tToute la nuance est là. PP405 vise les **follicules miniaturisés mais encore vivants**, typiques des stades intermédiaires.\n129\t\n130\t**Les bons candidats potentiels :**\n131\t\n132\t- Personnes aux **stades précoces à modérés** de chute, où le follicule respire encore.\n133\t- Stades intermédiaires de l'[échelle de Norwood-Hamilton](https://emrahcinik.com/fr/norwood-hamilton/) chez l'homme.\n134\t- Stades intermédiaires de l'[échelle de Ludwig](https://emrahcinik.com/fr/echelle-de-ludwig/) chez la femme, sachant que l'essai a inclus des femmes, ce qui est rare et encourageant.\n135\t\n136\t**Ceux pour qui PP405 ne fera rien :**\n137\t\n138\t- [Calvitie complète](https://emrahcinik.com/fr/greffe-de-cheveux-calvitie-complete/) installée depuis longtemps, où le réservoir de cellules souches a disparu.\n139\t- Zones lisses et brillantes, cicatricielles, sans aucun follicule résiduel.\n140\t- Alopécies cicatricielles d'autre origine, qui détruisent le follicule lui-même.\n141\t\n142\tPas de cellule, pas de réveil possible. Comprendre le [cycle du cheveu](https://emrahcinik.com/fr/cycle-du-cheveu/) aide à saisir pourquoi le **timing pèse autant** : il faut agir tant que le follicule est encore là. C'est aussi pour ça qu'attendre PP405 les bras croisés pendant des années peut être une mauvaise idée. Pendant que vous attendez, des follicules qui auraient pu être sauvés finissent de s'éteindre.\n143\t\n144\t## FAQ : vos questions sur PP405\n145\t\n146\t**PP405 est-il disponible en France ou ailleurs ?**\n147\tNon. PP405 est encore en phase d'essai clinique et n'est commercialisé nulle part dans le monde. Aucune pharmacie, aucun site sérieux ne peut vous en fournir en 2026.\n148\t\n149\t**Quand pourra-t-on l'acheter ?**\n150\tSi la phase 3 confirme les résultats et que les autorités donnent leur feu vert, une mise sur le marché ne serait pas attendue avant 2027 à 2029 au plus tôt. Et seulement si tout se passe bien.\n151\t\n152\t**PP405 remplacera-t-il la greffe de cheveux ?**\n153\tNon, ce sont deux logiques différentes. PP405 réveille des follicules encore vivants. La greffe redéploie des follicules là où il n'en reste plus du tout. Sur une zone totalement dégarnie, PP405 n'a rien à réveiller.\n154\t\n155\t**Y a-t-il des effets secondaires ?**\n156\tLes essais menés à ce jour montrent une bonne tolérance, sans passage de la molécule dans le sang ni effet hormonal. Mais le recul reste court : c'est la phase 3, plus longue, qui précisera vraiment le profil de sécurité sur la durée.\n157\t\n158\t**PP405 marche-t-il chez les femmes ?**\n159\tL'essai de phase 2a a inclus des hommes et des femmes, ce qui est rare et prometteur. Les résultats les plus marquants concernaient toutefois des hommes à perte avancée. À confirmer.\n160\t\n161\t**Peut-on combiner PP405 avec le minoxidil ou le finastéride ?**\n162\tEn théorie, leurs mécanismes sont complémentaires (réveil métabolique d'un côté, blocage hormonal de l'autre). Mais aucune étude ne l'a encore validé, et la phase 3 demandera justement d'arrêter ces traitements pour mesurer l'effet propre de PP405.\n163\t\n164\t## Que faire concrètement aujourd'hui ?\n165\t\n166\tPP405 ouvre une voie passionnante. Mais en 2026, vous devez composer avec ce qui existe déjà et qui a fait ses preuves. Et ce qui marche dépend d'abord de **votre stade de chute**.\n167\t\n168\tPour une perte débutante ou modérée, les **traitements médicaux validés** gardent toute leur place, comme on le détaille dans notre guide des [traitements contre la chute de cheveux qui fonctionnent vraiment](https://emrahcinik.com/fr/traitement-chute-cheveux-efficaces/). En parallèle, les **soins régénératifs** proposés en clinique stimulent déjà les follicules affaiblis, dans le même esprit que PP405, mais disponibles maintenant. Le [PRP](https://emrahcinik.com/fr/medecine-capillaire/prp/), inclus dans tous les forfaits de greffe, relance la microcirculation. Les [exosomes](https://emrahcinik.com/fr/exosomes-cheveux/) apportent des centaines de facteurs de croissance. La [mésothérapie](https://emrahcinik.com/fr/mesotherapie-cheveux/) nourrit le cuir chevelu en profondeur.\n169\t\n170\tEt quand le follicule a disparu sur certaines zones, la seule réponse durable reste la **greffe**. Les techniques actuelles, qu'il s'agisse de la [FUE Saphir](https://emrahcinik.com/fr/greffe-de-cheveux/sapphire-fue/) ou de la [DHI](https://emrahcinik.com/fr/greffe-de-cheveux/dhi/), redéploient vos propres follicules là où il en faut, pour un résultat naturel et permanent. Le Dr Emrah Cinik, fort de plus de 20 ans d'expérience et de protocoles conformes aux standards ISHRS, examine chaque cuir chevelu pour orienter vers la bonne approche. Parfois c'est du médical, parfois c'est de la [greffe de cheveux en Turquie](https://emrahcinik.com/fr/), souvent c'est une combinaison des deux.\n171\t\n172\tLe vrai conseil ? Ne misez pas tout sur une molécule encore en essai. Agissez sur ce qui est à votre portée pendant que vos follicules sont encore là à sauver. N'hésitez pas à demander une [consultation](https://emrahcinik.com/fr/contact/) personnalisée gratuite. C'est le meilleur moyen d'y voir clair sur votre situation réelle, sans attendre 2029.\n173\t\n174\t## Références scientifiques\n175\t\n176\tFlores, A., Schell, J., Krall, A. S., Jelinek, D., Miranda, M., Grigorian, M., Braas, D., White, A. C., Zhou, J. L., Graham, N. A., Graeber, T., Seth, P., Evseenko, D., Coller, H. A., Rutter, J., Christofk, H. R., & Lowry, W. E. (2017). Lactate dehydrogenase activity drives hair follicle stem cell activation. *Nature Cell Biology*, *19*(9), 1017-1026. https://pubmed.ncbi.nlm.nih.gov/28812580/\n177\t\n178\tLiu, X., Wang, Y., Christofk, H. R., Lowry, W. E., & Jung, M. E. (2021). Development of novel mitochondrial pyruvate carrier inhibitors to treat hair loss. *Journal of Medicinal Chemistry*, *64*(4), 2046-2063. https://pubmed.ncbi.nlm.nih.gov/33534563/\n179\t\n180\tPelage Pharmaceuticals. (2025, 17 juin). *Pelage Pharmaceuticals announces positive phase 2a clinical trial results for PP405 in regenerative hair loss therapy* [Communiqué de presse]. https://pelagepharma.com/press-releases/pelage-pharmaceuticals-announces-positive-phase-2a-clinical-trial-results-for-pp405-in-regenerative-hair-loss-therapy/\n181\t\n182\tPelage Pharmaceuticals. (2025, octobre). *Pelage Pharmaceuticals announces 120 million Series B financing to advance regenerative medicine treatments for hair loss* [Communiqué de presse]. https://pelagepharma.com/press-releases/pelage-pharmaceuticals-announces-120-million-series-b-financing-to-advance-regenerative-medicine-treatments-for-hair-loss/\n183\t\n184\tPelage Pharmaceuticals. (2026). *Pelage Pharmaceuticals PP405 and its impact on follicular regeneration to be presented at the American Academy of Dermatology (AAD) annual meeting 2026* [Communiqué de presse]. https://pelagepharma.com/press-releases/pelage-pp405-aad-2026/\n185\t\n186\tNational Library of Medicine. (2024). *A study to evaluate the safety, pharmacokinetics and efficacy of PP405 in androgenetic alopecia* (NCT06393452). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06393452\n187\t\n188\tHo, C. H., Sood, T., & Zito, P. M. (2024). *Androgenetic alopecia*. StatPearls. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK430924/\n189\t\n190\tDermatology Times. (2025). *Pelage's PP405 demonstrates efficacy in phase 2a trial for androgenetic alopecia*. https://www.dermatologytimes.com/view/pelage-s-pp405-demonstrates-efficacy-in-phase-2a-trial-for-androgenetic-alopecia\n191\t"}]},"uuid":"03762227-dd4d-440b-9075-46ea3d3194b9","timestamp":"2026-06-01T10:22:00.633Z","sourceToolAssistantUUID":"292f58b7-bdb3-40bd-b069-0bcdac907ce5","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"03762227-dd4d-440b-9075-46ea3d3194b9","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_016TQkbyqBfw8uNtqu68h8Tf","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01UvsixJ6TV8RvHmYRnZhWLx","name":"Read","input":{"file_path":"/home/dev/.claude/skills/cinik-translator/SKILL.md"},"caller":{"type":"direct"}}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":22711,"cache_creation_input_tokens":10566,"cache_read_input_tokens":0,"cache_creation":{"ephemeral_5m_input_tokens":10566,"ephemeral_1h_input_tokens":0},"output_tokens":7,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNdEB5cGBsv4bZ9Zu6z","attributionAgent":"general-purpose","type":"assistant","uuid":"08c90a83-8cc9-4eb2-978f-84a5dbc8b208","timestamp":"2026-06-01T10:22:03.821Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"08c90a83-8cc9-4eb2-978f-84a5dbc8b208","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01UvsixJ6TV8RvHmYRnZhWLx","type":"tool_result","content":"1\t---\n2\tname: cinik-translator\n3\tdescription: Traduire et localiser des articles de blog médicaux Cinik (greffe de cheveux, médecine esthétique) du français vers l'anglais (UK) ou l'italien, avec détection/génération de SEO, internal linking et humanisation anti-IA. Reproduit fidèlement les workflows N8N \"Cinik - Main Orchestrator + Process FR/EN/IT\". Déclencher dès que l'utilisateur demande de traduire un article Cinik en EN ou IT, mentionne le pipeline N8N de traduction Cinik, fournit une URL de Google Doc d'article Cinik à localiser, ou évoque l'humanisation/anti-IA d'une traduction médicale Cinik. Utilise un pipeline en 4 à 5 passes : Google Translate (1er jet) puis 2 à 3 passes Opus extended thinking (Improver, Humanizer pour EN, Internal Linking, SEO Metadata). À utiliser aussi pour traiter un article FR (sans traduction, juste linking + SEO).\n4\t---\n5\t\n6\t# Cinik Translator\n7\t\n8\tPipeline complet de traduction et localisation d'articles de blog Cinik (médical, greffe de cheveux). Reproduit les 4 workflows N8N opérationnels chez Tom.\n9\t\n10\t## Vue d'ensemble du pipeline\n11\t\n12\tL'article source est en français. Le pipeline diffère selon **le type de contenu** :\n13\t\n14\t### Articles de blog Cinik (cibles : EN, IT)\n15\t\n16\t```\n17\tFR (source)  : Internal Linking -> SEO Metadata -> Google Doc FR\n18\tEN (UK)      : Google Translate EN -> UK Improver -> UK Humanizer -> Internal Linking -> SEO Metadata -> Google Doc EN\n19\tIT           : Google Translate IT -> IT Improver                 -> Internal Linking -> SEO Metadata -> Google Doc IT\n20\t```\n21\t\n22\tEN passe par 2 passes Opus (Improver + Humanizer), IT par 1 seule passe (Improver). FR ne traduit pas. Comportement identique au workflow N8N originel.\n23\t\n24\t### Pages techniques Cinik (cibles : toutes les langues du site)\n25\t\n26\tLes pages techniques (avec patterns CMS, slugs comme `greffe-de-cheveux/<page>`) sont traduites du français vers **toutes les langues du site** :\n27\t\n28\t| Code | Langue | Notes |\n29\t|---|---|---|\n30\t| en | English (UK) | Pipeline complet : Improver + Humanizer |\n31\t| it | Italiano | Improver IT |\n32\t| es | Español | Improver générique |\n33\t| pt | Português | Improver générique |\n34\t| de | Deutsch | Improver générique |\n35\t| nl | Nederlands | Improver générique |\n36\t| ro | Română | Improver générique |\n37\t| he | עברית | Improver générique (RTL) |\n38\t| cs | Čeština | Improver générique |\n39\t| ru | Русский | Improver générique |\n40\t| pl | Polski | Improver générique |\n41\t| el | Ελληνικά | Improver générique |\n42\t| ar | العربية | Improver générique (RTL) |\n43\t| fa | فارسی | Improver générique (RTL) |\n44\t| tr | Türkçe | Improver générique |\n45\t| sr-Latn | Srpski (latinica) | **Toujours alphabet latin, jamais cyrillique** |\n46\t| hr | Hrvatski | Improver générique |\n47\t\n48\tPour les langues secondaires (tout sauf EN/IT), utiliser `prompts/improver-generic.md` paramétré par langue. Le rendu est moins poli qu'avec un prompt spécifique mais reste correct si la consigne anti-IA générique est suivie.\n49\t\n50\tPour les articles de blog, **ne jamais traduire au-delà de EN+IT** sans accord explicite.\n51\t\n52\t## Comment décider blog vs page\n53\t\n54\t- **Article de blog** : présence d'un H1 éditorial, pas de patterns CMS (`load-file-*`, `section__*`), généralement avec sources académiques NIH en bas. Cible : EN + IT.\n55\t- **Page technique** : présence de patterns CMS (codes en backticks, en-têtes `**▸ bloc-N · NOM**`, séparateurs box-drawing). Cible : toutes les langues du site.\n56\t\n57\tEn cas de doute, demander à Tom avant de lancer le pipeline complet.\n58\t\n59\t## Modèle et thinking\n60\t\n61\tLe workflow N8N originel utilise `anthropic/claude-opus-4.6`. Note pour Tom : il n'existe pas de \"4.7\", l'Opus actuel est 4.6 (équivalent au modèle qui fait tourner ce skill). À chaque passe créative (Improver, Humanizer, Internal Linking), exploiter le **extended thinking** : avant de produire l'output JSON, prendre le temps de vraiment analyser le texte phrase par phrase, repérer les marques d'IA, et reformuler avec attention. Pas de mode automatique. La qualité de la fluidification dépend de la profondeur de réflexion sur chaque paragraphe.\n62\t\n63\t## Architecture en 2 phases (zéro conflit bash)\n64\t\n65\tLe sandbox bash de Cowork est mono-process. Pour traiter plusieurs langues en parallèle sans collision, le pipeline est strictement découpé :\n66\t\n67\t### Phase 1 — Orchestrateur (parent uniquement, bash série)\n68\t\n69\tLe **parent** (Claude Cowork principal, jamais un subagent) lance UNE fois le script `scripts/prepare_batch.py` qui pré-calcule tous les artefacts :\n70\t\n71\t```bash\n72\tpython3 cinik-translator/scripts/prepare_batch.py \\\n73\t    --source /path/to/source-fr.md \\\n74\t    --workdir /path/to/test-sedation \\\n75\t    --langs en,es,pt,de,nl,ro,he,cs,ru,pl,el,ar,fa,tr,sr-Latn,hr\n76\t```\n77\t\n78\tCe script fait, **en série** :\n79\t- Google Translate FR -> chaque langue cible (via `deep-translator`)\n80\t- Hreflang lookup pour chaque URL FR du source (via `requests` sur le site Cinik)\n81\t- Sauvegarde tout dans `<workdir>/translations/` :\n82\t  - `raw-{lang}.md` — premier jet GT par langue\n83\t  - `hreflang-{lang}.json` — mapping URL FR -> URL traduite (ou `keep_anchor_remove_link`)\n84\t  - `manifest.json` — index général\n85\t\n86\tUne seule commande bash, un seul process, aucun conflit possible. Durée : ~30s à 2 min selon le nb de langues.\n87\t\n88\t### Phase 2 — Subagents (parallèle, ZÉRO bash)\n89\t\n90\tUne fois la Phase 1 terminée, le parent lance N subagents (un par langue, en parallèle). Chaque subagent reçoit en input :\n91\t- Chemin du `raw-{lang}.md` (déjà pré-calculé)\n92\t- Chemin du `hreflang-{lang}.json` (mapping fourni)\n93\t- Chemins des fichiers du skill à lire (SKILL.md, prompts, references)\n94\t- Code langue cible et nom natif\n95\t\n96\tLe subagent fait UNIQUEMENT du LLM thinking + écriture de fichiers + appels MCP. **JAMAIS de bash.** Concrètement :\n97\t- `Read` pour charger les artefacts et les prompts\n98\t- `Write` / `Edit` pour produire les versions Improver/Humanizer/Polish/Linking\n99\t- pour le doc final : écrire le `.md`, puis le parent (PAS le subagent) lance le CLI `gdoc_publish.py` (voir étape 7). Les subagents ne créent pas de Doc eux-mêmes.\n100\t\n101\tLes subagents en parallèle sont totalement isolés du sandbox bash. Aucune contention possible.\n102\t\n103\t### Pourquoi cette architecture\n104\t\n105\t- **Isolation bash** : un seul process bash (parent en Phase 1), zéro process bash (subagents en Phase 2)\n106\t- **Parallélisme massif** : on peut traiter 16 langues en parallèle sans collision\n107\t- **Reproductibilité** : si un subagent échoue, on relance UNIQUEMENT lui sans refaire la Phase 1\n108\t- **Économie** : la Phase 1 (translate + hreflang) ne se fait qu'une fois par doc, pas par langue × subagent\n109\t\n110\t## Étape 0 : Récupérer l'article source\n111\t\n112\tTrois sources possibles pour le doc à traduire :\n113\t\n114\t1. **URL de Google Doc** collée dans le chat\n115\t2. **Carte Trello** (colonne \"Images à Mettre\" ou \"A publier\") qui contient le lien Google Doc dans sa description ou un commentaire. Voir `references/trello-workflow.md` pour le détail.\n116\t3. **Contenu markdown collé** ou fichier local\n117\t\n118\tPour un Google Doc, utiliser le MCP **Google Drive** (`mcp__claude_ai_Google_Drive__read_file_content` / `download_file_content`) en récupérant le contenu en markdown. Vérifier que le contenu fait au moins 100 caractères, sinon arrêter et signaler. (Le MCP `google-docs` n'est pas branché sur ce VPS.)\n119\t\n120\t**Cas particulier des pages techniques.** Certaines pages contiennent des **instructions CMS** (codes de templates, classes CSS, séparateurs box-drawing, marqueurs de blocs). Ces instructions ne doivent **jamais** être traduites. Voir la section \"Patterns CMS\" plus bas et le détail dans `references/cms-patterns.md`. Le script `scripts/translate.py` protège automatiquement la plupart des patterns, mais l'Improver et le Humanizer doivent aussi être avertis dans leur prompt.\n121\t\n122\t## Patterns CMS à préserver (CRITIQUE)\n123\t\n124\tSi l'article contient un ou plusieurs de ces signaux, c'est une page technique avec instructions CMS :\n125\t\n126\t- des codes en backticks comme `load-file-hero-1`, `section__hero_1`, `theme_blue`, `ui__button`\n127\t- des lignes de séparation faites de caractères `━` ou `─` répétés\n128\t- des en-têtes au format `**▸ bloc-N · NOM**`\n129\t- des marqueurs emoji comme `**🥖 FIL D'ARIANE**` ou `**🔍 APERÇU GOOGLE**`\n130\t- des slugs URL relatifs comme `greffe-de-cheveux/greffe-avec-sedation`\n131\t\n132\tDans ce cas, **avant chaque passe Improver/Humanizer**, ajouter en tête du prompt cette consigne explicite :\n133\t\n134\t```\n135\tIMPORTANT : ce texte contient des instructions CMS qui doivent rester intactes.\n136\tNe traduis JAMAIS (= garder identique au source FR) :\n137\t- les codes entre backticks (ex: `load-file-hero-1`, `section__header__title`)\n138\t- les lignes de séparation ━━━ ou ───\n139\t- les en-têtes **▸ bloc-N · NOM DU BLOC** : le préfixe `bloc-N` et le NOM DU BLOC restent en source FR (ex: \"bloc-4 · 3 COLONNES CIRCLE SLIDER\" reste identique, ne devient PAS \"blocco-4 · 3 COLONNE CIRCLE SLIDER\")\n140\t- les marqueurs emoji + label (ex: **🥖 FIL D'ARIANE**, **🔍 APERÇU GOOGLE** restent en français)\n141\t- tous les labels structurels CMS en MAJUSCULES qui sont des annotations dev :\n142\t    PAGE TECHNIQUE, FIL D'ARIANE, APERÇU GOOGLE, SOUS-TITRE 1/2/3, CONTENU WYSIWYG,\n143\t    DESCRIPTION (entre parenthèses), 3 COLONNES TEXTE, Colonne 1/2/3, 2 CARTES DÉTAILLÉES,\n144\t    Carte 1/2, 7 ÉTAPES CLÉS, ÉTAPES, QUESTIONS / RÉPONSES, Sources académiques\n145\t- les classes CSS (theme_blue, button_blue, etc.)\n146\t\n147\tTu peux et dois TRADUIRE :\n148\t- le slug source dans **PAGE TECHNIQUE** • SLUG : il faut produire le slug équivalent dans la langue cible (ex: \"greffe-de-cheveux/greffe-avec-sedation\" devient \"trapianto-di-capelli/trapianto-con-sedazione\" en IT, \"hair-transplant/transplant-with-sedation\" en EN)\n149\t- les titres éditoriaux en MAJUSCULES (ex: \"CONFORT MAXIMAL, ZÉRO STRESS\" -> \"COMFORT MASSIMO, ZERO STRESS\")\n150\t- le contenu humain des sections\n151\t- les labels de boutons CTA (ex: \"DIAGNOSTIC GRATUIT\" -> \"DIAGNOSI GRATUITA\")\n152\t- les questions FAQ (Q1 · ...?)\n153\t- les titres de timeline (1. CONSULTATION PRÉ-ANESTHÉSIQUE -> 1. CONSULTO PRE-ANESTESIA)\n154\t\n155\tRègle simple pour distinguer label structurel vs contenu éditorial :\n156\t- Si c'est un label visible uniquement par le développeur (annotation pour le CMS), GARDER en FR source\n157\t- Si c'est un texte affiché à l'utilisateur final sur le site, TRADUIRE\n158\t```\n159\t\n160\tRéférence complète : `references/cms-patterns.md`.\n161\t\n162\t## Étape 1 : Détecter ou générer le SEO\n163\t\n164\tAvant de traduire, il faut identifier :\n165\t- la langue source détectée\n166\t- le mot-clé principal\n167\t- le titre SEO et la meta description (existants ou à générer)\n168\t- l'URL canonique\n169\t\n170\t**1a. Détection du SEO existant.** Utiliser le prompt dans `prompts/seo-detector.md`. Cherche les patterns `<title>`, `**MD**`, `**URL**`, `Title:`, etc. dans l'article. Output JSON.\n171\t\n172\t**1b. Génération si absent.** Si `hasExistingSEO` est `false`, utiliser le prompt dans `prompts/seo-metadata-maker.md` pour générer titre, meta description et URL conformes aux règles anti-IA Cinik. Le prompt inclut les bannissements de patterns (\"Ultimate Guide\", \"Discover\", \"Revolutionary\", etc.) en EN, FR et IT.\n173\t\n174\t**1c. Fusion.** Le résultat (existant ou généré) sert de référence pour toutes les passes suivantes. Stocker sous forme d'objet `seoData` avec `primaryKeyword`, `title`, `metaDescription`, `url`, `language`.\n175\t\n176\t## Étape 2 : Premier jet via Google Translate\n177\t\n178\t**Mode subagent (Phase 2)** : ne PAS lancer le script. Le fichier `raw-{lang}.md` est déjà fourni dans le dossier `translations/` par la Phase 1 de l'orchestrateur. Le subagent fait juste `Read` dessus.\n179\t\n180\t**Mode orchestrateur (Phase 1)** : lancer le script `scripts/prepare_batch.py` qui appelle en interne `translate.py` pour toutes les langues demandées en série. Pas d'appel direct à `translate.py` en mode skill.\n181\t\n182\tLe premier jet est volontairement brut. C'est la base que les passes suivantes vont raffiner. Le script protège automatiquement les patterns CMS (codes en backticks, box-drawing, slugs, URLs) avant de les envoyer à Google Translate.\n183\t\n184\t## Étape 3 : Improver (passe de localisation)\n185\t\n186\tCette passe transforme le texte brut de Google Translate en texte qui sonne natif, en respectant les règles anti-IA Cinik.\n187\t\n188\tSelon la cible :\n189\t- EN : utiliser le prompt complet dans `prompts/improver-en.md` (UK English, ~7400 chars de règles)\n190\t- IT : utiliser le prompt complet dans `prompts/improver-it.md` (italien, ~7800 chars)\n191\t\n192\tLes deux prompts ont la même structure : vocabulaire interdit, patterns de contenu à éliminer, patterns linguistiques, règles de style, conclusions, voix.\n193\t\n194\t**Comment travailler.** Lire le prompt en entier avant de commencer. Ensuite, lire le texte brut. Faire un premier passage mental section par section pour identifier les pires marques d'IA (importance gonflée, participes présents en chaîne, langage promotionnel). Réécrire en restant fidèle au sens. Output JSON `{\"improved_text\": \"...\"}`.\n195\t\n196\t**Préserver impérativement** : les liens markdown, les URLs, les noms propres médicaux, les chiffres, les sources scientifiques.\n197\t\n198\t## Étape 4 : Humanizer (EN uniquement)\n199\t\n200\tPour l'anglais seulement, après l'Improver, faire une seconde passe avec `prompts/humanizer-en.md`. Cette passe est plus exigeante : 3 lectures successives, identification des dernières marques d'IA, reformulation jusqu'à ce que le texte passe le test \"un collègue suspecterait-il l'IA ?\".\n201\t\n202\tL'IT n'a pas cette passe dans le workflow N8N originel. Si le résultat IT semble trop brut, on peut faire une 2ème passe Improver sur le texte avant Internal Linking, mais ce n'est pas le défaut.\n203\t\n204\tOutput JSON `{\"humanized_text\": \"...\"}`.\n205\t\n206\t## Étape 5 : Internal Linking (avec règle hreflang)\n207\t\n208\tEnrichir l'article avec des liens internes vers d'autres pages Cinik. **Approche prioritaire : utiliser les hreflang du site source pour mapper les URLs**.\n209\t\n210\t### Règle métier hreflang (Tom)\n211\t\n212\t**Approche :** pour chaque lien interne FR de l'article source, on cherche l'équivalent dans la langue cible via les hreflang du site Cinik. Si trouvé, on remplace. Sinon, on garde l'ancre sans lien.\n213\t\n214\t**Pas de lien home obligatoire.** Cette règle n'existe pas. On ne force jamais un lien vers la home, on traite uniquement les liens déjà présents dans le source.\n215\t\n216\t**Mode subagent (Phase 2)** : ne PAS lancer hreflang_lookup. Le mapping est déjà dans `translations/hreflang-{lang}.json`. Read ce fichier et applique l'`action` indiquée pour chaque URL FR.\n217\t\n218\tFormat du mapping :\n219\t```json\n220\t{\n221\t  \"https://emrahcinik.com/fr/greffe-de-cheveux/\": {\"found\": true, \"target_url\": \"https://emrahcinik.com/it/...\", \"action\": \"replace_url\"},\n222\t  \"https://emrahcinik.com/fr/prix-greffe-cheveux/\": {\"found\": false, \"action\": \"keep_anchor_remove_link\", \"reason\": \"home_fallback\"}\n223\t}\n224\t```\n225\t\n226\tActions :\n227\t1. `replace_url` : remplacer l'URL FR par `target_url`, traduire l'ancre naturellement.\n228\t2. `keep_anchor_remove_link` : garder le texte de l'ancre, supprimer le markdown link. Pas de fallback home, pas de lien.\n229\t\n230\t**Mode orchestrateur (Phase 1)** : `prepare_batch.py` calcule ce mapping pour toutes les langues en série. Le subagent ne touche pas à bash.\n231\t\n232\tExemple :\n233\t```\n234\tSource FR : Voir [notre page sur la greffe FUE](https://emrahcinik.com/fr/greffe-fue/) pour plus de détails.\n235\t\n236\tSi équivalent IT trouvé -> Vedi la nostra [pagina sul trapianto FUE](https://emrahcinik.com/it/trapianto-fue/) per maggiori dettagli.\n237\tSi pas d'équivalent IT -> Vedi la nostra pagina sul trapianto FUE per maggiori dettagli.   (texte sans lien)\n238\t```\n239\t\n240\tCette règle évite les liens cassés et les liens qui ramènent vers une home générique. Le site Cinik est la source de vérité.\n241\t\n242\t### Liens internes additionnels (au-delà des liens du source)\n243\t\n244\tSi l'article source contient peu de liens internes et qu'il y a des opportunités évidentes (mention d'une autre page Cinik dans le texte), on peut éventuellement en ajouter, **mais seulement si l'équivalent existe via hreflang dans la langue cible**. Si pas d'équivalent, on n'ajoute pas le lien.\n245\t\n246\tLes Google Sheets de pages par langue (`references/sources-databases.md`) restent disponibles en complément. Avec la règle hreflang, elles deviennent secondaires.\n247\t\n248\t### Prompts à utiliser\n249\t\n250\t- FR : `prompts/internal-linking-fr.md` (long, inclut les règles anti-IA car FR ne passe pas par l'Improver)\n251\t- EN : `prompts/internal-linking-en.md` (court)\n252\t- IT : `prompts/internal-linking-it.md` (court)\n253\t- Autres langues : adapter le prompt EN ou IT à la langue cible\n254\t\n255\t**Règles strictes.**\n256\t- Pas de lien home injecté de force\n257\t- Pas de doublon de lien vers la même URL\n258\t- Préserver les liens existants (en appliquant la règle hreflang)\n259\t- Format markdown\n260\t- Si l'URL d'un lien existant ne se traduit pas, garder l'ancre, virer le markdown link\n261\t\n262\tOutput JSON avec `enrichedArticleWithLinks`, `linksReplaced` (URLs FR remplacées par leur équivalent), `linksRemoved` (URLs FR sans équivalent, ancre conservée), `totalLinksTranslated`.\n263\t\n264\t## Étape 6 : SEO Metadata final\n265\t\n266\tSi on a généré le SEO à l'étape 1b, c'est déjà fait. Sinon, adapter au target language : utiliser `prompts/seo-metadata-maker.md` qui gère FR/EN/IT en respectant les règles anti-IA spécifiques à chaque langue.\n267\t\n268\tOutput JSON avec `primaryKeyword`, `language`, `title` (≤ 70 chars, finit par `| Dr Cinik`), `titleCharCount`, `metaDescription` (150-160 chars), `metaDescCharCount`, `url`.\n269\t\n270\t## Étape 7 : Créer le Google Doc final\n271\t\n272\tFormat à respecter dans le Google Doc :\n273\t\n274\t```markdown\n275\t**URL** : https://emrahcinik.com/{lang}/{slug}\n276\t\n277\t**<title>** : Titre SEO | Dr Cinik\n278\t\n279\t**MD** : Meta description optimisée\n280\t\n281\t---\n282\t\n283\t# Titre H1 de l'article\n284\t\n285\t[contenu enrichi avec liens internes]\n286\t```\n287\t\n288\tCréer le Doc via le **CLI partagé** du skill de rédaction (Markdown → Google Doc formaté + partage writer à assous.tom@gmail.com, en un appel) :\n289\t\n290\t```bash\n291\tVPY=/home/dev/.claude/skills/cinik-blog-brief/.venv/bin/python\n292\t\"$VPY\" ~/.claude/skills/cinik-blog-brief/scripts/gdoc_publish.py \\\n293\t  --md /chemin/vers/slug-{lang}.md \\\n294\t  --title \"Cinik - {primaryKeyword} ({lang}) - {date}\"\n295\t```\n296\t\n297\tRécupérer l'URL sur la dernière ligne (`URL=...`). Voir l'étape 6b du skill `cinik-blog-brief` pour l'autorisation initiale (une seule fois) et les options (`--share-email`, `--link-share`, `--folder`).\n298\t\n299\tImportant : pas de `.docx`, uniquement la conversion Markdown → Google Doc formaté via ce CLI. L'ancien MCP `mcp__google-docs__createDocument` n'est pas branché ; ne pas l'utiliser.\n300\t\n301\t## Étape 8 : Validation finale et présentation à Tom\n302\t\n303\tAvant de déclarer le travail terminé, vérifier :\n304\t\n305\t- 0 em dash (U+2014) et 0 en dash (U+2013) dans le texte final\n306\t- titre SEO ≤ 70 caractères, finit par ` | Dr Cinik`\n307\t- meta description entre 150 et 160 caractères\n308\t- au moins un lien vers la home avec l'anchor exacte\n309\t- aucun doublon de lien\n310\t- liens markdown valides\n311\t- pas de patterns IA flagrants en relisant le premier et le dernier paragraphe\n312\t\n313\tPrésenter à Tom :\n314\t- l'URL du Google Doc créé\n315\t- les stats : nombre de mots, nombre de liens internes, conformité titre/MD\n316\t- les choix éventuels qui méritent un coup d'œil (ex : un terme médical traduit de manière non triviale)\n317\t\n318\tTom valide AVANT toute publication ailleurs (cf. CLAUDE.md global). Ne jamais publier directement sans son go.\n319\t\n320\t## Inputs attendus\n321\t\n322\tL'utilisateur fournit en pratique :\n323\t1. URL d'un Google Doc FR, contenu collé, ou URL/ID d'une carte Trello\n324\t2. Langue(s) cible : `en`, `it`, `fr` (ou plusieurs)\n325\t3. Optionnel : SEO existant à respecter, contraintes spéciales\n326\t\n327\tSi plusieurs langues sont demandées, traiter en série (pas en parallèle dans la même passe). Faire FR d'abord (linking + SEO), puis EN, puis IT, en réutilisant le SEO source détecté/généré comme référence.\n328\t\n329\t## Intégration Trello\n330\t\n331\tQuand l'utilisateur demande \"check les cartes à traduire\" ou fournit l'URL d'un board Trello, utiliser le MCP Trello (`@delorenj/mcp-server-trello`) pour :\n332\t\n333\t1. **Lire les colonnes \"Images à Mettre\" et \"A publier\"** : identifier les cartes contenant un lien Google Doc FR sans traduction EN/IT déjà liée.\n334\t2. **Extraire le lien Google Doc** depuis la description ou les commentaires de chaque carte.\n335\t3. **Lancer le pipeline de traduction** sur chaque doc.\n336\t4. **Mettre à jour la description de la carte** avec un tableau récapitulatif des liens FR/EN/IT (voir format dans `references/trello-workflow.md`).\n337\t\n338\tSi le MCP Trello n'est pas installé/connecté, basculer en mode dégradé : demander à Tom de copier-coller manuellement les URLs des Google Docs. Lui rappeler les instructions d'installation dans `INSTALL.md`.\n339\t\n340\t**Important.** Ne jamais déplacer une carte automatiquement vers une colonne \"Traduit\" ou \"Validé\" : Tom valide la qualité d'abord. Le skill ajoute juste les liens, c'est Tom qui décide du mouvement.\n341\t\n342\tVoir `references/trello-workflow.md` pour les détails (tools MCP exposés, format des commentaires, gestion des erreurs).\n343\t\n344\t## Erreurs courantes à éviter\n345\t\n346\t- **Écrire un em dash dans le texte final.** Tom ne le tolère jamais. À chaque passe, vérifier que `grep -P '\\xe2\\x80\\x94' fichier.md` et `grep -P '\\xe2\\x80\\x93' fichier.md` ne renvoient rien (codes UTF-8 du em dash et en dash).\n347\t- **Sauter l'étape Google Translate** et essayer de traduire directement avec Opus. Le pipeline N8N a été calibré avec GT comme premier jet, c'est ce qui permet aux passes suivantes de se concentrer sur la naturalisation. Ne pas court-circuiter.\n348\t- **Localiser les noms propres ou les chiffres.** Dr Emrah Cinik reste Dr Emrah Cinik. Les pourcentages aussi.\n349\t- **Oublier le lien vers la home** dans Internal Linking. Toujours obligatoire.\n350\t- **Bourrer de liens internes.** Viser 5 à 10 liens uniques pour un article de 1500 mots, pas 30.\n351\t- **Ignorer les liens existants** dans le source FR. Les préserver dans la version traduite.\n352\t\n353\t## Fichiers du skill\n354\t\n355\t- `prompts/seo-detector.md` : détecte le SEO existant\n356\t- `prompts/seo-metadata-maker.md` : génère le SEO si absent (FR/EN/IT)\n357\t- `prompts/improver-en.md` : passe Improver UK English (long, complet)\n358\t- `prompts/humanizer-en.md` : passe Humanizer UK English\n359\t- `prompts/improver-it.md` : passe Improver italien\n360\t- `prompts/internal-linking-fr.md` : linking + anti-IA pour FR (long)\n361\t- `prompts/internal-linking-en.md` : linking EN (court)\n362\t- `prompts/internal-linking-it.md` : linking IT (court)\n363\t- `references/workflow-architecture.md` : doc de l'architecture N8N originelle\n364\t- `references/sources-databases.md` : IDs et structures des sheets de pages\n365\t- `references/cms-patterns.md` : patterns CMS Cinik à préserver pendant la traduction\n366\t- `references/trello-workflow.md` : intégration Trello (lecture cartes, mise à jour descriptions)\n367\t- `scripts/translate.py` : script Google Translate via deep-translator (avec protection des patterns CMS)\n368\t"}]},"uuid":"921a3689-7675-43cc-a0a4-3277ad35d0c7","timestamp":"2026-06-01T10:22:03.846Z","sourceToolAssistantUUID":"08c90a83-8cc9-4eb2-978f-84a5dbc8b208","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"921a3689-7675-43cc-a0a4-3277ad35d0c7","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01KuR4sjgXt1RPHcgWai5BGD","type":"message","role":"assistant","content":[{"type":"text","text":"Now let me read the prompt files for the translation passes."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":1740,"cache_creation_input_tokens":43651,"cache_read_input_tokens":10566,"cache_creation":{"ephemeral_5m_input_tokens":43651,"ephemeral_1h_input_tokens":0},"output_tokens":2,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNdjp3cpyoaZYPnuBZo","attributionAgent":"general-purpose","type":"assistant","uuid":"6586cbee-0dae-4af2-8687-c71809c7dcc4","timestamp":"2026-06-01T10:22:06.271Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"6586cbee-0dae-4af2-8687-c71809c7dcc4","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01KuR4sjgXt1RPHcgWai5BGD","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01DoQ1rsW9igAywBiH6yYBG7","name":"Read","input":{"file_path":"/home/dev/.claude/skills/cinik-translator/prompts/improver-en.md"},"caller":{"type":"direct"}}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":1740,"cache_creation_input_tokens":43651,"cache_read_input_tokens":10566,"cache_creation":{"ephemeral_5m_input_tokens":43651,"ephemeral_1h_input_tokens":0},"output_tokens":2,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNdjp3cpyoaZYPnuBZo","attributionAgent":"general-purpose","type":"assistant","uuid":"4d3a43f6-714c-4779-aa3a-58422370c190","timestamp":"2026-06-01T10:22:07.190Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"4d3a43f6-714c-4779-aa3a-58422370c190","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01DoQ1rsW9igAywBiH6yYBG7","type":"tool_result","content":"1\t=You are an expert linguist and content localiser specialising in adapting content for the United Kingdom. Your task is to translate, refine, and improve the following text, making it sound natural and relevant to a UK audience, as if written by a native UK English speaker.\n2\t\n3\t**Text to improve:** `{{ $json.translatedText }}`\n4\t\n5\t**Instructions:**\n6\t1. Analyse the content thoroughly\n7\t2. Apply UK localisation rules (British spelling, cultural references)\n8\t3. Enhance natural language with UK expressions\n9\t4. Handle specific content (preserve URLs, markdown)\n10\t5. Apply ALL anti-AI rules below rigorously\n11\t\n12\t---\n13\t\n14\t## ANTI-AI WRITING RULES (MANDATORY)\n15\t\n16\tYour output will be rejected if it contains AI writing patterns. Follow every rule below.\n17\t\n18\t### SECTION 1: Banned vocabulary\n19\t\n20\tNever use any of these words or phrases. Replace them with simpler, more specific alternatives:\n21\t\n22\tdelve, tapestry, vibrant, landscape (figurative), pivotal, crucial, foster, garner, underscore, showcase, testament, enduring, intricate, intricacies, interplay, additionally, furthermore, moreover, it is important to note, in order to, at its core, nestled, in the heart of, groundbreaking, renowned, breathtaking, serves as, stands as, represents a, marks a, not only...but also, it's not just about, seamless, comprehensive, robust, leverage, facilitate, navigate (figurative), realm, multifaceted, holistic, paradigm, synergy, empower, harness, spearhead, cutting-edge, state-of-the-art, game-changing, transformative, revolutionary\n23\t\n24\t### SECTION 2: Content patterns to eliminate\n25\t\n26\t**2a. Inflated significance and legacy language**\n27\tBAD: \"The procedure marks a pivotal moment in the evolution of hair restoration, underscoring its vital role in modern medicine.\"\n28\tGOOD: \"The procedure has become more common since 2015.\"\n29\t\n30\tBAD: \"This initiative serves as an enduring testament to the clinic's commitment to excellence.\"\n31\tGOOD: \"The clinic has offered this procedure since 2010.\"\n32\t\n33\tRule: Remove all claims about something being pivotal, transformative, a testament to, reshaping the landscape, setting the stage for, marking a shift, etc. Replace with specific facts.\n34\t\n35\t**2b. Superficial -ing analyses**\n36\tBAD: \"The clinic uses advanced technology, highlighting its dedication to patient care and showcasing the latest innovations, reflecting broader trends in the industry.\"\n37\tGOOD: \"The clinic uses FUE extraction with sapphire blades, which reduces healing time.\"\n38\t\n39\tRule: Delete every trailing participial phrase (highlighting, showcasing, reflecting, emphasising, underscoring, symbolising, contributing to, cultivating, fostering, encompassing). Rewrite as a separate sentence with a specific fact if the information matters.\n40\t\n41\t**2c. Promotional and advertisement language**\n42\tBAD: \"Nestled within the breathtaking region of Istanbul, Dr Cinik's renowned clinic boasts a vibrant atmosphere and stunning facilities.\"\n43\tGOOD: \"Dr Cinik's clinic is in Istanbul's Sisli district, with capacity for 50 patients per day.\"\n44\t\n45\tRule: Remove all of: nestled, breathtaking, stunning, vibrant, renowned, world-class, must-visit, boasts a, natural beauty, rich heritage, in the heart of. Replace vague praise with specific details.\n46\t\n47\t**2d. Vague attributions and weasel words**\n48\tBAD: \"Experts agree that this technique represents a breakthrough in hair restoration.\"\n49\tGOOD: \"A 2023 study in the Journal of Dermatologic Surgery found 94% graft survival with this technique.\"\n50\t\n51\tRule: Never write \"experts say\", \"studies show\", \"observers note\", \"industry reports suggest\" without naming a specific source. If you don't have a source, state the fact without attribution.\n52\t\n53\t**2e. Formulaic challenges sections**\n54\tBAD: \"Despite these challenges, the clinic continues to thrive, setting the stage for future innovations.\"\n55\tGOOD: \"Recovery takes 10-14 days. Some patients experience swelling for the first 3 days.\"\n56\t\n57\tRule: Don't create formulaic \"challenges and future outlook\" sections. State specific limitations factually.\n58\t\n59\t### SECTION 3: Language and grammar patterns\n60\t\n61\t**3a. Copula avoidance**\n62\tBAD: \"The FUE technique serves as the foundation for modern transplants.\"\n63\tGOOD: \"FUE is the basis for modern transplants.\"\n64\t\n65\tBAD: \"Dr Cinik stands as one of the leading surgeons.\"\n66\tGOOD: \"Dr Cinik is one of the leading surgeons.\"\n67\t\n68\tRule: Use \"is\", \"are\", \"has\" directly. Never write \"serves as\", \"stands as\", \"functions as\", \"marks a\", \"represents a\" when you mean \"is\".\n69\t\n70\t**3b. Negative parallelisms**\n71\tBAD: \"It's not just about the technique; it's about the entire patient experience.\"\n72\tGOOD: \"The technique matters, but so does aftercare.\"\n73\t\n74\tRule: Remove all \"not only...but also\" and \"it's not just...it's\" constructions.\n75\t\n76\t**3c. Rule of three**\n77\tBAD: \"Patients benefit from innovation, expertise, and compassion.\"\n78\tGOOD: \"Patients benefit from experienced surgeons and modern equipment.\"\n79\t\n80\tRule: Don't force ideas into groups of exactly three. Use two, four, or however many are actually needed.\n81\t\n82\t**3d. Synonym cycling**\n83\tBAD: \"The surgeon performs the operation. The physician conducts the procedure. The specialist carries out the intervention.\"\n84\tGOOD: \"The surgeon performs the operation over 6-8 hours.\"\n85\t\n86\tRule: Don't use four different words for the same thing just to avoid repetition. Repeating a word is fine.\n87\t\n88\t### SECTION 4: Style patterns\n89\t\n90\t**4a. Em dash overuse**\n91\tRule: Use em dashes (--) no more than once per 500 words. Use commas, full stops, or parentheses instead.\n92\t\n93\t**4b. Boldface and formatting**\n94\tRule: Don't bold key terms mechanically. Only use bold for actual headings. Don't create bold-colon list items like \"**Recovery:** The recovery period...\"\n95\t\n96\t**4c. Headers**\n97\tRule: Use sentence case in headings (\"Recovery after surgery\"), not Title Case (\"Recovery After Surgery\").\n98\t\n99\t### SECTION 5: Filler and hedging\n100\t\n101\tReplace these automatically:\n102\t- \"In order to\" -> \"To\"\n103\t- \"Due to the fact that\" -> \"Because\"\n104\t- \"At this point in time\" -> \"Now\"\n105\t- \"In the event that\" -> \"If\"\n106\t- \"Has the ability to\" -> \"Can\"\n107\t- \"It is important to note that\" -> delete, just state the fact\n108\t- \"It is worth mentioning that\" -> delete\n109\t- \"Furthermore\" / \"Moreover\" / \"Additionally\" -> delete or use \"Also\" sparingly\n110\t\n111\tRemove excessive hedging:\n112\tBAD: \"It could potentially be argued that the technique might have some positive effect.\"\n113\tGOOD: \"The technique may improve graft survival.\"\n114\t\n115\t### SECTION 6: Conclusions\n116\t\n117\tBAD: \"The future looks bright for hair restoration. Exciting times lie ahead.\"\n118\tGOOD: \"Clinical trials for stem cell treatments are expected to report results in 2026.\"\n119\t\n120\tRule: Never end with vague optimism. End with a specific fact, a practical recommendation, or simply stop when the content is done.\n121\t\n122\t---\n123\t\n124\t## VOICE AND SOUL\n125\t\n126\tAvoiding AI patterns is only half the job. Sterile, voiceless writing is equally obvious.\n127\t\n128\t**Vary your rhythm.** Short sentences. Then longer ones that take their time. Mix it up naturally.\n129\t\n130\t**Be specific.** Not \"advanced technology\" but \"a motorised punch with 0.8mm diameter\".\n131\t\n132\t**Use simple verbs.** \"Is\", \"has\", \"does\". Not \"encompasses\", \"facilitates\", \"leverages\".\n133\t\n134\t**Write for a knowledgeable reader.** Assume the reader knows what a hair transplant is. Don't over-explain basics.\n135\t\n136\t**Keep a professional but warm tone.** This is a medical blog, not a sales brochure and not a textbook.\n137\t\n138\t---\n139\t\n140\t**Output Format:** Return your response as a JSON object:\n141\t\n142\t```json\n143\t{\n144\t  \"improved_text\": \"The complete refined and adapted text in UK English\"\n145\t}\n146\t```"}]},"uuid":"70256359-8f04-4945-b628-2f54565374f0","timestamp":"2026-06-01T10:22:07.203Z","sourceToolAssistantUUID":"4d3a43f6-714c-4779-aa3a-58422370c190","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"70256359-8f04-4945-b628-2f54565374f0","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01KuR4sjgXt1RPHcgWai5BGD","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01CihfsvfTTHHBPUHKxXG3Ed","name":"Read","input":{"file_path":"/home/dev/.claude/skills/cinik-translator/prompts/humanizer-en.md"},"caller":{"type":"direct"}}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":1740,"cache_creation_input_tokens":43651,"cache_read_input_tokens":10566,"cache_creation":{"ephemeral_5m_input_tokens":43651,"ephemeral_1h_input_tokens":0},"output_tokens":2,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNdjp3cpyoaZYPnuBZo","attributionAgent":"general-purpose","type":"assistant","uuid":"14c917d9-869e-4ebd-a702-3c62af123742","timestamp":"2026-06-01T10:22:07.249Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"14c917d9-869e-4ebd-a702-3c62af123742","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01CihfsvfTTHHBPUHKxXG3Ed","type":"tool_result","content":"1\t=You are a senior medical content editor at a UK health publication. Your only job is to make this text sound like a real human wrote it. You must be ruthless about removing every trace of AI writing.\n2\t\n3\t**Input Text:** \"{{ $json.improved_text }}\"\n4\t\n5\t---\n6\t\n7\t## YOUR PROCESS (follow this exactly)\n8\t\n9\t**Pass 1:** Read the text. For every sentence, ask: \"Would a real UK medical writer phrase it this way?\" If no, rewrite it.\n10\t\n11\t**Pass 2:** Read your rewrite. Ask: \"What still makes this obviously AI-generated?\" Identify the remaining tells and fix them.\n12\t\n13\t**Pass 3:** Final read. If any paragraph sounds like it could appear in a ChatGPT response, rewrite that paragraph.\n14\t\n15\t---\n16\t\n17\t## COMPLETE PATTERN CATALOG\n18\t\n19\t### A. CONTENT PATTERNS\n20\t\n21\t**A1. Inflated significance**\n22\tWords that signal this: stands/serves as, is a testament/reminder, vital/significant/crucial/pivotal role, underscores/highlights importance, reflects broader, symbolising ongoing/enduring, setting the stage, marking/shaping, represents a shift, key turning point, evolving landscape, indelible mark, deeply rooted\n23\t\n24\tBAD: \"FUE transplantation marks a pivotal moment in the evolution of hair restoration, underscoring its vital role in modern aesthetic medicine and setting the stage for future innovations.\"\n25\tGOOD: \"FUE has been the most common transplant method since around 2010.\"\n26\t\n27\t**A2. Undue notability claims**\n28\tBAD: \"Dr Cinik's work has been featured in national and international media outlets, garnering widespread recognition.\"\n29\tGOOD: \"Dr Cinik was interviewed by the BBC in 2023 about medical tourism in Turkey.\"\n30\t\n31\t**A3. Superficial -ing analyses**\n32\tBanned endings: highlighting, underscoring, emphasising, ensuring, reflecting, symbolising, contributing to, cultivating, fostering, encompassing, showcasing\n33\t\n34\tBAD: \"The clinic uses sapphire blades, ensuring precision and showcasing their commitment to innovation, reflecting broader industry trends.\"\n35\tGOOD: \"The clinic uses sapphire blades. These make smaller incisions than steel, which helps grafts heal faster.\"\n36\t\n37\tRule: If you see a sentence ending with one of these -ing phrases, delete the phrase. If the information matters, make it a new sentence with a specific fact.\n38\t\n39\t**A4. Promotional language**\n40\tBanned: boasts a, vibrant, rich (figurative), profound, enhancing its, showcasing, exemplifies, commitment to, natural beauty, nestled, in the heart of, groundbreaking, renowned, breathtaking, must-visit, stunning, world-class, state-of-the-art, cutting-edge, seamless, unparalleled\n41\t\n42\tBAD: \"Nestled in the heart of Istanbul, this world-class clinic boasts stunning facilities and an unparalleled commitment to patient care.\"\n43\tGOOD: \"The clinic is in central Istanbul. It has 12 operating rooms and treats about 150 patients per week.\"\n44\t\n45\t**A5. Vague attributions**\n46\tBAD: \"Studies have shown that this technique produces superior results. Experts agree it represents a breakthrough.\"\n47\tGOOD: \"A 2022 trial at Ankara University found 96% graft survival with DHI compared to 91% with standard FUE.\"\n48\t\n49\tRule: Name the source or drop the attribution entirely. Never write \"experts say/believe/agree\" or \"studies show/suggest\".\n50\t\n51\t**A6. Formulaic challenges sections**\n52\tBAD: \"Despite its many advantages, the procedure faces certain challenges. Despite these challenges, the future remains bright.\"\n53\tGOOD: \"The main downside is cost: a full session runs between 2,000 and 4,000 pounds. Scarring is minimal but visible under very short haircuts.\"\n54\t\n55\t### B. LANGUAGE PATTERNS\n56\t\n57\t**B1. Overused AI vocabulary (replace every instance)**\n58\tAdditionally -> Also (or delete), align with -> match, crucial -> important (or delete), delve -> look at/examine, emphasising -> (delete), enduring -> lasting, enhance -> improve, fostering -> building/encouraging, garner -> get/earn, highlight (verb) -> show/point out, interplay -> connection, intricate -> complex/detailed, key (adjective) -> main/important, landscape (abstract) -> field/area, pivotal -> important, showcase -> show/demonstrate, tapestry (abstract) -> mix/range, testament -> proof/sign, underscore (verb) -> show, valuable -> useful, vibrant -> lively (or delete)\n59\t\n60\t**B2. Copula avoidance (use \"is\"/\"are\" directly)**\n61\tBAD: \"The procedure serves as a reliable option.\" -> GOOD: \"The procedure is a reliable option.\"\n62\tBAD: \"Dr Cinik stands as a leader.\" -> GOOD: \"Dr Cinik is a leader.\"\n63\tBAD: \"This marks a significant development.\" -> GOOD: \"This is a significant development.\" (or better: state what changed specifically)\n64\t\n65\t**B3. Negative parallelisms**\n66\tDelete all: \"Not only X but also Y\", \"It's not just X; it's Y\", \"It's not merely X, it's Y\"\n67\tRewrite as plain statements.\n68\t\n69\t**B4. Rule of three**\n70\tBAD: \"innovation, expertise, and compassion\" / \"speed, precision, and comfort\"\n71\tGOOD: Use two items, or four, or however many are actually relevant. Three in a row is an AI tell.\n72\t\n73\t**B5. Synonym cycling**\n74\tBAD: \"The surgeon performs the procedure. The physician conducts the operation. The specialist carries out the intervention. The doctor executes the treatment.\"\n75\tGOOD: \"The surgeon performs the procedure, which takes 6-8 hours.\"\n76\tRule: Repeating a word is fine. Cycling through synonyms is worse.\n77\t\n78\t**B6. False ranges**\n79\tBAD: \"from initial consultation to final result, from follicle extraction to post-operative care\"\n80\tGOOD: \"The process covers consultation, extraction, and aftercare.\"\n81\t\n82\t### C. STYLE PATTERNS\n83\t\n84\t**C1. Em dashes**: Maximum one per 500 words. Use commas or full stops instead.\n85\t\n86\t**C2. Boldface**: Don't bold terms mechanically. No \"**Key benefit:** ...\" patterns.\n87\t\n88\t**C3. Headers**: Sentence case only. \"Recovery after surgery\" not \"Recovery After Surgery\".\n89\t\n90\t**C4. Lists**: Don't create bold-colon vertical lists. Write in prose.\n91\t\n92\t### D. FILLER AND HEDGING\n93\t\n94\tReplace automatically:\n95\t- \"In order to\" -> \"To\"\n96\t- \"Due to the fact that\" -> \"Because\"\n97\t- \"At this point in time\" -> \"Now\"\n98\t- \"It is important to note that\" -> (delete, state the fact)\n99\t- \"It is worth mentioning\" -> (delete)\n100\t- \"Furthermore\" / \"Moreover\" / \"Additionally\" -> (delete or \"Also\")\n101\t- \"Has the ability to\" -> \"Can\"\n102\t- \"In the event that\" -> \"If\"\n103\t\n104\tHedging: \"It could potentially be argued that X might have some effect\" -> \"X may help.\"\n105\t\n106\t### E. CONCLUSIONS\n107\t\n108\tBAD: \"The future looks bright. Exciting times lie ahead as the field continues to evolve.\"\n109\tGOOD: End with a practical recommendation or specific fact. Or just stop.\n110\t\n111\t---\n112\t\n113\t## VOICE AND SOUL\n114\t\n115\tSterile, voiceless writing is as obvious as slop. Good writing has a human behind it.\n116\t\n117\t**Signs of soulless writing (even if technically clean):**\n118\t- Every sentence is the same length and structure\n119\t- No opinions, just neutral reporting\n120\t- No acknowledgment of uncertainty or nuance\n121\t- Reads like a press release\n122\t\n123\t**How to fix it:**\n124\t- Vary rhythm. Short sentences. Then longer ones that take their time getting somewhere.\n125\t- Be specific about details. Not \"advanced equipment\" but \"a HARRTS X2 robotic arm\".\n126\t- Use simple verbs. \"Is\", \"has\", \"does\". Not \"encompasses\", \"facilitates\".\n127\t- Acknowledge complexity when it exists. \"Recovery is usually straightforward, though some patients find the first three days uncomfortable\" is more honest than pretending it's always easy.\n128\t- Write as if explaining to a knowledgeable colleague, not selling to a customer.\n129\t\n130\t---\n131\t\n132\t## FINAL CHECK\n133\t\n134\tBefore returning your output, reread it and honestly answer: \"If I showed this to a colleague, would they suspect AI wrote it?\" If the answer is yes or maybe, revise until the answer is no.\n135\t\n136\t**Output Format:**\n137\t```json\n138\t{\n139\t  \"humanized_text\": \"The naturally enhanced UK English text\"\n140\t}\n141\t```"}]},"uuid":"9fe46cd2-4f5f-45cd-b24a-c4653d151f2c","timestamp":"2026-06-01T10:22:07.269Z","sourceToolAssistantUUID":"14c917d9-869e-4ebd-a702-3c62af123742","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"9fe46cd2-4f5f-45cd-b24a-c4653d151f2c","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01GNkQqVNLvYm1SsbVa46Yw8","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01MYimsX1p4ffBfSxZmHM9Gg","name":"Read","input":{"file_path":"/home/dev/.claude/skills/cinik-translator/prompts/improver-it.md"},"caller":{"type":"direct"}}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":8286,"cache_read_input_tokens":54217,"cache_creation":{"ephemeral_5m_input_tokens":8286,"ephemeral_1h_input_tokens":0},"output_tokens":44,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNdydFMaaSr9igw1fSy","attributionAgent":"general-purpose","type":"assistant","uuid":"2e6378a5-0c16-4bc5-9220-298c6e7ae388","timestamp":"2026-06-01T10:22:09.753Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"2e6378a5-0c16-4bc5-9220-298c6e7ae388","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01MYimsX1p4ffBfSxZmHM9Gg","type":"tool_result","content":"1\t=Sei un esperto linguista e redattore medico specializzato nella localizzazione di contenuti in italiano. Il tuo compito e raffinare e migliorare il seguente testo per un pubblico italiano, facendolo suonare come se fosse stato scritto da un giornalista medico italiano madrelingua.\n2\t\n3\t**Testo da migliorare:** `{{ $json.translatedText }}`\n4\t\n5\t**Istruzioni:**\n6\t1. Analizza il contenuto a fondo\n7\t2. Applica le regole di localizzazione italiana (espressioni naturali, riferimenti culturali)\n8\t3. Preserva URL e markdown\n9\t4. Applica TUTTE le regole anti-IA qui sotto in modo rigoroso\n10\t\n11\t---\n12\t\n13\t## REGOLE ANTI-IA (OBBLIGATORIE)\n14\t\n15\tIl tuo output sara rifiutato se contiene pattern di scrittura IA. Segui ogni regola.\n16\t\n17\t### SEZIONE 1: Vocabolario vietato\n18\t\n19\tNon usare mai queste parole/frasi. Sostituiscile con alternative piu semplici e specifiche:\n20\t\n21\tapprofondire (senso figurato), tessuto/trama (figurato), vibrante (figurato), panorama/paesaggio (astratto), cruciale, fondamentale (inflazionato), promuovere/favorire (generico), sottolineare, mettere in mostra/vetrina, testimonianza, duraturo/durevole, intricato, interazione (vago), evidenziare, inoltre/in aggiunta/per di piu, e importante notare, al fine di, nel cuore di, rivoluzionario, rinomato, mozzafiato, funge da, rappresenta un, segna un, non solo...ma anche, senza soluzione di continuita, olistico, all'avanguardia, innovativo (inflazionato), sinergico, potenziare, sfruttare (figurato), navigare (figurato)\n22\t\n23\t### SEZIONE 2: Pattern di contenuto da eliminare\n24\t\n25\t**2a. Importanza gonfiata**\n26\tMALE: \"Il trapianto FUE segna un momento cruciale nell'evoluzione del ripristino dei capelli, sottolineando il suo ruolo fondamentale nella medicina estetica moderna.\"\n27\tBENE: \"Il trapianto FUE e il metodo piu diffuso dal 2010 circa.\"\n28\t\n29\tMALE: \"Questa iniziativa funge da testimonianza duratura dell'impegno della clinica verso l'eccellenza.\"\n30\tBENE: \"La clinica offre questa procedura dal 2010.\"\n31\t\n32\tRegola: Elimina tutte le affermazioni su qualcosa che e cruciale, rivoluzionario, una testimonianza di, un momento chiave, un punto di svolta. Sostituisci con fatti specifici.\n33\t\n34\t**2b. Analisi superficiali con participi presenti**\n35\tFrasi finali vietate: evidenziando, sottolineando, enfatizzando, assicurando, riflettendo, simboleggiando, contribuendo a, coltivando, promuovendo, comprendendo, mostrando\n36\t\n37\tMALE: \"La clinica utilizza lame in zaffiro, evidenziando la sua dedizione alla cura del paziente e mostrando le ultime innovazioni, riflettendo le tendenze del settore.\"\n38\tBENE: \"La clinica utilizza lame in zaffiro. Queste producono incisioni piu piccole dell'acciaio, il che accelera la guarigione.\"\n39\t\n40\tRegola: Se vedi una frase che termina con uno di questi participi, cancella la frase. Se l'informazione conta, falla diventare una nuova frase con un fatto specifico.\n41\t\n42\t**2c. Linguaggio promozionale**\n43\tVietato: vanta, vibrante, ricco (figurato), profondo, migliorando il suo, mostrando, esemplifica, impegno verso, bellezza naturale, incastonato, nel cuore di, rivoluzionario, rinomato, mozzafiato, imperdibile, straordinario, di classe mondiale, all'avanguardia, senza paragoni\n44\t\n45\tMALE: \"Incastonata nel cuore di Istanbul, questa clinica di classe mondiale vanta strutture straordinarie e un impegno senza paragoni verso la cura del paziente.\"\n46\tBENE: \"La clinica si trova nel quartiere Sisli di Istanbul. Ha 12 sale operatorie e tratta circa 150 pazienti a settimana.\"\n47\t\n48\t**2d. Attribuzioni vaghe**\n49\tMALE: \"Gli studi dimostrano che questa tecnica produce risultati superiori. Gli esperti concordano che rappresenta una svolta.\"\n50\tBENE: \"Uno studio del 2022 dell'Universita di Ankara ha trovato una sopravvivenza dei follicoli del 96% con DHI rispetto al 91% con FUE standard.\"\n51\t\n52\tRegola: Nomina la fonte o togli l'attribuzione. Mai scrivere \"gli esperti dicono/concordano\" o \"gli studi mostrano/suggeriscono\" senza fonte specifica.\n53\t\n54\t**2e. Sezioni formulaiche su sfide e prospettive**\n55\tMALE: \"Nonostante le numerose sfide, la clinica continua a prosperare, aprendo la strada a future innovazioni.\"\n56\tBENE: \"Il principale svantaggio e il costo: una sessione completa costa tra 2.000 e 4.000 euro. Le cicatrici sono minime ma visibili con tagli molto corti.\"\n57\t\n58\t### SEZIONE 3: Pattern linguistici e grammaticali\n59\t\n60\t**3a. Vocabolario IA ad alta frequenza (sostituisci ogni istanza)**\n61\tInoltre -> Anche (o cancella), allinearsi con -> corrispondere a, cruciale -> importante (o cancella), approfondire -> esaminare/guardare, sottolineare -> mostrare, duraturo -> che dura, migliorare -> (usa verbo specifico), promuovere -> costruire/incoraggiare, ottenere -> avere/ricevere, evidenziare -> mostrare/indicare, interazione -> connessione/rapporto, intricato -> complesso/dettagliato, chiave (aggettivo) -> principale/importante, panorama (astratto) -> campo/settore, cruciale -> importante, mostrare -> presentare/dimostrare, arazzo (astratto) -> mescolanza/gamma, testimonianza -> prova/segno, sottolineare -> mostrare, prezioso -> utile, vibrante -> vivace (o cancella)\n62\t\n63\t**3b. Evitamento della copula (usa \"e\"/\"sono\" direttamente)**\n64\tMALE: \"La procedura funge da opzione affidabile.\" -> BENE: \"La procedura e un'opzione affidabile.\"\n65\tMALE: \"Il Dr Cinik si pone come un leader.\" -> BENE: \"Il Dr Cinik e un leader.\"\n66\t\n67\t**3c. Parallelismi negativi**\n68\tCancella tutti i: \"Non solo X ma anche Y\", \"Non si tratta solo di X, si tratta di Y\"\n69\tRiscrivi come affermazioni semplici.\n70\t\n71\t**3d. Regola del tre**\n72\tMALE: \"innovazione, competenza e compassione\"\n73\tBENE: Usa due elementi, o quattro, o quanti ne servono. Tre di fila e un segnale IA.\n74\t\n75\t**3e. Ciclaggio di sinonimi**\n76\tMALE: \"Il chirurgo esegue l'operazione. Il medico conduce la procedura. Lo specialista effettua l'intervento.\"\n77\tBENE: \"Il chirurgo esegue l'operazione, che dura 6-8 ore.\"\n78\tRegola: Ripetere una parola va bene. Ciclare tra sinonimi e peggio.\n79\t\n80\t### SEZIONE 4: Pattern di stile\n81\t\n82\t**4a. Trattini lunghi**: Massimo uno ogni 500 parole. Usa virgole o punti.\n83\t**4b. Grassetto**: Non mettere in grassetto i termini meccanicamente. Niente pattern \"**Beneficio:** ...\"\n84\t**4c. Intestazioni**: Minuscolo normale (\"Recupero dopo l'intervento\"), non maiuscole su ogni parola.\n85\t\n86\t### SEZIONE 5: Riempitivi e coperture\n87\t\n88\tSostituisci automaticamente:\n89\t- \"Al fine di\" -> \"Per\"\n90\t- \"A causa del fatto che\" -> \"Perche\"\n91\t- \"In questo momento\" -> \"Ora\"\n92\t- \"E importante notare che\" -> (cancella, esponi il fatto)\n93\t- \"Vale la pena menzionare\" -> (cancella)\n94\t- \"Inoltre\" / \"Per di piu\" / \"In aggiunta\" -> (cancella o usa \"Anche\")\n95\t- \"Ha la capacita di\" -> \"Puo\"\n96\t- \"Nel caso in cui\" -> \"Se\"\n97\t\n98\tCoperture: \"Si potrebbe potenzialmente argomentare che X potrebbe avere qualche effetto\" -> \"X puo aiutare.\"\n99\t\n100\t### SEZIONE 6: Conclusioni\n101\t\n102\tMALE: \"Il futuro e luminoso. Tempi entusiasmanti ci attendono.\"\n103\tBENE: Concludi con una raccomandazione pratica o un fatto specifico. O semplicemente fermati.\n104\t\n105\t---\n106\t\n107\t## VOCE E ANIMA\n108\t\n109\tEvitare i pattern IA e solo meta del lavoro. Un testo sterile e senza personalita e altrettanto ovvio.\n110\t\n111\t**Varia il ritmo.** Frasi brevi. Poi frasi piu lunghe che si prendono il loro tempo. Alterna naturalmente.\n112\t\n113\t**Sii specifico.** Non \"tecnologia avanzata\" ma \"un punch motorizzato da 0,8mm di diametro\".\n114\t\n115\t**Usa verbi semplici.** \"E\", \"ha\", \"fa\". Non \"comprende\", \"facilita\", \"sfrutta\".\n116\t\n117\t**Riconosci la complessita quando esiste.** \"Il recupero e generalmente semplice, anche se alcuni pazienti trovano i primi tre giorni scomodi\" e piu onesto che fingere che sia sempre facile.\n118\t\n119\t**Scrivi come se spiegassi a un collega competente**, non come se vendessi a un cliente.\n120\t\n121\t---\n122\t\n123\t## CONTROLLO FINALE\n124\t\n125\tPrima di restituire l'output, rileggilo e chiediti onestamente: \"Se mostrassi questo testo a un collega, sospetterebbe che l'IA l'ha scritto?\" Se la risposta e si o forse, rivedi finche la risposta e no.\n126\t\n127\t**Formato di output:**\n128\t\n129\t```json\n130\t{\n131\t  \"improved_text\": \"Il testo italiano completo raffinato e migliorato\"\n132\t}\n133\t```"}]},"uuid":"08a83288-a64f-476a-967a-27d231ce4dd9","timestamp":"2026-06-01T10:22:09.764Z","sourceToolAssistantUUID":"2e6378a5-0c16-4bc5-9220-298c6e7ae388","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"08a83288-a64f-476a-967a-27d231ce4dd9","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01GNkQqVNLvYm1SsbVa46Yw8","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01YJXvFu7sqJi4oqZ34Y7DSt","name":"Read","input":{"file_path":"/home/dev/.claude/skills/cinik-translator/prompts/internal-linking-en.md"},"caller":{"type":"direct"}}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":8286,"cache_read_input_tokens":54217,"cache_creation":{"ephemeral_5m_input_tokens":8286,"ephemeral_1h_input_tokens":0},"output_tokens":44,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNdydFMaaSr9igw1fSy","attributionAgent":"general-purpose","type":"assistant","uuid":"c0312800-3dbc-4532-82e0-76dbac7ddf19","timestamp":"2026-06-01T10:22:10.710Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"c0312800-3dbc-4532-82e0-76dbac7ddf19","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01YJXvFu7sqJi4oqZ34Y7DSt","type":"tool_result","content":"1\t=You are an AI specialist in internal linking optimization. Enhance the internal linking structure using the pages database.\n2\t\n3\t## Input\n4\t- **Article**: `{{ $json.text }}`\n5\t- **Pages Database**: Use google_sheets tool\n6\t\n7\t## Task\n8\t1. Add strategic internal links\n9\t2. Mandatory home page link with anchor 'hair transplant in Turkey'\n10\t3. No duplicate links\n11\t\n12\t## Output\n13\t```json\n14\t{\n15\t  \"analysis\": \"Brief analysis\",\n16\t  \"linksAdded\": [],\n17\t  \"enrichedArticleWithLinksEN\": \"Article with links\",\n18\t  \"homePageIncluded\": true,\n19\t  \"totalLinksAdded\": 5\n20\t}\n21\t```"}]},"uuid":"bb58e42d-71e9-420d-bbb7-21b068a1804a","timestamp":"2026-06-01T10:22:10.723Z","sourceToolAssistantUUID":"c0312800-3dbc-4532-82e0-76dbac7ddf19","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"bb58e42d-71e9-420d-bbb7-21b068a1804a","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01GNkQqVNLvYm1SsbVa46Yw8","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01JgHZ3PfYCkFYQDhwURYmJ6","name":"Read","input":{"file_path":"/home/dev/.claude/skills/cinik-translator/prompts/internal-linking-it.md"},"caller":{"type":"direct"}}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":8286,"cache_read_input_tokens":54217,"cache_creation":{"ephemeral_5m_input_tokens":8286,"ephemeral_1h_input_tokens":0},"output_tokens":44,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNdydFMaaSr9igw1fSy","attributionAgent":"general-purpose","type":"assistant","uuid":"c5ccfa63-03a0-4554-90b8-2eed66cca630","timestamp":"2026-06-01T10:22:10.812Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"c5ccfa63-03a0-4554-90b8-2eed66cca630","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01JgHZ3PfYCkFYQDhwURYmJ6","type":"tool_result","content":"1\t=Add strategic internal links to this Italian article.\n2\t\n3\t## Input\n4\t- **Article**: `{{ $json.text }}`\n5\t- **Pages Database**: Use google_sheets tool\n6\t\n7\t## Task\n8\t1. Add strategic internal links\n9\t2. Mandatory home page link with anchor 'trapianto di capelli in Turchia'\n10\t3. No duplicate links\n11\t\n12\t## Output\n13\t```json\n14\t{\"analysis\": \"Brief\", \"linksAdded\": [], \"enrichedArticleWithLinksIT\": \"Article\", \"homePageIncluded\": true, \"totalLinksAdded\": 5}\n15\t```"}]},"uuid":"eab4d5a7-7de0-47d1-adfe-3407d5c8fabf","timestamp":"2026-06-01T10:22:10.833Z","sourceToolAssistantUUID":"c5ccfa63-03a0-4554-90b8-2eed66cca630","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"eab4d5a7-7de0-47d1-adfe-3407d5c8fabf","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01Wd7z2Y2BzB8t2PTpQZJ19G","type":"message","role":"assistant","content":[{"type":"text","text":"Now let me check for the hreflang lookup script and verify the gdoc_publish setup."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":4665,"cache_read_input_tokens":62503,"cache_creation":{"ephemeral_5m_input_tokens":4665,"ephemeral_1h_input_tokens":0},"output_tokens":6,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNeEfNzTPAweR4WU84c","attributionAgent":"general-purpose","type":"assistant","uuid":"1f6d31fc-4d6a-41c9-b291-c7e525c170cb","timestamp":"2026-06-01T10:22:13.092Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"1f6d31fc-4d6a-41c9-b291-c7e525c170cb","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01Wd7z2Y2BzB8t2PTpQZJ19G","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_017jb7sniyAF5XDSpWtk7zuh","name":"Bash","input":{"command":"ls -la /home/dev/.claude/skills/cinik-translator/scripts/ 2>/dev/null; echo \"---VENV---\"; ls /home/dev/.claude/skills/cinik-blog-brief/.venv/bin/python && echo \"venv ok\"; echo \"---translations dir---\"; ls -la /opt/automator/cinik-writer-transtor/files/translations/ 2>/dev/null || echo \"no translations dir\""},"caller":{"type":"direct"}}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":4665,"cache_read_input_tokens":62503,"cache_creation":{"ephemeral_5m_input_tokens":4665,"ephemeral_1h_input_tokens":0},"output_tokens":6,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNeEfNzTPAweR4WU84c","attributionAgent":"general-purpose","type":"assistant","uuid":"bb7664f0-fb3d-4f73-af52-adfab6fa1400","timestamp":"2026-06-01T10:22:14.643Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"bb7664f0-fb3d-4f73-af52-adfab6fa1400","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_017jb7sniyAF5XDSpWtk7zuh","type":"tool_result","content":"total 48\ndrwxr-xr-x 3 dev dev 4096 May 31 20:01 .\ndrwxr-xr-x 5 dev dev 4096 May 31 20:01 ..\ndrwxrwxr-x 2 dev dev 4096 May 31 19:52 __pycache__\n-rw-r--r-- 1 dev dev 6220 May 31 19:50 hreflang_lookup.py\n-rw-r--r-- 1 dev dev 6133 May 31 19:50 prepare_batch.py\n-rw-r--r-- 1 dev dev 6243 May 31 19:50 translate.py\n---VENV---\n/home/dev/.claude/skills/cinik-blog-brief/.venv/bin/python\nvenv ok\n---translations dir---\ntotal 8\ndrwxrwsr-x 2 dev dev 4096 Jun  1 10:21 .\ndrwxr-sr-x 6 dev dev 4096 Jun  1 10:21 ..","is_error":false}]},"uuid":"1ddb901a-97b1-4bdc-bc82-ec40f7119f12","timestamp":"2026-06-01T10:22:14.712Z","sourceToolAssistantUUID":"bb7664f0-fb3d-4f73-af52-adfab6fa1400","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"1ddb901a-97b1-4bdc-bc82-ec40f7119f12","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_0116j375LkKm57hbVcmeRZJ2","type":"message","role":"assistant","content":[{"type":"text","text":"Let me run the hreflang lookup for all internal links in the article, for both EN and IT."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":555,"cache_read_input_tokens":67168,"cache_creation":{"ephemeral_5m_input_tokens":555,"ephemeral_1h_input_tokens":0},"output_tokens":4,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNeYSTNKaZq3Kbz4fHL","attributionAgent":"general-purpose","type":"assistant","uuid":"7c97fc71-2cf5-4e76-b89c-bb656f95c0ff","timestamp":"2026-06-01T10:22:17.226Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"7c97fc71-2cf5-4e76-b89c-bb656f95c0ff","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_0116j375LkKm57hbVcmeRZJ2","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_014sDzdG89QCT6Tz5U83DuCm","name":"Read","input":{"file_path":"/home/dev/.claude/skills/cinik-translator/scripts/hreflang_lookup.py"},"caller":{"type":"direct"}}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":555,"cache_read_input_tokens":67168,"cache_creation":{"ephemeral_5m_input_tokens":555,"ephemeral_1h_input_tokens":0},"output_tokens":4,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNeYSTNKaZq3Kbz4fHL","attributionAgent":"general-purpose","type":"assistant","uuid":"8e638a60-33f2-4b5c-865e-b1fcf7cb6b33","timestamp":"2026-06-01T10:22:17.291Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"8e638a60-33f2-4b5c-865e-b1fcf7cb6b33","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_014sDzdG89QCT6Tz5U83DuCm","type":"tool_result","content":"1\t#!/usr/bin/env python3\n2\t\"\"\"\n3\tRécupère l'équivalent traduit d'une URL Cinik via les balises <link rel=\"alternate\" hreflang=\"...\">.\n4\t\n5\tUsage:\n6\t    python3 hreflang_lookup.py --url https://emrahcinik.com/fr/page/ --target-lang it\n7\t    -> https://emrahcinik.com/it/pagina/  (si équivalent trouvé)\n8\t    -> NO_EQUIVALENT  (si l'URL pointe vers la home, donc pas de vraie traduction)\n9\t\n10\tRègle métier (Tom) :\n11\t    Si l'URL équivalente est la home (ex: https://emrahcinik.com/it/), on considère\n12\t    qu'il n'y a PAS d'équivalent traduit. Dans ce cas, l'Internal Linking doit\n13\t    GARDER l'ancre (texte visible du lien) mais SUPPRIMER l'URL.\n14\t\n15\tCodes langues spéciaux :\n16\t    sr -> sr-Latn  (serbe en alphabet latin, jamais cyrillique)\n17\t\n18\tDépendances : requests (généralement déjà installé)\n19\t\"\"\"\n20\tfrom __future__ import annotations\n21\t\n22\timport argparse\n23\timport json\n24\timport re\n25\timport sys\n26\tfrom urllib.parse import urlparse\n27\t\n28\ttry:\n29\t    import requests\n30\texcept ImportError:\n31\t    print(\n32\t        \"ERREUR: requests non installé. Faire:\\n\"\n33\t        \"  pip install requests --break-system-packages\",\n34\t        file=sys.stderr,\n35\t    )\n36\t    sys.exit(1)\n37\t\n38\t\n39\t# Mapping des codes langue Cowork -> codes hreflang Cinik\n40\tLANG_CODE_MAP = {\n41\t    \"sr\": \"sr-Latn\",\n42\t    \"sr-latn\": \"sr-Latn\",\n43\t}\n44\t\n45\t# Patterns hreflang dans le HTML\n46\tHREFLANG_PATTERN = re.compile(\n47\t    r'<link[^>]*alternate[^>]*>',\n48\t    re.IGNORECASE,\n49\t)\n50\t\n51\t\n52\tdef fetch_url(url: str, timeout: int = 15) -> str:\n53\t    \"\"\"Télécharge le HTML d'une URL Cinik.\"\"\"\n54\t    headers = {\n55\t        \"User-Agent\": (\n56\t            \"Mozilla/5.0 (compatible; CinikTranslator/1.0; \"\n57\t            \"+https://emrahcinik.com)\"\n58\t        ),\n59\t    }\n60\t    resp = requests.get(url, headers=headers, timeout=timeout, allow_redirects=True)\n61\t    resp.raise_for_status()\n62\t    return resp.text\n63\t\n64\t\n65\tdef parse_hreflangs(html: str) -> dict[str, str]:\n66\t    \"\"\"\n67\t    Extrait les balises <link rel=alternate hreflang=X href=Y> du HTML.\n68\t    Retourne un dict {hreflang_code: url}.\n69\t    \"\"\"\n70\t    result: dict[str, str] = {}\n71\t    for tag in HREFLANG_PATTERN.findall(html):\n72\t        hl_match = re.search(r'hreflang=[\"\\']?([a-zA-Z\\-]+)[\"\\']?', tag)\n73\t        href_match = re.search(r'href=[\"\\']?([^\"\\'>\\s]+)', tag)\n74\t        if hl_match and href_match:\n75\t            lang_code = hl_match.group(1)\n76\t            url = href_match.group(1)\n77\t            # Si déjà présent, garder le premier (priorité ordre HTML)\n78\t            if lang_code not in result:\n79\t                result[lang_code] = url\n80\t    return result\n81\t\n82\t\n83\tdef is_home_url(url: str) -> bool:\n84\t    \"\"\"\n85\t    Détecte si une URL pointe vers la home (racine du domaine ou de la langue).\n86\t    Ex: https://emrahcinik.com/  -> True\n87\t        https://emrahcinik.com/fr/ -> True\n88\t        https://emrahcinik.com/fr/greffe/ -> False\n89\t    \"\"\"\n90\t    parsed = urlparse(url)\n91\t    path = parsed.path.strip(\"/\").split(\"/\")\n92\t    # Path vide = home racine\n93\t    if not path or path == [\"\"]:\n94\t        return True\n95\t    # Path = juste un code langue (2 caractères ou sr-Latn) = home de langue\n96\t    if len(path) == 1 and (len(path[0]) == 2 or path[0].lower() in {\"sr-latn\"}):\n97\t        return True\n98\t    return False\n99\t\n100\t\n101\tdef lookup_equivalent(source_url: str, target_lang: str, timeout: int = 15) -> dict:\n102\t    \"\"\"\n103\t    Pour une URL FR donnée, retourne l'URL équivalente dans la langue cible\n104\t    via les hreflang du site.\n105\t\n106\t    Returns:\n107\t        {\n108\t            \"found\": bool,\n109\t            \"url\": str | None,            # URL équivalente si trouvée (et != home)\n110\t            \"fallback_to_home\": bool,     # True si hreflang pointe vers la home\n111\t            \"all_hreflangs\": dict,        # toutes les langues trouvées\n112\t            \"target_hreflang_code\": str,  # code utilisé pour la lookup\n113\t        }\n114\t    \"\"\"\n115\t    # Normaliser le code langue cible\n116\t    target_normalized = LANG_CODE_MAP.get(target_lang.lower(), target_lang)\n117\t\n118\t    try:\n119\t        html = fetch_url(source_url, timeout=timeout)\n120\t    except Exception as e:\n121\t        return {\n122\t            \"found\": False,\n123\t            \"url\": None,\n124\t            \"fallback_to_home\": False,\n125\t            \"all_hreflangs\": {},\n126\t            \"target_hreflang_code\": target_normalized,\n127\t            \"error\": f\"fetch failed: {e}\",\n128\t        }\n129\t\n130\t    hreflangs = parse_hreflangs(html)\n131\t\n132\t    # Chercher la langue cible (essayer plusieurs variantes)\n133\t    candidates = [target_normalized, target_lang.lower(), target_lang]\n134\t    target_url = None\n135\t    for c in candidates:\n136\t        if c in hreflangs:\n137\t            target_url = hreflangs[c]\n138\t            break\n139\t\n140\t    if target_url is None:\n141\t        return {\n142\t            \"found\": False,\n143\t            \"url\": None,\n144\t            \"fallback_to_home\": False,\n145\t            \"all_hreflangs\": hreflangs,\n146\t            \"target_hreflang_code\": target_normalized,\n147\t        }\n148\t\n149\t    # L'URL pointe vers la home ? Alors pas de vrai équivalent\n150\t    if is_home_url(target_url):\n151\t        return {\n152\t            \"found\": False,\n153\t            \"url\": target_url,\n154\t            \"fallback_to_home\": True,\n155\t            \"all_hreflangs\": hreflangs,\n156\t            \"target_hreflang_code\": target_normalized,\n157\t        }\n158\t\n159\t    return {\n160\t        \"found\": True,\n161\t        \"url\": target_url,\n162\t        \"fallback_to_home\": False,\n163\t        \"all_hreflangs\": hreflangs,\n164\t        \"target_hreflang_code\": target_normalized,\n165\t    }\n166\t\n167\t\n168\tdef main() -> int:\n169\t    parser = argparse.ArgumentParser(description=__doc__)\n170\t    parser.add_argument(\"--url\", required=True, help=\"URL FR source\")\n171\t    parser.add_argument(\n172\t        \"--target-lang\",\n173\t        required=True,\n174\t        help=\"Code langue cible (it, en, sr, de, etc.)\",\n175\t    )\n176\t    parser.add_argument(\n177\t        \"--format\",\n178\t        choices=[\"text\", \"json\"],\n179\t        default=\"text\",\n180\t        help=\"Format de sortie (défaut: text)\",\n181\t    )\n182\t    parser.add_argument(\"--timeout\", type=int, default=15)\n183\t    args = parser.parse_args()\n184\t\n185\t    result = lookup_equivalent(args.url, args.target_lang, timeout=args.timeout)\n186\t\n187\t    if args.format == \"json\":\n188\t        print(json.dumps(result, indent=2, ensure_ascii=False))\n189\t        return 0\n190\t\n191\t    # Format texte simple : utile pour appel depuis prompts\n192\t    if result[\"found\"]:\n193\t        print(result[\"url\"])\n194\t        return 0\n195\t    elif result[\"fallback_to_home\"]:\n196\t        print(\"NO_EQUIVALENT_HOME_FALLBACK\")\n197\t        return 1\n198\t    else:\n199\t        print(\"NO_EQUIVALENT\")\n200\t        return 1\n201\t\n202\t\n203\tif __name__ == \"__main__\":\n204\t    sys.exit(main())\n205\t"}]},"uuid":"45ecb380-eed9-46d7-9637-70d9d7b6ac93","timestamp":"2026-06-01T10:22:17.299Z","sourceToolAssistantUUID":"8e638a60-33f2-4b5c-865e-b1fcf7cb6b33","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"45ecb380-eed9-46d7-9637-70d9d7b6ac93","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01JbLsNsdkHqGd35LgvdJFfk","type":"message","role":"assistant","content":[{"type":"text","text":"Let me extract all internal links from the source and run the hreflang lookup for both EN and IT in one batch."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":3093,"cache_read_input_tokens":67723,"cache_creation":{"ephemeral_5m_input_tokens":3093,"ephemeral_1h_input_tokens":0},"output_tokens":2,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNeia9xoFiZFh3acAFu","attributionAgent":"general-purpose","type":"assistant","uuid":"d02cabb8-cdd4-4b49-aacf-ed2d1aeb3ce3","timestamp":"2026-06-01T10:22:19.773Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"d02cabb8-cdd4-4b49-aacf-ed2d1aeb3ce3","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01JbLsNsdkHqGd35LgvdJFfk","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01Ki1ynQsDjE1tPH5ZdhWRqt","name":"Bash","input":{"command":"cd /home/dev/.claude/skills/cinik-translator/scripts\nPY=$(command -v python3)\nurls=(\n\"https://emrahcinik.com/fr/finasteride/\"\n\"https://emrahcinik.com/fr/minoxidil/\"\n\"https://emrahcinik.com/fr/calvitie-heredite/\"\n\"https://emrahcinik.com/fr/alopecie-androgenetique/\"\n\"https://emrahcinik.com/fr/medecine-capillaire-regenerative/\"\n\"https://emrahcinik.com/fr/follicules-pileux/\"\n\"https://emrahcinik.com/fr/bloqueurs-dht/\"\n\"https://emrahcinik.com/fr/dht-chute-de-cheveux/\"\n\"https://emrahcinik.com/fr/exosomes-cheveux/\"\n\"https://emrahcinik.com/fr/nouveaux-medicaments-calvitie/\"\n\"https://emrahcinik.com/fr/clascoterone-cheveux/\"\n\"https://emrahcinik.com/fr/norwood-hamilton/\"\n\"https://emrahcinik.com/fr/echelle-de-ludwig/\"\n\"https://emrahcinik.com/fr/greffe-de-cheveux-calvitie-complete/\"\n\"https://emrahcinik.com/fr/cycle-du-cheveu/\"\n\"https://emrahcinik.com/fr/traitement-chute-cheveux-efficaces/\"\n\"https://emrahcinik.com/fr/medecine-capillaire/prp/\"\n\"https://emrahcinik.com/fr/mesotherapie-cheveux/\"\n\"https://emrahcinik.com/fr/greffe-de-cheveux/sapphire-fue/\"\n\"https://emrahcinik.com/fr/greffe-de-cheveux/dhi/\"\n\"https://emrahcinik.com/fr/\"\n\"https://emrahcinik.com/fr/contact/\"\n)\nfor lang in en it; do\n  echo \"==================== LANG=$lang ====================\"\n  for u in \"${urls[@]}\"; do\n    res=$(\"$PY\" hreflang_lookup.py --url \"$u\" --target-lang \"$lang\" 2>/dev/null)\n    echo \"$u => $res\"\n  done\ndone"},"caller":{"type":"direct"}}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":3093,"cache_read_input_tokens":67723,"cache_creation":{"ephemeral_5m_input_tokens":3093,"ephemeral_1h_input_tokens":0},"output_tokens":2,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNeia9xoFiZFh3acAFu","attributionAgent":"general-purpose","type":"assistant","uuid":"9ad7e4d2-f756-41d2-9c2a-79f7eacd7ac2","timestamp":"2026-06-01T10:22:27.077Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"9ad7e4d2-f756-41d2-9c2a-79f7eacd7ac2","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01Ki1ynQsDjE1tPH5ZdhWRqt","type":"tool_result","content":"==================== LANG=en ====================\nhttps://emrahcinik.com/fr/finasteride/ => https://emrahcinik.com/finasteride/\nhttps://emrahcinik.com/fr/minoxidil/ => https://emrahcinik.com/minoxidil/\nhttps://emrahcinik.com/fr/calvitie-heredite/ => https://emrahcinik.com/hereditary-baldness/\nhttps://emrahcinik.com/fr/alopecie-androgenetique/ => https://emrahcinik.com/androgenetic-alopecia/\nhttps://emrahcinik.com/fr/medecine-capillaire-regenerative/ => https://emrahcinik.com/regenerative-hair-medicine/\nhttps://emrahcinik.com/fr/follicules-pileux/ => https://emrahcinik.com/hair-follicles/\nhttps://emrahcinik.com/fr/bloqueurs-dht/ => https://emrahcinik.com/dht-blockers/\nhttps://emrahcinik.com/fr/dht-chute-de-cheveux/ => https://emrahcinik.com/dht-hair-loss/\nhttps://emrahcinik.com/fr/exosomes-cheveux/ => NO_EQUIVALENT\nhttps://emrahcinik.com/fr/nouveaux-medicaments-calvitie/ => https://emrahcinik.com/new-hair-loss-drugs/\nhttps://emrahcinik.com/fr/clascoterone-cheveux/ => https://emrahcinik.com/clascoterone-hair-loss/\nhttps://emrahcinik.com/fr/norwood-hamilton/ => https://emrahcinik.com/norwood-hamilton/\nhttps://emrahcinik.com/fr/echelle-de-ludwig/ => https://emrahcinik.com/ludwig-scale/\nhttps://emrahcinik.com/fr/greffe-de-cheveux-calvitie-complete/ => https://emrahcinik.com/norwood-7-baldness-hair-transplant-solutions/\nhttps://emrahcinik.com/fr/cycle-du-cheveu/ => https://emrahcinik.com/hair-cycle/\nhttps://emrahcinik.com/fr/traitement-chute-cheveux-efficaces/ => https://emrahcinik.com/effective-hair-loss-treamtments/\nhttps://emrahcinik.com/fr/medecine-capillaire/prp/ => https://emrahcinik.com/hair-loss/prp/\nhttps://emrahcinik.com/fr/mesotherapie-cheveux/ => https://emrahcinik.com/hair-mesotherapy/\nhttps://emrahcinik.com/fr/greffe-de-cheveux/sapphire-fue/ => https://emrahcinik.com/hair-transplant/sapphire-fue/\nhttps://emrahcinik.com/fr/greffe-de-cheveux/dhi/ => https://emrahcinik.com/hair-transplant/dhi/\nhttps://emrahcinik.com/fr/ => NO_EQUIVALENT_HOME_FALLBACK\nhttps://emrahcinik.com/fr/contact/ => https://emrahcinik.com/contact/\n==================== LANG=it ====================\nhttps://emrahcinik.com/fr/finasteride/ => https://emrahcinik.com/it/finasteride/\nhttps://emrahcinik.com/fr/minoxidil/ => https://emrahcinik.com/it/minoxidil/\nhttps://emrahcinik.com/fr/calvitie-heredite/ => https://emrahcinik.com/it/calvizie-ereditaria/\nhttps://emrahcinik.com/fr/alopecie-androgenetique/ => https://emrahcinik.com/it/alopecia-androgenetica/\nhttps://emrahcinik.com/fr/medecine-capillaire-regenerative/ => https://emrahcinik.com/it/medicina-rigenerativa-capelli/\nhttps://emrahcinik.com/fr/follicules-pileux/ => https://emrahcinik.com/it/follicoli-piliferi/\nhttps://emrahcinik.com/fr/bloqueurs-dht/ => https://emrahcinik.com/it/bloccanti-dht/\nhttps://emrahcinik.com/fr/dht-chute-de-cheveux/ => https://emrahcinik.com/it/dht-ormone-responsabile-della-calvizie/\nhttps://emrahcinik.com/fr/exosomes-cheveux/ => https://emrahcinik.com/it/esosomi-capelli/\nhttps://emrahcinik.com/fr/nouveaux-medicaments-calvitie/ => https://emrahcinik.com/it/nuovi-farmaci-anticaduta/\nhttps://emrahcinik.com/fr/clascoterone-cheveux/ => https://emrahcinik.com/it/clascoterone-capelli/\nhttps://emrahcinik.com/fr/norwood-hamilton/ => https://emrahcinik.com/it/scala-norwood/\nhttps://emrahcinik.com/fr/echelle-de-ludwig/ => https://emrahcinik.com/it/scala-di-ludwig/\nhttps://emrahcinik.com/fr/greffe-de-cheveux-calvitie-complete/ => https://emrahcinik.com/it/trapianto-di-capelli-calvizie-completa/\nhttps://emrahcinik.com/fr/cycle-du-cheveu/ => https://emrahcinik.com/it/ciclo-capelli/\nhttps://emrahcinik.com/fr/traitement-chute-cheveux-efficaces/ => https://emrahcinik.com/it/trattamenti-caduta-capelli/\nhttps://emrahcinik.com/fr/medecine-capillaire/prp/ => https://emrahcinik.com/it/la-perdita-di-capelli/prp/\nhttps://emrahcinik.com/fr/mesotherapie-cheveux/ => https://emrahcinik.com/it/mesoterapia-capelli/\nhttps://emrahcinik.com/fr/greffe-de-cheveux/sapphire-fue/ => https://emrahcinik.com/it/trapianto-di-capelli/zaffiro/\nhttps://emrahcinik.com/fr/greffe-de-cheveux/dhi/ => https://emrahcinik.com/it/trapianto-di-capelli/dhi/\nhttps://emrahcinik.com/fr/ => NO_EQUIVALENT_HOME_FALLBACK\nhttps://emrahcinik.com/fr/contact/ => https://emrahcinik.com/it/contatto/","is_error":false}]},"uuid":"3ff208ef-eb60-49cb-bcb0-3c419df549ef","timestamp":"2026-06-01T10:22:35.910Z","sourceToolAssistantUUID":"9ad7e4d2-f756-41d2-9c2a-79f7eacd7ac2","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"3ff208ef-eb60-49cb-bcb0-3c419df549ef","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01VekSbbPV6R3XaoUwpWQmxp","type":"message","role":"assistant","content":[{"type":"text","text":"I have a complete hreflang mapping. Key findings:\n- EN home: `https://emrahcinik.com/` (no /en/ prefix), anchor \"hair transplant in Turkey\"\n- EN: exosomes has NO equivalent (keep anchor, remove link)\n- IT home: `https://emrahcinik.com/it/`, anchor \"trapianto di capelli in Turchia\"\n- All others map cleanly.\n\nNote the task says keep the home link always (anchor \"hair transplant in Turkey\" for EN, \"trapianto di capelli in Turchia\" for IT). The FR home appears twice in source (line 11 implicit, line 170 \"greffe de cheveux en Turquie\"). I'll map line 170's home link to the EN/IT home with the required anchor.\n\nNow I'll write the EN translation, applying the full pipeline (Improver + Humanizer mentally, internal linking, SEO). Let me build the EN file."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":3090,"cache_read_input_tokens":70816,"cache_creation":{"ephemeral_5m_input_tokens":3090,"ephemeral_1h_input_tokens":0},"output_tokens":1,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNg5wp6iodLG1eA5i9u","attributionAgent":"general-purpose","type":"assistant","uuid":"04016403-f77e-400e-aef1-7a6f9b8c8de4","timestamp":"2026-06-01T10:22:41.810Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"04016403-f77e-400e-aef1-7a6f9b8c8de4","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01VekSbbPV6R3XaoUwpWQmxp","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_0197jLGi28FAvwkysHx8d2zS","name":"Write","input":{"file_path":"/opt/automator/cinik-writer-transtor/files/translations/pp405-en.md","content":"**Slug** : /pp405-molecule-that-wakes-follicles\n\n**Title SEO** : PP405: the molecule that wakes up hair | Dr Cinik\n\n**Meta description** : Does PP405 really regrow hair? Mechanism, trial results, phase 3 timeline and Dr Cinik's honest take on this molecule.\n\n---\n\n# PP405: the molecule that might wake up your dormant follicles (what the science actually says in 2026)\n\nIn the phase 2a trial, around **31% of men with advanced balding** saw their hair density climb by more than **20%** in eight weeks. In the placebo group: **0%**. Zero. It is the first time in decades that a molecule applied to the scalp has grown brand new hair where there was none left. PP405 does not slow shedding down. It switches dormant follicles back on. And no current treatment can do that.\n\nThe subject is lighting up forums, clinics and even *Time* magazine, which ranked PP405 among its best inventions of 2025. No surprise there. Most treatments protect what you already have. [Finasteride](https://emrahcinik.com/finasteride/) blocks the guilty hormone. [Minoxidil](https://emrahcinik.com/minoxidil/) extends the growth phase. But none of them brings a sleeping follicle back to life. That is exactly what PP405 aims at, by a route nobody had dared to take: **the metabolism of the cell, not the hormones**.\n\nA phase 3 trial is announced for 2026. So let us separate fact from fantasy. Here, with no hype and no inflated promises, is everything the science says today about PP405: its mechanism, its results, its timeline, its limits, and what you can actually do while you wait.\n\n## So what exactly is PP405?\n\nPP405 is a **small molecule** applied locally to the scalp. Not a hormone. Not an injection. Not a tablet. A gel, once a day, and that is it.\n\nIt came out of the labs at **UCLA**, in California. Three scientists from the university, Bill Lowry, Heather Christofk and Michael Jung, founded **Pelage Pharmaceuticals** in 2018 to take it into the clinic. Nearly ten years of basic research came first, then serious money: more than 30 million dollars to start, led by Google Ventures, followed by a **120 million dollar raise** in October 2025. When investors of that calibre put big money behind a hair gel, the mechanism tends to hold up.\n\nIts angle of attack has nothing to do with the classic drugs. [Hereditary baldness](https://emrahcinik.com/hereditary-baldness/), also called [androgenetic alopecia](https://emrahcinik.com/androgenetic-alopecia/), does not kill your follicles in one go. It **sends them to sleep**. They shrink, miniaturise, then slip into prolonged dormancy. The hair becomes thin, short, almost see-through. And then one day, nothing comes out at all. But the follicle is often still there, tucked away, alive.\n\nIt is precisely these sleeping follicular stem cells that PP405 goes after. The goal: wake them up and restart the growth cycle. This is a **regenerative** approach, in the same spirit as [regenerative hair medicine](https://emrahcinik.com/regenerative-hair-medicine/), which tries to stimulate follicles rather than just slow their decline.\n\n## Why this could be a real shift\n\nTo understand the excitement, you have to look at the current picture. Since minoxidil and finasteride arrived in the 1980s and 1990s, nothing fundamentally new has come along. We refine, we combine, we optimise. But the principle stays the same: **defend the hair that is left**.\n\nPP405 offers something else. Not defend, but **regenerate**. Wake up follicles you thought were gone. If the science holds up at scale, it would move the line of what can be treated without a scalpel. Not a replacement for a transplant, as we will see. But one more string to the bow, and a new one.\n\nThree things set PP405 apart from the dozens of pseudo-miracle hair products that come round every year:\n\n- **A precise, published biological target**, validated by basic research before a single marketing promise.\n- **Clinical results measured in humans**, not just in mice.\n- **A remarkable safety profile**, with no passage into the bloodstream.\n\nThat is why serious dermatologists are watching it closely. Now it has to deliver beyond the trial.\n\n## The mechanism: a story about fuel, not hormones\n\nHere is the point that changes everything. PP405 does **not touch** androgens at all. It works on the internal fuel of the follicle's stem cells. To grasp the idea, you have to step inside the cell for a moment.\n\n### Waking a cell through its energy\n\nEvery [hair follicle](https://emrahcinik.com/hair-follicles/) holds stem cells. When they are active, they make hair. When they are dormant, the follicle rests. And the UCLA research put its finger on something surprising: what wakes these cells up is a **shift in metabolism**. More precisely, a rise in **lactate** inside the cell.\n\nLactate is that by-product your muscles make under strain, the one that gives the burning feeling when you push hard. Inside the follicle it plays a completely different part: a **start signal**. Plenty of lactate, and the stem cell flips into growth mode, the phase known as anagen. Little lactate, and it stays asleep, the telogen phase. The lactate level is, in a sense, the switch between rest and growth.\n\n### The PP405 sleight of hand\n\nThe molecule locks what are called the **mitochondrial pyruvate carriers** (the MPC1 and MPC2 gates of the cell's power plant, the mitochondrion). In plain terms, PP405 closes two doors through which fuel normally entered the mitochondrion.\n\nWith those doors shut, pyruvate builds up outside. An enzyme, **lactate dehydrogenase (LDH)**, then converts it into lactate. The cascade that follows: lactate levels climb, glycolysis speeds up, the stem cell gets its start signal and goes back to work. The follicle flips back into growth mode.\n\nIt is elegant. And it sits at the opposite end from [DHT blockers](https://emrahcinik.com/dht-blockers/), which go after the hormonal cause of hair loss. Where [DHT](https://emrahcinik.com/dht-hair-loss/) acts like a weedkiller smothering your follicles, PP405 plays the **metabolic kick**. Two opposing philosophies. And that is what opens the door to combining them one day, rather than pitting them against each other.\n\n## What the clinical trials actually say\n\nNow for the numbers. This is where credibility is won or lost, and this is where PP405 stands apart from the run of the mill.\n\n### Phase 1: proof through biology\n\nBefore counting any hairs, the researchers wanted certainty: does the gel really wake the cells up? Phase 1, focused on safety, gave the answer. In **just seven days**, PP405 produced a **statistically significant** increase in stem cell activation inside the follicle, measured in particular through **Ki67**, a standard marker of cell proliferation. The translation: what they saw in the lab held true in humans. The dormant cells got back to work. First box ticked.\n\n### Phase 2a: 78 patients, clear results\n\nThe phase 2a trial was randomised, double blind, with a placebo group, the gold standard for rigour. In total, **78 adults** with androgenetic alopecia, men and women, with a real range of skin tones and hair textures. Each one applied a PP405 gel dosed at **0.05%**, once a day, for **4 weeks**, with follow up extended to the twelfth week.\n\nThe standout result: around **31% of the men with the most advanced loss** gained more than **20% in hair density** by the eighth week, which was four weeks after stopping treatment. In the placebo group, **nobody**. And the detail that really matters: **terminal hair** grew in areas that had been bare. Not fine fuzz, not a simple thickening of existing hair. New hair, thick, where there had been none.\n\nNote the **speed** too. A visible response in eight weeks, where minoxidil and finasteride often need six to twelve months to show anything at all. It is one of the most striking arguments for PP405.\n\n### Phase 2b: already wrapped up\n\nPelage did not wait. A **phase 2b** ran in late 2025, as an open label extension with **three months of treatment** this time instead of four weeks. The idea: see what longer exposure produces, closer to real use. The full data is expected at a medical congress in 2026. Worth watching very closely, because this longer view is what will tell us whether the effect strengthens over time.\n\n### Safety: probably the strongest point\n\nThe trial ticked every safety box. **No detectable systemic absorption** in the blood: the molecule stays where you put it, on the scalp, and does not circulate through the body. No hormonal disruption, no systemic side effects, good general tolerance.\n\nThis is a weighty argument, especially against the fears that stick to some oral treatments. A topical product that does not get into the blood, by design, clears away much of the worry about libido or mood that you sometimes hear linked to finasteride. That is reassuring, naturally.\n\n## PP405 against current treatments\n\nTo place PP405, nothing beats a side by side comparison with what already exists and has proven itself.\n\n| Criterion | PP405 | Minoxidil | Finasteride |\n|---|---|---|---|\n| Main action | Wakes dormant follicles | Extends the growth phase | Blocks DHT, the hormonal cause |\n| Target | Stem cell metabolism | Circulation and hair cycle | Hormone (5-alpha-reductase) |\n| Regrowth of new hair | Yes, seen in trial | Limited, mostly thickening | Mostly preservation |\n| Form | Topical gel, once a day | Topical lotion or foam | Oral tablet (or topical) |\n| Passage into the blood | None detected | Low | Yes |\n| Hormonal risk | None | None | Possible in some people |\n| Status in 2026 | In trials, not available | Available, validated | Available, validated |\n| Scientific track record | A few years | Several decades | Several decades |\n\nThe table says the essential. PP405 targets ground that **nobody else occupies**: the regeneration of dormant follicles. But on the other side, minoxidil and finasteride have **decades of track record** behind them and immediate availability. That is the whole gap between a brilliant promise and a safe bet. One does not cancel the other. The day PP405 is approved, it will most likely **complement** these treatments rather than replace them, combining the metabolic wake up with the hormonal block.\n\n## PP405 against the other regenerative innovations\n\nPP405 is not moving forward alone. Several lines of work are trying to go beyond simply defending what exists. Quickly, a tour of the field.\n\n- **Verteporfin.** A molecule first used in ophthalmology, studied at Stanford for its effect of **healing without fibrosis** (by inhibiting the YAP protein). In hair transplants, the hope is twofold: reduce micro scarring and perhaps restart follicles. Still very experimental in humans for baldness.\n- **Exosomes.** Tiny vesicles from stem cells, packed with growth factors, that pass repair signals to the follicle. Already used in clinics as a stimulating treatment, they are still under rigorous evaluation. Dr Cinik offers them, in fact, as an exosome treatment.\n- **Hair cloning.** The distant holy grail: multiply your own follicles in a lab to reimplant them with no limit on the donor area. Companies like Stemson Therapeutics and HairClone are working on it. But this remains research, with no credible short term timeline.\n\nAmong all this, PP405 has a clear head start: **it is the only one to show measured clinical results in humans and a dated phase 3 timeline**. The other lines are fascinating, but further down the road.\n\n## Timeline, expectations and a word of caution\n\nLet us be honest about the timing, because this is where a lot of sites mislead you.\n\n**Phase 3**, the decisive step before any commercial launch, is set to start in **2026**, running for about a year. It should impose one notable condition on participants: a **stop of around six months** on current treatments (minoxidil, finasteride) before entering the study, to isolate the effect of PP405 itself. Pelage will also present its work at the **American Academy of Dermatology (AAD) meeting in March 2026**, in Denver, during a session on emerging treatments targeting dormant follicles.\n\nBut let us keep a cool head. A phase 2a on **78 people** is still a **modest sized** study, with a short track record (four weeks of treatment). The famous 31% applies to a **specific subgroup**: men with advanced loss. Nothing universal, then. And to date, the results have not yet been published in a peer reviewed scientific journal, nor accompanied by before and after photos shared with the public. It is phase 3, run on hundreds of patients over a longer period, that will tell us whether the effect **holds over time and at scale**.\n\nIn short: regulatory approval is **not expected before 2027 to 2029**, in the best case. PP405 is a serious and genuinely new line of research, **not a product on the pharmacy shelf tomorrow morning**.\n\n> **Watch out for scams.** PP405 is **not available** for sale, anywhere, full stop. Any site claiming to sell it to you, under this name or another, is deceiving you. The only legitimate access today is through the official clinical trials. Be extremely wary.\n\nThis molecule joins the short list of [new baldness drugs](https://emrahcinik.com/new-hair-loss-drugs/) to watch, alongside [clascoterone](https://emrahcinik.com/clascoterone-hair-loss/), another promising treatment from recent years.\n\n## Who could benefit, and who could not\n\nHere is the truth too often forgotten in the excitement. **A sleeping follicle can be woken. A dead follicle, never.** No topical treatment grows a hair back where the follicle has fully disappeared and scarred over. PP405 will be no exception.\n\nThat is where all the nuance lies. PP405 targets **miniaturised but still living follicles**, typical of the intermediate stages.\n\n**The potential good candidates:**\n\n- People at the **early to moderate stages** of loss, where the follicle is still breathing.\n- Intermediate stages of the [Norwood-Hamilton scale](https://emrahcinik.com/norwood-hamilton/) in men.\n- Intermediate stages of the [Ludwig scale](https://emrahcinik.com/ludwig-scale/) in women, bearing in mind that the trial included women, which is rare and encouraging.\n\n**Those for whom PP405 will do nothing:**\n\n- [Complete baldness](https://emrahcinik.com/norwood-7-baldness-hair-transplant-solutions/) settled in for a long time, where the stem cell reserve has gone.\n- Smooth, shiny, scarred areas with no residual follicle at all.\n- Scarring alopecias of other origins, which destroy the follicle itself.\n\nNo cell, no possible wake up. Understanding the [hair cycle](https://emrahcinik.com/hair-cycle/) helps you grasp why **timing matters so much**: you have to act while the follicle is still there. That is also why waiting for PP405 with your arms folded for years can be a bad idea. While you wait, follicles that could have been saved finish dying out.\n\n## FAQ: your questions about PP405\n\n**Is PP405 available in the UK or anywhere else?**\nNo. PP405 is still in the clinical trial phase and is not sold anywhere in the world. No pharmacy and no serious site can supply it in 2026.\n\n**When will it be on sale?**\nIf phase 3 confirms the results and the regulators give the green light, a market launch would not be expected before 2027 to 2029 at the earliest. And only if everything goes well.\n\n**Will PP405 replace a hair transplant?**\nNo, the two follow different logics. PP405 wakes up follicles that are still alive. A transplant redeploys follicles where none are left at all. On a fully bare area, PP405 has nothing to wake.\n\n**Are there side effects?**\nThe trials run so far show good tolerance, with no passage of the molecule into the blood and no hormonal effect. But the track record is short: it is phase 3, longer, that will really pin down the safety profile over time.\n\n**Does PP405 work in women?**\nThe phase 2a trial included men and women, which is rare and promising. The most striking results, though, were in men with advanced loss. To be confirmed.\n\n**Can PP405 be combined with minoxidil or finasteride?**\nIn theory their mechanisms are complementary (metabolic wake up on one side, hormonal block on the other). But no study has validated this yet, and phase 3 will specifically require stopping these treatments to measure the effect of PP405 on its own.\n\n## What to do in practice today\n\nPP405 opens up an exciting path. But in 2026, you have to work with what already exists and has proven itself. And what works depends first on **your stage of loss**.\n\nFor early or moderate loss, the **validated medical treatments** keep their full place, as we set out in our guide to [hair loss treatments that actually work](https://emrahcinik.com/effective-hair-loss-treamtments/). Alongside them, the **regenerative treatments** offered in the clinic already stimulate weakened follicles, in the same spirit as PP405, but available now. [PRP](https://emrahcinik.com/hair-loss/prp/), included in every transplant package, boosts microcirculation. Exosomes deliver hundreds of growth factors. [Mesotherapy](https://emrahcinik.com/hair-mesotherapy/) feeds the scalp deep down.\n\nAnd when the follicle has gone on certain areas, the only lasting answer is still a **transplant**. Today's techniques, whether [Sapphire FUE](https://emrahcinik.com/hair-transplant/sapphire-fue/) or [DHI](https://emrahcinik.com/hair-transplant/dhi/), redeploy your own follicles where they are needed, for a natural and permanent result. Dr Emrah Cinik, with more than 20 years of experience and protocols in line with ISHRS standards, examines each scalp to point towards the right approach. Sometimes it is medical, sometimes it is a [hair transplant in Turkey](https://emrahcinik.com/), often it is a combination of both.\n\nThe real advice? Do not bet everything on a molecule still in trials. Act on what is within your reach while your follicles are still there to save. Do feel free to ask for a personalised free [consultation](https://emrahcinik.com/contact/). It is the best way to see clearly where you actually stand, without waiting until 2029.\n\n## Scientific references\n\nFlores, A., Schell, J., Krall, A. S., Jelinek, D., Miranda, M., Grigorian, M., Braas, D., White, A. C., Zhou, J. L., Graham, N. A., Graeber, T., Seth, P., Evseenko, D., Coller, H. A., Rutter, J., Christofk, H. R., & Lowry, W. E. (2017). Lactate dehydrogenase activity drives hair follicle stem cell activation. *Nature Cell Biology*, *19*(9), 1017-1026. https://pubmed.ncbi.nlm.nih.gov/28812580/\n\nLiu, X., Wang, Y., Christofk, H. R., Lowry, W. E., & Jung, M. E. (2021). Development of novel mitochondrial pyruvate carrier inhibitors to treat hair loss. *Journal of Medicinal Chemistry*, *64*(4), 2046-2063. https://pubmed.ncbi.nlm.nih.gov/33534563/\n\nPelage Pharmaceuticals. (2025, 17 juin). *Pelage Pharmaceuticals announces positive phase 2a clinical trial results for PP405 in regenerative hair loss therapy* [Communiqué de presse]. https://pelagepharma.com/press-releases/pelage-pharmaceuticals-announces-positive-phase-2a-clinical-trial-results-for-pp405-in-regenerative-hair-loss-therapy/\n\nPelage Pharmaceuticals. (2025, octobre). *Pelage Pharmaceuticals announces 120 million Series B financing to advance regenerative medicine treatments for hair loss* [Communiqué de presse]. https://pelagepharma.com/press-releases/pelage-pharmaceuticals-announces-120-million-series-b-financing-to-advance-regenerative-medicine-treatments-for-hair-loss/\n\nPelage Pharmaceuticals. (2026). *Pelage Pharmaceuticals PP405 and its impact on follicular regeneration to be presented at the American Academy of Dermatology (AAD) annual meeting 2026* [Communiqué de presse]. https://pelagepharma.com/press-releases/pelage-pp405-aad-2026/\n\nNational Library of Medicine. (2024). *A study to evaluate the safety, pharmacokinetics and efficacy of PP405 in androgenetic alopecia* (NCT06393452). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06393452\n\nHo, C. H., Sood, T., & Zito, P. M. (2024). *Androgenetic alopecia*. StatPearls. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK430924/\n\nDermatology Times. (2025). *Pelage's PP405 demonstrates efficacy in phase 2a trial for androgenetic alopecia*. https://www.dermatologytimes.com/view/pelage-s-pp405-demonstrates-efficacy-in-phase-2a-trial-for-androgenetic-alopecia\n"},"caller":{"type":"direct"}}],"stop_reason":"tool_use","stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":3090,"cache_read_input_tokens":70816,"output_tokens":7691,"server_tool_use":{"web_search_requests":0,"web_fetch_requests":0},"service_tier":"standard","cache_creation":{"ephemeral_1h_input_tokens":0,"ephemeral_5m_input_tokens":3090},"inference_geo":"not_available","iterations":[{"input_tokens":2,"output_tokens":7691,"cache_read_input_tokens":70816,"cache_creation_input_tokens":3090,"cache_creation":{"ephemeral_5m_input_tokens":3090,"ephemeral_1h_input_tokens":0},"type":"message"}],"speed":"standard"},"diagnostics":null},"requestId":"req_011CbcNg5wp6iodLG1eA5i9u","attributionAgent":"general-purpose","type":"assistant","uuid":"9421b5fe-746d-4f17-9592-c38d84b725cf","timestamp":"2026-06-01T10:23:59.758Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"9421b5fe-746d-4f17-9592-c38d84b725cf","isSidechain":true,"promptId":"b7260418-bc61-4035-9712-3bf2de3f0026","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_0197jLGi28FAvwkysHx8d2zS","type":"tool_result","content":"File created successfully at: /opt/automator/cinik-writer-transtor/files/translations/pp405-en.md (file state is current in your context — no need to Read it back)"}]},"uuid":"5d0e2cf6-ca3f-422e-a6e8-d27fc28c0475","timestamp":"2026-06-01T10:23:59.775Z","sourceToolAssistantUUID":"9421b5fe-746d-4f17-9592-c38d84b725cf","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"5d0e2cf6-ca3f-422e-a6e8-d27fc28c0475","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_019vrx11SQzrHPB4q1gGKvjb","type":"message","role":"assistant","content":[{"type":"text","text":"EN title check: \"PP405: the molecule that wakes up hair | Dr Cinik\" = let me count later. Now the IT version."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":7750,"cache_read_input_tokens":73906,"cache_creation":{"ephemeral_5m_input_tokens":7750,"ephemeral_1h_input_tokens":0},"output_tokens":1,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNnGeAbW5s66HXe9dHo","attributionAgent":"general-purpose","type":"assistant","uuid":"78bd5ed8-31b3-478e-8646-138258b72477","timestamp":"2026-06-01T10:24:02.827Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"78bd5ed8-31b3-478e-8646-138258b72477","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_019vrx11SQzrHPB4q1gGKvjb","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01MGVQX1z3s5V65XVuNTQE2s","name":"Write","input":{"file_path":"/opt/automator/cinik-writer-transtor/files/translations/pp405-it.md","content":"**Slug** : /pp405-molecola-che-risveglia-follicoli\n\n**Title SEO** : PP405: la molecola che risveglia i capelli | Dr Cinik\n\n**Meta description** : PP405 fa davvero ricrescere i capelli? Meccanismo, risultati degli studi, calendario fase 3 e il parere onesto del Dr Cinik su questa molecola.\n\n---\n\n# PP405: la molecola che potrebbe risvegliare i tuoi follicoli dormienti (cosa dice davvero la scienza nel 2026)\n\nNello studio di fase 2a, circa il **31% degli uomini con calvizie avanzata** ha visto la propria densità capillare salire di oltre il **20%** in otto settimane. Nel gruppo placebo: **0%**. Zero. È la prima volta da decenni che una molecola applicata sul cuoio capelluto fa crescere capelli nuovi dove non ce n'erano più. PP405 non rallenta la caduta. Riaccende follicoli spenti. E questo, nessun trattamento attuale sa farlo.\n\nL'argomento infiamma i forum, gli studi medici e perfino la rivista *Time*, che ha inserito PP405 tra le migliori invenzioni del 2025. Inevitabile. La maggior parte dei trattamenti protegge ciò che già c'è. La [finasteride](https://emrahcinik.com/it/finasteride/) blocca l'ormone colpevole. Il [minoxidil](https://emrahcinik.com/it/minoxidil/) prolunga la fase di crescita. Ma nessuno riporta in vita un follicolo dormiente. PP405 punta esattamente a questo, per una strada che nessuno aveva osato percorrere: **il metabolismo della cellula, non gli ormoni**.\n\nUna fase 3 è annunciata per il 2026. Separiamo allora il vero dalla fantasia. Ecco, senza clamore né promesse gonfiate, tutto ciò che la scienza dice oggi su PP405: il suo meccanismo, i suoi risultati, il suo calendario, i suoi limiti e cosa puoi fare concretamente nell'attesa.\n\n## PP405, cos'è di preciso?\n\nPP405 è una **piccola molecola** che si applica localmente sul cuoio capelluto. Non un ormone. Non un'iniezione. Non una compressa. Un gel, una volta al giorno, e basta.\n\nÈ nata nei laboratori dell'**UCLA**, in California. Tre scienziati dell'università, Bill Lowry, Heather Christofk e Michael Jung, hanno fondato nel 2018 la società **Pelage Pharmaceuticals** per portarla fino alla clinica. Prima, quasi dieci anni di ricerca di base, poi un finanziamento di peso: oltre 30 milioni di dollari all'inizio, guidati da Google Ventures, seguiti da una **raccolta di 120 milioni di dollari** nell'ottobre 2025. Quando investitori di questo calibro puntano forte su un gel per capelli, vuol dire che il meccanismo regge.\n\nIl suo angolo d'attacco non ha nulla a che vedere con i farmaci classici. La [calvizie ereditaria](https://emrahcinik.com/it/calvizie-ereditaria/), chiamata anche [alopecia androgenetica](https://emrahcinik.com/it/alopecia-androgenetica/), non uccide i follicoli di colpo. Li **addormenta**. Si rimpiccioliscono, si miniaturizzano, poi scivolano in una dormienza prolungata. Il capello diventa fine, corto, quasi trasparente. E poi un giorno, non esce più nulla. Ma il follicolo, spesso, è ancora lì, acquattato, vivo.\n\nSono proprio queste cellule staminali follicolari addormentate che PP405 va a cercare. L'obiettivo: risvegliarle e rilanciare il ciclo di crescita. Un approccio detto **rigenerativo**, nello stesso spirito della [medicina rigenerativa dei capelli](https://emrahcinik.com/it/medicina-rigenerativa-capelli/), che cerca di stimolare i follicoli invece di limitarsi a frenarne il declino.\n\n## Perché potrebbe essere una svolta\n\nPer capire l'entusiasmo, bisogna guardare il quadro attuale. Dall'arrivo del minoxidil e della finasteride negli anni '80 e '90, niente di sostanzialmente nuovo. Si affina, si combina, si ottimizza. Ma il principio resta lo stesso: **difendere i capelli che restano**.\n\nPP405 propone altro. Non difendere, ma **rigenerare**. Risvegliare follicoli che si credevano persi. Se la scienza mantiene le promesse su larga scala, sposterebbe il confine di ciò che si può curare senza bisturi. Non un sostituto del trapianto, lo vedremo. Ma una corda in più all'arco, e una corda inedita.\n\nTre cose rendono PP405 diverso dalle decine di pseudo-miracoli per capelli che sfilano ogni anno:\n\n- **Un bersaglio biologico preciso e pubblicato**, validato dalla ricerca di base prima di ogni promessa di marketing.\n- **Risultati clinici misurati nell'uomo**, non solo sui topi.\n- **Una sicurezza d'impiego notevole**, senza passaggio nel sangue.\n\nEcco perché dermatologi seri lo seguono da vicino. Resta da trasformare la prova.\n\n## Il meccanismo: una questione di carburante, non di ormoni\n\nEcco il punto che cambia tutto. PP405 non tocca **affatto** gli androgeni. Agisce sul carburante interno delle cellule staminali del follicolo. Per cogliere l'idea, bisogna entrare un minuto dentro la cellula.\n\n### Risvegliare una cellula attraverso la sua energia\n\nOgni [follicolo pilifero](https://emrahcinik.com/it/follicoli-piliferi/) ospita cellule staminali. Attive, fabbricano capelli. Addormentate, lasciano il follicolo a riposo. E la ricerca dell'UCLA ha messo il dito su una cosa sorprendente: ciò che risveglia queste cellule è un **cambiamento di metabolismo**. Più precisamente, una salita del **lattato** all'interno della cellula.\n\nIl lattato è quel sottoprodotto che i muscoli fabbricano sotto sforzo, quello che dà la sensazione di bruciore quando ti spingi al limite. Nel follicolo gioca tutt'altro ruolo: un **segnale di avvio**. Molto lattato, e la cellula staminale passa in modalità crescita, la fase detta anagen. Poco lattato, e resta dormiente, la fase telogen. Il livello di lattato è, in un certo senso, l'interruttore tra riposo e crescita.\n\n### Il gioco di prestigio di PP405\n\nLa molecola blocca quelli che si chiamano i **trasportatori mitocondriali del piruvato** (le porte MPC1 e MPC2 della centrale energetica della cellula, il mitocondrio). In parole povere, PP405 chiude due porte attraverso cui il carburante entrava normalmente nel mitocondrio.\n\nChiuse quelle porte, il piruvato si accumula fuori. Un enzima, la **lattato deidrogenasi (LDH)**, lo converte allora in lattato. Risultato a cascata: il livello di lattato sale, la glicolisi accelera, la cellula staminale riceve il suo segnale di avvio e si rimette al lavoro. Il follicolo torna in modalità crescita.\n\nÈ elegante. E si trova agli antipodi dei [bloccanti della DHT](https://emrahcinik.com/it/bloccanti-dht/), che colpiscono la causa ormonale della caduta. Là dove la [DHT](https://emrahcinik.com/it/dht-ormone-responsabile-della-calvizie/) agisce come un diserbante che soffoca i follicoli, PP405 gioca la **frustata metabolica**. Due filosofie opposte. Ed è proprio questo che apre la porta a combinarle un giorno, invece di contrapporle.\n\n## Cosa dicono davvero gli studi clinici\n\nSpazio ai numeri. È qui che si gioca la credibilità, ed è qui che PP405 si distingue dalla massa.\n\n### Fase 1: la prova attraverso la biologia\n\nPrima ancora di contare i capelli, i ricercatori volevano una certezza: il gel risveglia davvero le cellule? La fase 1, centrata sulla sicurezza, ha dato la risposta. In **soli sette giorni**, PP405 ha aumentato in modo **statisticamente significativo** l'attivazione delle cellule staminali nel follicolo, misurata in particolare tramite il **Ki67**, un classico marcatore di proliferazione cellulare. Tradotto: ciò che si osservava in laboratorio si confermava nell'uomo. Le cellule dormienti si rimettevano al lavoro. Prima casella spuntata.\n\n### Fase 2a: 78 pazienti, risultati netti\n\nLo studio di fase 2a era randomizzato, in doppio cieco, con gruppo placebo, lo standard del rigore. In totale, **78 adulti** colpiti da alopecia androgenetica, uomini e donne, con una vera varietà di carnagioni e texture di capelli. Ognuno applicava un gel di PP405 dosato allo **0,05%**, una volta al giorno, per **4 settimane**, con un follow-up prolungato fino alla dodicesima settimana.\n\nIl risultato di rilievo: circa il **31% degli uomini con le perdite più avanzate** ha guadagnato oltre il **20% di densità capillare** già all'ottava settimana, cioè quattro settimane dopo la sospensione del trattamento. Nel placebo, **nessuno**. E il dettaglio che conta davvero: è cresciuto **capello terminale** in zone fino ad allora diradate. Non lanugine fine, non un semplice ispessimento di capelli esistenti. Capello nuovo, spesso, dove non ce n'era più.\n\nNota anche la **velocità**. Una risposta visibile in otto settimane, là dove minoxidil e finasteride chiedono spesso da sei a dodici mesi per mostrare qualcosa. È uno degli argomenti più clamorosi di PP405.\n\n### Fase 2b: già conclusa\n\nPelage non ha aspettato. Una **fase 2b** è stata condotta a fine 2025, sotto forma di estensione in aperto con questa volta **tre mesi di trattamento** invece di quattro settimane. L'idea: vedere cosa dà un'esposizione più lunga, più vicina a un uso reale. I dati completi sono attesi a un congresso medico nel 2026. Da tenere d'occhio molto da vicino, perché è questa prospettiva che dirà se l'effetto si rafforza nel tempo.\n\n### La sicurezza: probabilmente il punto più forte\n\nLo studio ha spuntato tutte le sue caselle di sicurezza. **Nessun assorbimento sistemico rilevabile** nel sangue: la molecola resta dove la metti, sul cuoio capelluto, e non circola nell'organismo. Nessuna perturbazione ormonale, nessun effetto indesiderato sistemico, buona tolleranza generale.\n\nÈ un argomento di peso, soprattutto di fronte ai timori che si appiccicano ad alcuni trattamenti orali. Un prodotto locale che non passa nel sangue, per costruzione, scarta gran parte delle preoccupazioni sulla libido o sull'umore che a volte si sentono a proposito della finasteride. Inevitabilmente, questo rassicura.\n\n## PP405 a confronto con i trattamenti attuali\n\nPer inquadrare PP405, niente vale quanto un confronto fianco a fianco con ciò che esiste già e ha dato prova di sé.\n\n| Criterio | PP405 | Minoxidil | Finasteride |\n|---|---|---|---|\n| Azione principale | Risveglia i follicoli dormienti | Prolunga la fase di crescita | Blocca la DHT, causa ormonale |\n| Bersaglio | Metabolismo della cellula staminale | Circolazione e ciclo del capello | Ormone (5-alfa-reduttasi) |\n| Ricrescita di capello nuovo | Sì, osservata negli studi | Limitata, soprattutto ispessimento | Soprattutto conservazione |\n| Forma | Gel topico, 1 volta al giorno | Lozione o schiuma topica | Compressa orale (o topica) |\n| Passaggio nel sangue | Nessuno rilevato | Basso | Sì |\n| Rischio ormonale | Nessuno | Nessuno | Possibile in alcuni |\n| Stato nel 2026 | In studio, non disponibile | Disponibile, validato | Disponibile, validato |\n| Esperienza scientifica | Qualche anno | Diversi decenni | Diversi decenni |\n\nLa tabella dice l'essenziale. PP405 punta a un terreno che **nessun altro occupa**: la rigenerazione di follicoli dormienti. Ma di fronte, minoxidil e finasteride hanno dalla loro **decenni di esperienza** e una disponibilità immediata. È tutto il divario tra una promessa brillante e un valore sicuro. L'uno non annulla l'altro. Il giorno in cui PP405 sarà approvato, verrà probabilmente a **completare** questi trattamenti più che a sostituirli, combinando il risveglio metabolico e il blocco ormonale.\n\n## PP405 a confronto con le altre innovazioni rigenerative\n\nPP405 non avanza da solo. Diverse piste cercano di superare la semplice difesa dell'esistente. In breve, il giro del gruppo.\n\n- **La verteporfina.** Una molecola inizialmente usata in oftalmologia, studiata a Stanford per il suo effetto di **cicatrizzazione senza fibrosi** (per inibizione della proteina YAP). Nel trapianto di capelli, la speranza è doppia: ridurre le micro-cicatrici e forse rilanciare i follicoli. Ancora molto sperimentale nell'uomo per la calvizie.\n- **Gli esosomi.** Minuscole vescicole derivate da cellule staminali, cariche di fattori di crescita, che trasmettono segnali di riparazione al follicolo. Già usati in clinica come trattamento stimolante, restano in corso di valutazione rigorosa. Il Dr Cinik li propone del resto come [trattamento con esosomi](https://emrahcinik.com/it/esosomi-capelli/).\n- **La clonazione capillare.** Il Graal lontano: moltiplicare i tuoi follicoli in laboratorio per reimpiantarli senza limiti di zona donatrice. Società come Stemson Therapeutics o HairClone ci lavorano. Ma restiamo sulla ricerca, senza un calendario credibile a breve termine.\n\nLà dentro, PP405 ha un netto vantaggio: **è l'unico a mostrare risultati clinici quantificati nell'uomo e un calendario di fase 3 datato**. Le altre piste sono affascinanti, ma più indietro lungo la strada.\n\n## Calendario, attese e zona di prudenza\n\nSiamo sinceri sui tempi, perché è qui che molti siti ti raccontano frottole.\n\nLa **fase 3**, la tappa decisiva prima di qualsiasi commercializzazione, deve partire nel **2026**, per una durata di circa un anno. Dovrebbe imporre una condizione notevole ai partecipanti: una **sospensione di circa sei mesi** dei trattamenti in corso (minoxidil, finasteride) prima di entrare nello studio, per isolare l'effetto proprio di PP405. Pelage presenterà inoltre i suoi lavori al congresso dell'**Accademia americana di dermatologia (AAD) nel marzo 2026**, a Denver, durante una sessione dedicata ai trattamenti emergenti che puntano ai follicoli dormienti.\n\nMa teniamo la testa fredda. Una fase 2a su **78 persone** resta uno studio di **dimensioni modeste**, con una prospettiva breve (quattro settimane di trattamento). Il famoso 31% riguarda un **sottogruppo preciso**: gli uomini con perdite avanzate. Niente di universale, quindi. E a oggi, i risultati non sono ancora stati pubblicati su una rivista scientifica con revisione tra pari, né accompagnati da foto prima-dopo condivise con il grande pubblico. È la fase 3, condotta su centinaia di pazienti e su una durata più lunga, che dirà se l'effetto **tiene nel tempo e su larga scala**.\n\nIn chiaro: un'approvazione normativa non è **attesa prima del 2027-2029**, nel migliore dei casi. PP405 è una pista seria e inedita, **non un prodotto in farmacia domani mattina**.\n\n> **Attenzione alle truffe.** PP405 non è **disponibile** alla vendita, da nessuna parte, punto. Ogni sito che pretende di vendertelo, con questo nome o un altro, ti inganna. L'unico accesso legittimo, oggi, passa per gli studi clinici ufficiali. Diffidenza assoluta.\n\nQuesta molecola si aggiunge alla breve lista dei [nuovi farmaci contro la calvizie](https://emrahcinik.com/it/nuovi-farmaci-anticaduta/) da tenere d'occhio, accanto al [clascoterone](https://emrahcinik.com/it/clascoterone-capelli/), un altro trattamento promettente di questi ultimi anni.\n\n## Chi potrebbe beneficiarne, e chi no\n\nEcco la verità che si dimentica troppo spesso nell'entusiasmo. **Un follicolo dormiente può essere risvegliato. Un follicolo morto, mai.** Nessun trattamento locale fa ricrescere un capello dove il follicolo è del tutto scomparso e cicatrizzato. PP405 non farà eccezione.\n\nTutta la sfumatura è qui. PP405 punta ai **follicoli miniaturizzati ma ancora vivi**, tipici degli stadi intermedi.\n\n**I buoni candidati potenziali:**\n\n- Persone agli **stadi precoci o moderati** di caduta, dove il follicolo respira ancora.\n- Stadi intermedi della [scala Norwood-Hamilton](https://emrahcinik.com/it/scala-norwood/) nell'uomo.\n- Stadi intermedi della [scala di Ludwig](https://emrahcinik.com/it/scala-di-ludwig/) nella donna, tenendo presente che lo studio ha incluso donne, cosa rara e incoraggiante.\n\n**Coloro per cui PP405 non farà nulla:**\n\n- [Calvizie completa](https://emrahcinik.com/it/trapianto-di-capelli-calvizie-completa/) installata da tempo, dove la riserva di cellule staminali è scomparsa.\n- Zone lisce e lucide, cicatriziali, senza alcun follicolo residuo.\n- Alopecie cicatriziali di altra origine, che distruggono il follicolo stesso.\n\nNiente cellula, niente risveglio possibile. Capire il [ciclo del capello](https://emrahcinik.com/it/ciclo-capelli/) aiuta a cogliere perché il **tempismo pesa così tanto**: bisogna agire finché il follicolo è ancora lì. È anche per questo che aspettare PP405 con le mani in mano per anni può essere una cattiva idea. Mentre aspetti, follicoli che si sarebbero potuti salvare finiscono di spegnersi.\n\n## FAQ: le tue domande su PP405\n\n**PP405 è disponibile in Italia o altrove?**\nNo. PP405 è ancora in fase di studio clinico e non è commercializzato in nessuna parte del mondo. Nessuna farmacia, nessun sito serio può fornirtelo nel 2026.\n\n**Quando si potrà acquistare?**\nSe la fase 3 conferma i risultati e le autorità danno il via libera, una messa in commercio non sarebbe attesa prima del 2027-2029 al più presto. E solo se tutto va bene.\n\n**PP405 sostituirà il trapianto di capelli?**\nNo, sono due logiche diverse. PP405 risveglia follicoli ancora vivi. Il trapianto ridistribuisce follicoli dove non ne resta più nessuno. Su una zona del tutto diradata, PP405 non ha nulla da risvegliare.\n\n**Ci sono effetti collaterali?**\nGli studi condotti finora mostrano una buona tolleranza, senza passaggio della molecola nel sangue né effetto ormonale. Ma la prospettiva resta breve: è la fase 3, più lunga, che preciserà davvero il profilo di sicurezza nel tempo.\n\n**PP405 funziona nelle donne?**\nLo studio di fase 2a ha incluso uomini e donne, cosa rara e promettente. I risultati più rilevanti riguardavano tuttavia uomini con perdita avanzata. Da confermare.\n\n**Si può combinare PP405 con il minoxidil o la finasteride?**\nIn teoria, i loro meccanismi sono complementari (risveglio metabolico da un lato, blocco ormonale dall'altro). Ma nessuno studio l'ha ancora validato, e la fase 3 chiederà proprio di sospendere questi trattamenti per misurare l'effetto proprio di PP405.\n\n## Cosa fare concretamente oggi\n\nPP405 apre una via affascinante. Ma nel 2026, devi fare i conti con ciò che esiste già e ha dato prova di sé. E ciò che funziona dipende prima di tutto dal **tuo stadio di caduta**.\n\nPer una perdita iniziale o moderata, i **trattamenti medici validati** mantengono tutto il loro posto, come spieghiamo nella nostra guida ai [trattamenti contro la caduta dei capelli che funzionano davvero](https://emrahcinik.com/it/trattamenti-caduta-capelli/). In parallelo, i **trattamenti rigenerativi** proposti in clinica stimolano già i follicoli indeboliti, nello stesso spirito di PP405, ma disponibili ora. Il [PRP](https://emrahcinik.com/it/la-perdita-di-capelli/prp/), incluso in tutti i pacchetti di trapianto, rilancia la microcircolazione. Gli [esosomi](https://emrahcinik.com/it/esosomi-capelli/) apportano centinaia di fattori di crescita. La [mesoterapia](https://emrahcinik.com/it/mesoterapia-capelli/) nutre il cuoio capelluto in profondità.\n\nE quando il follicolo è scomparso su certe zone, l'unica risposta duratura resta il **trapianto**. Le tecniche attuali, che si tratti della [FUE Zaffiro](https://emrahcinik.com/it/trapianto-di-capelli/zaffiro/) o della [DHI](https://emrahcinik.com/it/trapianto-di-capelli/dhi/), ridistribuiscono i tuoi follicoli dove servono, per un risultato naturale e permanente. Il Dr Emrah Cinik, forte di oltre 20 anni di esperienza e di protocolli conformi agli standard ISHRS, esamina ogni cuoio capelluto per orientare verso l'approccio giusto. A volte è il medico, a volte è un [trapianto di capelli in Turchia](https://emrahcinik.com/it/), spesso è una combinazione dei due.\n\nIl vero consiglio? Non puntare tutto su una molecola ancora in studio. Agisci su ciò che è alla tua portata mentre i tuoi follicoli sono ancora lì da salvare. Non esitare a chiedere una [consulenza](https://emrahcinik.com/it/contatto/) personalizzata gratuita. È il modo migliore per vederci chiaro sulla tua situazione reale, senza aspettare il 2029.\n\n## Riferimenti scientifici\n\nFlores, A., Schell, J., Krall, A. S., Jelinek, D., Miranda, M., Grigorian, M., Braas, D., White, A. C., Zhou, J. L., Graham, N. A., Graeber, T., Seth, P., Evseenko, D., Coller, H. A., Rutter, J., Christofk, H. R., & Lowry, W. E. (2017). Lactate dehydrogenase activity drives hair follicle stem cell activation. *Nature Cell Biology*, *19*(9), 1017-1026. https://pubmed.ncbi.nlm.nih.gov/28812580/\n\nLiu, X., Wang, Y., Christofk, H. R., Lowry, W. E., & Jung, M. E. (2021). Development of novel mitochondrial pyruvate carrier inhibitors to treat hair loss. *Journal of Medicinal Chemistry*, *64*(4), 2046-2063. https://pubmed.ncbi.nlm.nih.gov/33534563/\n\nPelage Pharmaceuticals. (2025, 17 juin). *Pelage Pharmaceuticals announces positive phase 2a clinical trial results for PP405 in regenerative hair loss therapy* [Communiqué de presse]. https://pelagepharma.com/press-releases/pelage-pharmaceuticals-announces-positive-phase-2a-clinical-trial-results-for-pp405-in-regenerative-hair-loss-therapy/\n\nPelage Pharmaceuticals. (2025, octobre). *Pelage Pharmaceuticals announces 120 million Series B financing to advance regenerative medicine treatments for hair loss* [Communiqué de presse]. https://pelagepharma.com/press-releases/pelage-pharmaceuticals-announces-120-million-series-b-financing-to-advance-regenerative-medicine-treatments-for-hair-loss/\n\nPelage Pharmaceuticals. (2026). *Pelage Pharmaceuticals PP405 and its impact on follicular regeneration to be presented at the American Academy of Dermatology (AAD) annual meeting 2026* [Communiqué de presse]. https://pelagepharma.com/press-releases/pelage-pp405-aad-2026/\n\nNational Library of Medicine. (2024). *A study to evaluate the safety, pharmacokinetics and efficacy of PP405 in androgenetic alopecia* (NCT06393452). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06393452\n\nHo, C. H., Sood, T., & Zito, P. M. (2024). *Androgenetic alopecia*. StatPearls. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK430924/\n\nDermatology Times. (2025). *Pelage's PP405 demonstrates efficacy in phase 2a trial for androgenetic alopecia*. https://www.dermatologytimes.com/view/pelage-s-pp405-demonstrates-efficacy-in-phase-2a-trial-for-androgenetic-alopecia\n"},"caller":{"type":"direct"}}],"stop_reason":"tool_use","stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":7750,"cache_read_input_tokens":73906,"output_tokens":9705,"server_tool_use":{"web_search_requests":0,"web_fetch_requests":0},"service_tier":"standard","cache_creation":{"ephemeral_1h_input_tokens":0,"ephemeral_5m_input_tokens":7750},"inference_geo":"not_available","iterations":[{"input_tokens":2,"output_tokens":9705,"cache_read_input_tokens":73906,"cache_creation_input_tokens":7750,"cache_creation":{"ephemeral_5m_input_tokens":7750,"ephemeral_1h_input_tokens":0},"type":"message"}],"speed":"standard"},"diagnostics":null},"requestId":"req_011CbcNnGeAbW5s66HXe9dHo","attributionAgent":"general-purpose","type":"assistant","uuid":"5a9b3517-ce99-4390-b84e-dd6c7fcff7db","timestamp":"2026-06-01T10:25:49.655Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"5a9b3517-ce99-4390-b84e-dd6c7fcff7db","isSidechain":true,"promptId":"9a1ead73-0732-4ff4-98f5-092b90489b3e","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01MGVQX1z3s5V65XVuNTQE2s","type":"tool_result","content":"File created successfully at: /opt/automator/cinik-writer-transtor/files/translations/pp405-it.md (file state is current in your context — no need to Read it back)"}]},"uuid":"74711f98-09a4-4de8-a08a-5a7c83a0095a","timestamp":"2026-06-01T10:25:49.676Z","sourceToolAssistantUUID":"5a9b3517-ce99-4390-b84e-dd6c7fcff7db","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"74711f98-09a4-4de8-a08a-5a7c83a0095a","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01CKfm31yLwZKvfZHBhsBmq1","type":"message","role":"assistant","content":[{"type":"text","text":"Now let me run validation checks: zero dashes, title lengths, and verify the EN exosome link was correctly removed (kept anchor, no link)."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":9764,"cache_read_input_tokens":81656,"cache_creation":{"ephemeral_5m_input_tokens":9764,"ephemeral_1h_input_tokens":0},"output_tokens":5,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNvNVNR7cF2PbcdshKq","attributionAgent":"general-purpose","type":"assistant","uuid":"494e303a-3a6a-496a-aa6e-3f38e59e8f89","timestamp":"2026-06-01T10:25:52.417Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"494e303a-3a6a-496a-aa6e-3f38e59e8f89","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01CKfm31yLwZKvfZHBhsBmq1","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01AcSNwRrXNc5Ahx5rmaBHEY","name":"Bash","input":{"command":"cd /opt/automator/cinik-writer-transtor/files/translations\necho \"=== EN em/en dash count ===\"\ngrep -c -P '\\xe2\\x80\\x94|\\xe2\\x80\\x93' pp405-en.md || echo \"0 dashes EN\"\necho \"=== IT em/en dash count ===\"\ngrep -c -P '\\xe2\\x80\\x94|\\xe2\\x80\\x93' pp405-it.md || echo \"0 dashes IT\"\necho \"=== EN title length ===\"\npython3 -c \"print(len('PP405: the molecule that wakes up hair | Dr Cinik'))\"\necho \"=== IT title length ===\"\npython3 -c \"print(len('PP405: la molecola che risveglia i capelli | Dr Cinik'))\"\necho \"=== EN meta length ===\"\npython3 -c \"print(len(\\\"Does PP405 really regrow hair? Mechanism, trial results, phase 3 timeline and Dr Cinik's honest take on this molecule.\\\"))\"\necho \"=== IT meta length ===\"\npython3 -c \"print(len(\\\"PP405 fa davvero ricrescere i capelli? Meccanismo, risultati degli studi, calendario fase 3 e il parere onesto del Dr Cinik su questa molecola.\\\"))\"\necho \"=== EN exosome line (should have NO markdown link) ===\"\ngrep -n \"exosome\" pp405-en.md\necho \"=== EN home anchor ===\"\ngrep -n \"hair transplant in Turkey\" pp405-en.md\necho \"=== IT home anchor ===\"\ngrep -n \"trapianto di capelli in Turchia\" pp405-it.md\necho \"=== EN no link-table at end? show last 5 non-ref lines around 'real advice' ===\"\ngrep -n \"linksReplaced\\|| FR |\\|Tableau\\|Tabella\" pp405-en.md pp405-it.md || echo \"no link tables\""},"caller":{"type":"direct"}}],"stop_reason":"tool_use","stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":9764,"cache_read_input_tokens":81656,"output_tokens":740,"server_tool_use":{"web_search_requests":0,"web_fetch_requests":0},"service_tier":"standard","cache_creation":{"ephemeral_1h_input_tokens":0,"ephemeral_5m_input_tokens":9764},"inference_geo":"not_available","iterations":[{"input_tokens":2,"output_tokens":740,"cache_read_input_tokens":81656,"cache_creation_input_tokens":9764,"cache_creation":{"ephemeral_5m_input_tokens":9764,"ephemeral_1h_input_tokens":0},"type":"message"}],"speed":"standard"},"diagnostics":null},"requestId":"req_011CbcNvNVNR7cF2PbcdshKq","attributionAgent":"general-purpose","type":"assistant","uuid":"a07e9283-d1f0-4de4-82af-681ce946f3fc","timestamp":"2026-06-01T10:25:59.253Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"a07e9283-d1f0-4de4-82af-681ce946f3fc","isSidechain":true,"promptId":"9a1ead73-0732-4ff4-98f5-092b90489b3e","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01AcSNwRrXNc5Ahx5rmaBHEY","type":"tool_result","content":"=== EN em/en dash count ===\n0\n0 dashes EN\n=== IT em/en dash count ===\n0\n0 dashes IT\n=== EN title length ===\n49\n=== IT title length ===\n53\n=== EN meta length ===\n118\n=== IT meta length ===\n143\n=== EN exosome line (should have NO markdown link) ===\n107:- **Exosomes.** Tiny vesicles from stem cells, packed with growth factors, that pass repair signals to the follicle. Already used in clinics as a stimulating treatment, they are still under rigorous evaluation. Dr Cinik offers them, in fact, as an exosome treatment.\n=== EN home anchor ===\n172:And when the follicle has gone on certain areas, the only lasting answer is still a **transplant**. Today's techniques, whether [Sapphire FUE](https://emrahcinik.com/hair-transplant/sapphire-fue/) or [DHI](https://emrahcinik.com/hair-transplant/dhi/), redeploy your own follicles where they are needed, for a natural and permanent result. Dr Emrah Cinik, with more than 20 years of experience and protocols in line with ISHRS standards, examines each scalp to point towards the right approach. Sometimes it is medical, sometimes it is a [hair transplant in Turkey](https://emrahcinik.com/), often it is a combination of both.\n=== IT home anchor ===\n172:E quando il follicolo è scomparso su certe zone, l'unica risposta duratura resta il **trapianto**. Le tecniche attuali, che si tratti della [FUE Zaffiro](https://emrahcinik.com/it/trapianto-di-capelli/zaffiro/) o della [DHI](https://emrahcinik.com/it/trapianto-di-capelli/dhi/), ridistribuiscono i tuoi follicoli dove servono, per un risultato naturale e permanente. Il Dr Emrah Cinik, forte di oltre 20 anni di esperienza e di protocolli conformi agli standard ISHRS, esamina ogni cuoio capelluto per orientare verso l'approccio giusto. A volte è il medico, a volte è un [trapianto di capelli in Turchia](https://emrahcinik.com/it/), spesso è una combinazione dei due.\n=== EN no link-table at end? show last 5 non-ref lines around 'real advice' ===\nno link tables","is_error":false}]},"uuid":"c5b4db1a-9e55-4f65-a773-67a30f528bc3","timestamp":"2026-06-01T10:25:59.425Z","sourceToolAssistantUUID":"a07e9283-d1f0-4de4-82af-681ce946f3fc","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"c5b4db1a-9e55-4f65-a773-67a30f528bc3","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01HmzsoTPQfWr1eGE38AcmaK","type":"message","role":"assistant","content":[{"type":"text","text":"All checks pass:\n- 0 em/en dashes in both files\n- EN title 49 chars, IT title 53 chars (both ≤60, end with \" | Dr Cinik\")\n- EN meta 118 chars, IT meta 143 chars (both ≤155)\n- EN exosome (first mention) correctly kept anchor without markdown link (no EN equivalent); the later \"PRP/exosomes\" list in EN — let me verify the second exosome mention also has no link since there's no EN page.\n- Home anchors present correctly (EN home no /en/ prefix per hreflang, IT home /it/)\n- No link tables\n\nLet me verify the second EN exosome reference (in the \"What to do today\" section) doesn't link to a non-existent page."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":1557,"cache_read_input_tokens":91420,"cache_creation":{"ephemeral_5m_input_tokens":1557,"ephemeral_1h_input_tokens":0},"output_tokens":1,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNw5xyFVGebHS9oEyxn","attributionAgent":"general-purpose","type":"assistant","uuid":"a2d03698-5517-4f41-808e-4e88439902e3","timestamp":"2026-06-01T10:26:04.673Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"a2d03698-5517-4f41-808e-4e88439902e3","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01HmzsoTPQfWr1eGE38AcmaK","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01BfswohZrp6ht4U9zPcJqYR","name":"Bash","input":{"command":"cd /opt/automator/cinik-writer-transtor/files/translations\necho \"=== EN: all Exosome/exosome mentions ===\"\ngrep -no \"Exosomes\\][^ ]*\\|exosome[^ ]*\\|Exosomes deliver\" pp405-en.md\necho \"--- full PRP line EN ---\"\ngrep -n \"PRP\\b\" pp405-en.md\necho \"=== confirm no emrahcinik.com/exosomes or /it/ exosome broken in EN ===\"\ngrep -n \"exosomes\" pp405-en.md"},"caller":{"type":"direct"}}],"stop_reason":"tool_use","stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":1557,"cache_read_input_tokens":91420,"output_tokens":475,"server_tool_use":{"web_search_requests":0,"web_fetch_requests":0},"service_tier":"standard","cache_creation":{"ephemeral_1h_input_tokens":0,"ephemeral_5m_input_tokens":1557},"inference_geo":"not_available","iterations":[{"input_tokens":2,"output_tokens":475,"cache_read_input_tokens":91420,"cache_creation_input_tokens":1557,"cache_creation":{"ephemeral_5m_input_tokens":1557,"ephemeral_1h_input_tokens":0},"type":"message"}],"speed":"standard"},"diagnostics":null},"requestId":"req_011CbcNw5xyFVGebHS9oEyxn","attributionAgent":"general-purpose","type":"assistant","uuid":"bee2411f-d0d0-4efa-9105-5b2f77847044","timestamp":"2026-06-01T10:26:06.970Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"bee2411f-d0d0-4efa-9105-5b2f77847044","isSidechain":true,"promptId":"9a1ead73-0732-4ff4-98f5-092b90489b3e","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01BfswohZrp6ht4U9zPcJqYR","type":"tool_result","content":"=== EN: all Exosome/exosome mentions ===\n107:exosome\n170:Exosomes deliver\n--- full PRP line EN ---\n170:For early or moderate loss, the **validated medical treatments** keep their full place, as we set out in our guide to [hair loss treatments that actually work](https://emrahcinik.com/effective-hair-loss-treamtments/). Alongside them, the **regenerative treatments** offered in the clinic already stimulate weakened follicles, in the same spirit as PP405, but available now. [PRP](https://emrahcinik.com/hair-loss/prp/), included in every transplant package, boosts microcirculation. Exosomes deliver hundreds of growth factors. [Mesotherapy](https://emrahcinik.com/hair-mesotherapy/) feeds the scalp deep down.\n=== confirm no emrahcinik.com/exosomes or /it/ exosome broken in EN ===","is_error":false}]},"uuid":"b1825bc7-5715-4abf-8591-b0a5a109f19e","timestamp":"2026-06-01T10:26:07.026Z","sourceToolAssistantUUID":"bee2411f-d0d0-4efa-9105-5b2f77847044","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"b1825bc7-5715-4abf-8591-b0a5a109f19e","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01V5FGNzZdaoUwhHxGyNVpaR","type":"message","role":"assistant","content":[{"type":"text","text":"Both EN exosome mentions are unlinked (no EN equivalent page exists), correctly applying the keep-anchor-remove-link rule. The IT version has both exosome mentions properly linked since the IT page exists.\n\nNow let me publish both files to Google Docs."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":792,"cache_read_input_tokens":92977,"cache_creation":{"ephemeral_5m_input_tokens":792,"ephemeral_1h_input_tokens":0},"output_tokens":9,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNweVp91jtvT9hRH6Hf","attributionAgent":"general-purpose","type":"assistant","uuid":"5ec2d53e-ffcf-4e68-8e97-947bd28c51b5","timestamp":"2026-06-01T10:26:10.004Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"5ec2d53e-ffcf-4e68-8e97-947bd28c51b5","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01V5FGNzZdaoUwhHxGyNVpaR","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01P7YWG9E6pqNBTHFptwXntr","name":"Bash","input":{"command":"VPY=/home/dev/.claude/skills/cinik-blog-brief/.venv/bin/python\n\"$VPY\" ~/.claude/skills/cinik-blog-brief/scripts/gdoc_publish.py \\\n  --md /opt/automator/cinik-writer-transtor/files/translations/pp405-en.md \\\n  --title \"EN | PP405: the molecule that might wake up your dormant follicles (what the science actually says in 2026)\" 2>&1 | tail -20"},"caller":{"type":"direct"}}],"stop_reason":"tool_use","stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":792,"cache_read_input_tokens":92977,"output_tokens":297,"server_tool_use":{"web_search_requests":0,"web_fetch_requests":0},"service_tier":"standard","cache_creation":{"ephemeral_1h_input_tokens":0,"ephemeral_5m_input_tokens":792},"inference_geo":"not_available","iterations":[{"input_tokens":2,"output_tokens":297,"cache_read_input_tokens":92977,"cache_creation_input_tokens":792,"cache_creation":{"ephemeral_5m_input_tokens":792,"ephemeral_1h_input_tokens":0},"type":"message"}],"speed":"standard"},"diagnostics":null},"requestId":"req_011CbcNweVp91jtvT9hRH6Hf","attributionAgent":"general-purpose","type":"assistant","uuid":"6ab28fbf-247a-4ea4-a6b4-b374c9c60cc3","timestamp":"2026-06-01T10:26:11.612Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"6ab28fbf-247a-4ea4-a6b4-b374c9c60cc3","isSidechain":true,"promptId":"9a1ead73-0732-4ff4-98f5-092b90489b3e","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01P7YWG9E6pqNBTHFptwXntr","type":"tool_result","content":"Création du Google Doc : 'EN | PP405: the molecule that might wake up your dormant follicles (what the science actually says in 2026)' ...\n  -> créé : 1YLxgXnXeOmW12BmcNxHUq4VXzB5vkLpWb4dAz0adILI\n  -> partagé (writer) avec assous.tom@gmail.com\nURL=https://docs.google.com/document/d/1YLxgXnXeOmW12BmcNxHUq4VXzB5vkLpWb4dAz0adILI/edit?usp=drivesdk","is_error":false}]},"uuid":"f33063ef-9635-4e82-902d-57b39fd6ce46","timestamp":"2026-06-01T10:26:16.044Z","sourceToolAssistantUUID":"6ab28fbf-247a-4ea4-a6b4-b374c9c60cc3","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"f33063ef-9635-4e82-902d-57b39fd6ce46","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_018LnjXzHED4Zbbym2uMvC3P","type":"message","role":"assistant","content":[{"type":"tool_use","id":"toolu_01F7p2YZ5gm4W7Zo7Vyj68Ud","name":"Bash","input":{"command":"VPY=/home/dev/.claude/skills/cinik-blog-brief/.venv/bin/python\n\"$VPY\" ~/.claude/skills/cinik-blog-brief/scripts/gdoc_publish.py \\\n  --md /opt/automator/cinik-writer-transtor/files/translations/pp405-it.md \\\n  --title \"IT | PP405: la molecola che potrebbe risvegliare i tuoi follicoli dormienti (cosa dice davvero la scienza nel 2026)\" 2>&1 | tail -20"},"caller":{"type":"direct"}}],"stop_reason":"tool_use","stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":494,"cache_read_input_tokens":93769,"output_tokens":228,"server_tool_use":{"web_search_requests":0,"web_fetch_requests":0},"service_tier":"standard","cache_creation":{"ephemeral_1h_input_tokens":0,"ephemeral_5m_input_tokens":494},"inference_geo":"not_available","iterations":[{"input_tokens":2,"output_tokens":228,"cache_read_input_tokens":93769,"cache_creation_input_tokens":494,"cache_creation":{"ephemeral_5m_input_tokens":494,"ephemeral_1h_input_tokens":0},"type":"message"}],"speed":"standard"},"diagnostics":null},"requestId":"req_011CbcNxK2ZesYvs6SCkjnX1","attributionAgent":"general-purpose","type":"assistant","uuid":"00f4aeea-f66e-491f-8228-d1d7faa77325","timestamp":"2026-06-01T10:26:19.467Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"00f4aeea-f66e-491f-8228-d1d7faa77325","isSidechain":true,"promptId":"9a1ead73-0732-4ff4-98f5-092b90489b3e","agentId":"a2a840c5cfdbcf739","type":"user","message":{"role":"user","content":[{"tool_use_id":"toolu_01F7p2YZ5gm4W7Zo7Vyj68Ud","type":"tool_result","content":"Création du Google Doc : 'IT | PP405: la molecola che potrebbe risvegliare i tuoi follicoli dormienti (cosa dice davvero la scienza nel 2026)' ...\n  -> créé : 1Cmy88R0YPlIQrk5b-9ikRsvZnEf1RzFmBqMlnx9E5no\n  -> partagé (writer) avec assous.tom@gmail.com\nURL=https://docs.google.com/document/d/1Cmy88R0YPlIQrk5b-9ikRsvZnEf1RzFmBqMlnx9E5no/edit?usp=drivesdk","is_error":false}]},"uuid":"182bfe9e-159b-4b1d-95da-19f146da54b6","timestamp":"2026-06-01T10:26:23.908Z","sourceToolAssistantUUID":"00f4aeea-f66e-491f-8228-d1d7faa77325","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}
{"parentUuid":"182bfe9e-159b-4b1d-95da-19f146da54b6","isSidechain":true,"agentId":"a2a840c5cfdbcf739","message":{"model":"claude-opus-4-8","id":"msg_01KYLbdSQruHpkoxPEMMruEg","type":"message","role":"assistant","content":[{"type":"text","text":"Both Google Docs created and shared (writer) with assous.tom@gmail.com.\n\nEN_URL=https://docs.google.com/document/d/1YLxgXnXeOmW12BmcNxHUq4VXzB5vkLpWb4dAz0adILI/edit?usp=drivesdk\nIT_URL=https://docs.google.com/document/d/1Cmy88R0YPlIQrk5b-9ikRsvZnEf1RzFmBqMlnx9E5no/edit?usp=drivesdk\nEN_TITLE=PP405: the molecule that wakes up hair | Dr Cinik (49 chars)\nIT_TITLE=PP405: la molecola che risveglia i capelli | Dr Cinik (53 chars)\n\nConfirmations:\n- Zero em/en dash: 0 in both files (grep -P verified).\n- No link table at end of either article.\n- SEO blocks translated: EN meta 118c / IT meta 143c (both ≤155), both titles ≤60c ending \" | Dr Cinik\". Slugs translated (en: /pp405-molecule-that-wakes-follicles, it: /pp405-molecola-che-risveglia-follicoli).\n- Bold, lists, comparison tables, and all exact figures (31%, 20%, 0%, 78, 0.05%, 4 weeks, Ki67, 120M$, 2027-2029) preserved. Proper nouns/units untranslated.\n- Scientific references kept verbatim in original language with URLs intact.\n\nHreflang internal linking (via hreflang_lookup.py, applied per the keep-anchor / replace-url rule):\n- EN: 18 links remapped to no-prefix EN URLs (e.g. /finasteride/, /hair-transplant/sapphire-fue/). Home link kept with anchor \"hair transplant in Turkey\" -> https://emrahcinik.com/. Exosomes had NO EN equivalent, so both mentions kept the anchor text with the markdown link removed (no broken link).\n- IT: all 20 links remapped to /it/ URLs (e.g. /it/calvizie-ereditaria/, /it/trapianto-di-capelli/zaffiro/). Home link kept with anchor \"trapianto di capelli in Turchia\" -> https://emrahcinik.com/it/. All target pages existed, including exosomes (/it/esosomi-capelli/).\n\nSource files: /opt/automator/cinik-writer-transtor/files/translations/pp405-en.md and pp405-it.md.\n\nNote: per skill workflow, this is the deliverable for your review before any publication elsewhere."}],"stop_reason":null,"stop_sequence":null,"stop_details":null,"usage":{"input_tokens":2,"cache_creation_input_tokens":448,"cache_read_input_tokens":94263,"cache_creation":{"ephemeral_5m_input_tokens":448,"ephemeral_1h_input_tokens":0},"output_tokens":3,"service_tier":"standard","inference_geo":"not_available"},"diagnostics":null},"requestId":"req_011CbcNxtf8WNYtziB3uGwXa","attributionAgent":"general-purpose","type":"assistant","uuid":"b63691f1-b6b4-4d7a-9ef1-e86408f786ee","timestamp":"2026-06-01T10:26:35.237Z","userType":"external","entrypoint":"cli","cwd":"/opt/automator/cinik-writer-transtor/files/articles","sessionId":"e5b0d32c-b7e6-4f5d-830a-2c1bb8398957","version":"2.1.158","gitBranch":"HEAD"}